Introduction  ||| S:24 E:45 ||| NN
The  ||| S:45 E:49 ||| DT
knowledge  ||| S:49 E:59 ||| NN
of  ||| S:59 E:62 ||| IN
a  ||| S:62 E:64 ||| DT
complete  ||| S:64 E:73 ||| JJ
genome  ||| S:73 E:80 ||| JJ
sequence  ||| S:80 E:89 ||| NN
holds  ||| S:89 E:95 ||| VBZ
the  ||| S:95 E:107 ||| DT
potential  ||| S:107 E:117 ||| JJ
to  ||| S:117 E:120 ||| TO
reveal  ||| S:120 E:127 ||| VB
the  ||| S:127 E:131 ||| DT
' ||| S:131 E:132 ||| POS
blueprints ||| S:132 E:142 ||| NN
'  ||| S:142 E:144 ||| ''
for  ||| S:144 E:148 ||| IN
cellular  ||| S:148 E:157 ||| JJ
life ||| S:157 E:161 ||| NN
.  ||| S:161 E:163 ||| .
The  ||| S:163 E:175 ||| DT
genome  ||| S:175 E:182 ||| JJ
sequence  ||| S:182 E:191 ||| NN
contains  ||| S:191 E:200 ||| VBZ
the  ||| S:200 E:204 ||| DT
information  ||| S:204 E:216 ||| NN
to  ||| S:216 E:219 ||| TO
propagate  ||| S:219 E:229 ||| VB
the  ||| S:229 E:241 ||| DT
living  ||| S:241 E:248 ||| NN
system ||| S:248 E:254 ||| NN
,  ||| S:254 E:256 ||| ,
and  ||| S:256 E:260 ||| CC
this  ||| S:260 E:265 ||| DT
information  ||| S:265 E:277 ||| NN
exists  ||| S:277 E:284 ||| VBZ
as  ||| S:284 E:287 ||| RB
open  ||| S:287 E:292 ||| JJ
reading  ||| S:292 E:308 ||| NN
frames  ||| S:308 E:315 ||| NNS
( ||| S:315 E:316 ||| -LRB-
ORFs ||| S:316 E:320 ||| NNP
)  ||| S:320 E:322 ||| -RRB-
and  ||| S:322 E:326 ||| CC
regulatory  ||| S:326 E:337 ||| JJ
information ||| S:337 E:348 ||| NN
.  ||| S:348 E:350 ||| .
Computational  ||| S:350 E:372 ||| JJ
approaches  ||| S:372 E:383 ||| NNS
have  ||| S:383 E:388 ||| VBP
been  ||| S:388 E:393 ||| VBN
developed  ||| S:393 E:403 ||| VBN
( ||| S:403 E:404 ||| -LRB-
and  ||| S:404 E:408 ||| CC
are  ||| S:408 E:412 ||| VBP
continuously  ||| S:412 E:425 ||| RB
being  ||| S:425 E:439 ||| VBG
improved ||| S:439 E:447 ||| VBN
)  ||| S:447 E:449 ||| -RRB-
to  ||| S:449 E:452 ||| TO
decipher  ||| S:452 E:461 ||| VB
the  ||| S:461 E:465 ||| DT
information  ||| S:465 E:477 ||| NN
encoded  ||| S:477 E:485 ||| NN
in  ||| S:485 E:488 ||| IN
the  ||| S:488 E:492 ||| DT
DNA  ||| S:492 E:496 ||| NNP
[  ||| S:496 E:506 ||| -LRB-
1 ||| S:506 E:507 ||| CD
,  ||| S:507 E:509 ||| ,
2 ||| S:509 E:510 ||| CD
,  ||| S:510 E:512 ||| ,
3 ||| S:512 E:513 ||| CD
,  ||| S:513 E:515 ||| ,
4 ||| S:515 E:516 ||| CD
,  ||| S:516 E:518 ||| ,
5 ||| S:518 E:519 ||| CD
,  ||| S:519 E:521 ||| ,
6 ||| S:521 E:522 ||| CD
,  ||| S:522 E:524 ||| ,
7 ||| S:524 E:525 ||| CD
] ||| S:525 E:526 ||| -RRB-
.  ||| S:526 E:528 ||| .
However ||| S:528 E:535 ||| RB
,  ||| S:535 E:537 ||| ,
it  ||| S:537 E:540 ||| PRP
is  ||| S:540 E:543 ||| VBZ
becoming  ||| S:543 E:552 ||| VBG
evident  ||| S:552 E:560 ||| JJ
that  ||| S:560 E:573 ||| IN
cellular  ||| S:573 E:582 ||| JJ
functions  ||| S:582 E:592 ||| NNS
are  ||| S:592 E:596 ||| VBP
intricate  ||| S:596 E:606 ||| JJ
and  ||| S:606 E:610 ||| CC
the  ||| S:610 E:614 ||| DT
integrated  ||| S:614 E:633 ||| JJ
function  ||| S:633 E:642 ||| NN
of  ||| S:642 E:645 ||| IN
biological  ||| S:645 E:656 ||| JJ
systems  ||| S:656 E:664 ||| NNS
involves  ||| S:664 E:673 ||| VBZ
many  ||| S:673 E:678 ||| JJ
complex  ||| S:678 E:694 ||| JJ
interactions  ||| S:694 E:707 ||| NNS
among  ||| S:707 E:713 ||| IN
the  ||| S:713 E:717 ||| DT
molecular  ||| S:717 E:727 ||| JJ
components  ||| S:727 E:738 ||| NNS
within  ||| S:738 E:745 ||| IN
the  ||| S:745 E:757 ||| DT
cell ||| S:757 E:761 ||| NN
.  ||| S:761 E:763 ||| .
To  ||| S:763 E:766 ||| TO
understand  ||| S:766 E:777 ||| VB
the  ||| S:777 E:781 ||| DT
complexity  ||| S:781 E:792 ||| NN
inherent  ||| S:792 E:801 ||| NN
in  ||| S:801 E:804 ||| IN
cellular  ||| S:804 E:821 ||| JJ
networks ||| S:821 E:829 ||| NNS
,  ||| S:829 E:831 ||| ,
approaches  ||| S:831 E:842 ||| VBZ
that  ||| S:842 E:847 ||| DT
focus  ||| S:847 E:853 ||| NN
on  ||| S:853 E:856 ||| IN
the  ||| S:856 E:860 ||| DT
systemic  ||| S:860 E:869 ||| JJ
properties  ||| S:869 E:888 ||| NNS
of  ||| S:888 E:891 ||| IN
the  ||| S:891 E:895 ||| DT
network  ||| S:895 E:903 ||| NN
are  ||| S:903 E:907 ||| VBP
also  ||| S:907 E:912 ||| RB
required ||| S:912 E:920 ||| VBN
.  ||| S:920 E:930 ||| .
The  ||| S:930 E:934 ||| DT
complexity  ||| S:934 E:945 ||| NN
of  ||| S:945 E:948 ||| IN
integrated  ||| S:948 E:959 ||| JJ
cellular  ||| S:959 E:968 ||| JJ
systems  ||| S:968 E:976 ||| NNS
leads  ||| S:976 E:982 ||| VBZ
to  ||| S:982 E:993 ||| TO
an  ||| S:993 E:996 ||| DT
important  ||| S:996 E:1006 ||| JJ
point ||| S:1006 E:1011 ||| NN
,  ||| S:1011 E:1013 ||| ,
namely  ||| S:1013 E:1020 ||| RB
that  ||| S:1020 E:1025 ||| IN
the  ||| S:1025 E:1029 ||| DT
properties  ||| S:1029 E:1040 ||| NNS
of  ||| S:1040 E:1043 ||| IN
complex  ||| S:1043 E:1059 ||| JJ
biological  ||| S:1059 E:1070 ||| NN
processes  ||| S:1070 E:1080 ||| VBZ
cannot  ||| S:1080 E:1087 ||| RB
be  ||| S:1087 E:1090 ||| VB
analyzed  ||| S:1090 E:1099 ||| VBN
or  ||| S:1099 E:1102 ||| CC
predicted  ||| S:1102 E:1112 ||| VBD
based  ||| S:1112 E:1126 ||| VBN
solely  ||| S:1126 E:1133 ||| RB
on  ||| S:1133 E:1136 ||| IN
a  ||| S:1136 E:1138 ||| DT
description  ||| S:1138 E:1150 ||| NN
of  ||| S:1150 E:1153 ||| IN
the  ||| S:1153 E:1157 ||| DT
individual  ||| S:1157 E:1168 ||| JJ
components ||| S:1168 E:1178 ||| NNS
,  ||| S:1178 E:1180 ||| ,
and  ||| S:1180 E:1192 ||| CC
integrated  ||| S:1192 E:1203 ||| JJ
systems  ||| S:1203 E:1211 ||| NNS
based  ||| S:1211 E:1217 ||| VBN
approaches  ||| S:1217 E:1228 ||| NNS
must  ||| S:1228 E:1233 ||| MD
be  ||| S:1233 E:1236 ||| VB
applied  ||| S:1236 E:1244 ||| VBN
[  ||| S:1244 E:1246 ||| -LRB-
8 ||| S:1246 E:1247 ||| CD
] ||| S:1247 E:1248 ||| -RRB-
.  ||| S:1248 E:1258 ||| .
The  ||| S:1258 E:1262 ||| DT
focus  ||| S:1262 E:1268 ||| NN
of  ||| S:1268 E:1271 ||| IN
such  ||| S:1271 E:1276 ||| JJ
research  ||| S:1276 E:1285 ||| NN
represents  ||| S:1285 E:1296 ||| VBZ
a  ||| S:1296 E:1298 ||| DT
departure  ||| S:1298 E:1308 ||| NN
from  ||| S:1308 E:1313 ||| IN
the  ||| S:1313 E:1325 ||| DT
classical  ||| S:1325 E:1344 ||| JJ
reductionist  ||| S:1344 E:1357 ||| JJ
approach  ||| S:1357 E:1366 ||| NN
in  ||| S:1366 E:1369 ||| IN
the  ||| S:1369 E:1381 ||| DT
biological  ||| S:1381 E:1392 ||| JJ
sciences ||| S:1392 E:1400 ||| NNS
,  ||| S:1400 E:1402 ||| ,
and  ||| S:1402 E:1406 ||| CC
moves  ||| S:1406 E:1412 ||| NNS
toward  ||| S:1412 E:1419 ||| IN
the  ||| S:1419 E:1432 ||| DT
integrated  ||| S:1432 E:1443 ||| JJ
approach  ||| S:1443 E:1452 ||| NN
to  ||| S:1452 E:1455 ||| TO
understanding  ||| S:1455 E:1477 ||| VB
the  ||| S:1477 E:1481 ||| DT
interrelatedness  ||| S:1481 E:1498 ||| NN
of  ||| S:1498 E:1501 ||| IN
gene  ||| S:1501 E:1506 ||| NN
function  ||| S:1506 E:1515 ||| NN
and  ||| S:1515 E:1519 ||| CC
the  ||| S:1519 E:1523 ||| DT
role  ||| S:1523 E:1528 ||| NN
of  ||| S:1528 E:1531 ||| IN
each  ||| S:1531 E:1544 ||| DT
gene  ||| S:1544 E:1549 ||| NN
in  ||| S:1549 E:1552 ||| IN
the  ||| S:1552 E:1556 ||| DT
context  ||| S:1556 E:1564 ||| NN
of  ||| S:1564 E:1567 ||| IN
multi  ||| S:1567 E:1573 ||| JJ
genetic  ||| S:1573 E:1581 ||| JJ
cellular  ||| S:1581 E:1590 ||| JJ
functions  ||| S:1590 E:1600 ||| NNS
or  ||| S:1600 E:1612 ||| CC
genetic  ||| S:1612 E:1620 ||| JJ
circuits  ||| S:1620 E:1629 ||| NNS
[  ||| S:1629 E:1631 ||| -LRB-
8 ||| S:1631 E:1632 ||| CD
,  ||| S:1632 E:1634 ||| ,
9 ||| S:1634 E:1635 ||| CD
,  ||| S:1635 E:1637 ||| ,
10 ||| S:1637 E:1639 ||| CD
] ||| S:1639 E:1640 ||| -RRB-
.  ||| S:1640 E:1650 ||| .
The  ||| S:1650 E:1654 ||| DT
engineering  ||| S:1654 E:1666 ||| NN
approach  ||| S:1666 E:1675 ||| NN
to  ||| S:1675 E:1678 ||| TO
analysis  ||| S:1678 E:1687 ||| NN
and  ||| S:1687 E:1691 ||| CC
design  ||| S:1691 E:1698 ||| NN
of  ||| S:1698 E:1709 ||| IN
complex  ||| S:1709 E:1717 ||| JJ
systems  ||| S:1717 E:1725 ||| NNS
is  ||| S:1725 E:1728 ||| VBZ
to  ||| S:1728 E:1731 ||| TO
have  ||| S:1731 E:1736 ||| VB
a  ||| S:1736 E:1738 ||| DT
mathematical  ||| S:1738 E:1751 ||| JJ
or  ||| S:1751 E:1754 ||| CC
computer  ||| S:1754 E:1771 ||| NN
model ||| S:1771 E:1776 ||| NN
;  ||| S:1776 E:1778 ||| :
e.g.  ||| S:1778 E:1783 ||| CD
a  ||| S:1783 E:1785 ||| DT
dynamic  ||| S:1785 E:1793 ||| JJ
simulator  ||| S:1793 E:1803 ||| NN
of  ||| S:1803 E:1806 ||| IN
a  ||| S:1806 E:1808 ||| DT
cellular  ||| S:1808 E:1817 ||| JJ
process  ||| S:1817 E:1825 ||| NN
that  ||| S:1825 E:1838 ||| WDT
is  ||| S:1838 E:1841 ||| VBZ
based  ||| S:1841 E:1847 ||| VBN
on  ||| S:1847 E:1850 ||| IN
fundamental  ||| S:1850 E:1862 ||| JJ
physicochemical  ||| S:1862 E:1878 ||| JJ
laws  ||| S:1878 E:1883 ||| NNS
and  ||| S:1883 E:1895 ||| CC
principles ||| S:1895 E:1905 ||| NNS
.  ||| S:1905 E:1907 ||| .
Herein ||| S:1907 E:1913 ||| NNP
,  ||| S:1913 E:1915 ||| ,
we  ||| S:1915 E:1918 ||| PRP
will  ||| S:1918 E:1923 ||| MD
analyze  ||| S:1923 E:1931 ||| VB
the  ||| S:1931 E:1935 ||| DT
integrated  ||| S:1935 E:1946 ||| JJ
function  ||| S:1946 E:1963 ||| NN
of  ||| S:1963 E:1966 ||| IN
the  ||| S:1966 E:1970 ||| DT
metabolic  ||| S:1970 E:1980 ||| JJ
pathways ||| S:1980 E:1988 ||| NN
,  ||| S:1988 E:1990 ||| ,
and  ||| S:1990 E:1994 ||| CC
there  ||| S:1994 E:2000 ||| EX
has  ||| S:2000 E:2004 ||| VBZ
been  ||| S:2004 E:2009 ||| VBN
a  ||| S:2009 E:2011 ||| DT
long  ||| S:2011 E:2024 ||| JJ
history  ||| S:2024 E:2032 ||| NN
of  ||| S:2032 E:2035 ||| IN
mathematical  ||| S:2035 E:2048 ||| JJ
modeling  ||| S:2048 E:2057 ||| NN
of  ||| S:2057 E:2060 ||| IN
metabolic  ||| S:2060 E:2070 ||| JJ
networks  ||| S:2070 E:2079 ||| NNS
in  ||| S:2079 E:2090 ||| IN
cellular  ||| S:2090 E:2099 ||| JJ
systems ||| S:2099 E:2106 ||| NNS
,  ||| S:2106 E:2108 ||| ,
which  ||| S:2108 E:2114 ||| WDT
dates  ||| S:2114 E:2120 ||| VBZ
back  ||| S:2120 E:2125 ||| RB
to  ||| S:2125 E:2128 ||| TO
the  ||| S:2128 E:2132 ||| DT
1960s  ||| S:2132 E:2138 ||| NNS
[  ||| S:2138 E:2140 ||| -LRB-
11 ||| S:2140 E:2142 ||| CD
,  ||| S:2142 E:2144 ||| ,
12 ||| S:2144 E:2146 ||| CD
] ||| S:2146 E:2147 ||| -RRB-
.  ||| S:2147 E:2157 ||| .
While  ||| S:2157 E:2163 ||| IN
the  ||| S:2163 E:2167 ||| DT
ultimate  ||| S:2167 E:2176 ||| JJ
goal  ||| S:2176 E:2181 ||| NN
is  ||| S:2181 E:2184 ||| VBZ
the  ||| S:2184 E:2188 ||| DT
development  ||| S:2188 E:2200 ||| NN
of  ||| S:2200 E:2203 ||| IN
dynamic  ||| S:2203 E:2219 ||| JJ
models  ||| S:2219 E:2226 ||| NNS
for  ||| S:2226 E:2230 ||| IN
the  ||| S:2230 E:2234 ||| DT
complete  ||| S:2234 E:2243 ||| JJ
simulation  ||| S:2243 E:2254 ||| NN
of  ||| S:2254 E:2257 ||| IN
cellular  ||| S:2257 E:2266 ||| JJ
metabolism ||| S:2266 E:2276 ||| NN
,  ||| S:2276 E:2286 ||| ,
the  ||| S:2286 E:2290 ||| DT
success  ||| S:2290 E:2298 ||| NN
of  ||| S:2298 E:2301 ||| IN
such  ||| S:2301 E:2306 ||| JJ
approaches  ||| S:2306 E:2317 ||| NNS
has  ||| S:2317 E:2321 ||| VBZ
been  ||| S:2321 E:2326 ||| VBN
severely  ||| S:2326 E:2335 ||| RB
hampered  ||| S:2335 E:2352 ||| VBN
by  ||| S:2352 E:2355 ||| IN
the  ||| S:2355 E:2359 ||| DT
lack  ||| S:2359 E:2364 ||| NN
of  ||| S:2364 E:2367 ||| IN
kinetic  ||| S:2367 E:2375 ||| JJ
information  ||| S:2375 E:2387 ||| NN
on  ||| S:2387 E:2390 ||| IN
the  ||| S:2390 E:2394 ||| DT
dynamics  ||| S:2394 E:2403 ||| NNS
and  ||| S:2403 E:2415 ||| CC
regulation  ||| S:2415 E:2426 ||| NN
of  ||| S:2426 E:2429 ||| IN
metabolism ||| S:2429 E:2439 ||| NN
.  ||| S:2439 E:2441 ||| .
However ||| S:2441 E:2448 ||| RB
,  ||| S:2448 E:2450 ||| ,
in  ||| S:2450 E:2453 ||| IN
the  ||| S:2453 E:2457 ||| DT
absence  ||| S:2457 E:2465 ||| NN
of  ||| S:2465 E:2476 ||| IN
kinetic  ||| S:2476 E:2484 ||| JJ
information  ||| S:2484 E:2496 ||| NN
it  ||| S:2496 E:2499 ||| PRP
is  ||| S:2499 E:2502 ||| VBZ
still  ||| S:2502 E:2508 ||| RB
possible  ||| S:2508 E:2517 ||| JJ
to  ||| S:2517 E:2520 ||| TO
assess  ||| S:2520 E:2527 ||| VB
the  ||| S:2527 E:2539 ||| DT
theoretical  ||| S:2539 E:2551 ||| JJ
capabilities  ||| S:2551 E:2564 ||| NNS
and  ||| S:2564 E:2568 ||| CC
operative  ||| S:2568 E:2578 ||| JJ
modes  ||| S:2578 E:2584 ||| NNS
of  ||| S:2584 E:2587 ||| IN
metabolism  ||| S:2587 E:2606 ||| NNS
using  ||| S:2606 E:2612 ||| VBG
flux  ||| S:2612 E:2617 ||| JJ
balance  ||| S:2617 E:2625 ||| NN
analysis  ||| S:2625 E:2634 ||| NN
( ||| S:2634 E:2635 ||| -LRB-
FBA ||| S:2635 E:2638 ||| NNP
)  ||| S:2638 E:2640 ||| -RRB-
[  ||| S:2640 E:2642 ||| -LRB-
10 ||| S:2642 E:2644 ||| CD
,  ||| S:2644 E:2646 ||| ,
13 ||| S:2646 E:2648 ||| CD
,  ||| S:2648 E:2650 ||| ,
14 ||| S:2650 E:2652 ||| CD
,  ||| S:2652 E:2654 ||| ,
15 ||| S:2654 E:2656 ||| CD
,  ||| S:2656 E:2658 ||| ,
16 ||| S:2658 E:2660 ||| CD
,  ||| S:2660 E:2670 ||| ,
17 ||| S:2670 E:2672 ||| CD
] ||| S:2672 E:2673 ||| -RRB-
.  ||| S:2673 E:2683 ||| .
We  ||| S:2683 E:2686 ||| PRP
have  ||| S:2686 E:2691 ||| VBP
developed  ||| S:2691 E:2701 ||| VBN
an  ||| S:2701 E:2713 ||| DT
in  ||| S:2713 E:2716 ||| IN
silico  ||| S:2716 E:2723 ||| JJ
representation  ||| S:2723 E:2738 ||| NN
of  ||| S:2738 E:2750 ||| IN
Escherichia  ||| S:2750 E:2762 ||| NNP
coli  ||| S:2762 E:2767 ||| NNS
( ||| S:2767 E:2768 ||| -LRB-
E.  ||| S:2768 E:2771 ||| NNP
coli  ||| S:2771 E:2776 ||| NNS
in  ||| S:2776 E:2787 ||| IN
silico ||| S:2787 E:2793 ||| CD
)  ||| S:2793 E:2795 ||| -RRB-
to  ||| S:2795 E:2798 ||| TO
describe  ||| S:2798 E:2807 ||| VB
the  ||| S:2807 E:2811 ||| DT
bacterium ||| S:2811 E:2820 ||| NN
's  ||| S:2820 E:2823 ||| POS
metabolic  ||| S:2823 E:2841 ||| JJ
capabilities  ||| S:2841 E:2854 ||| NNS
[  ||| S:2854 E:2856 ||| -LRB-
18 ||| S:2856 E:2858 ||| CD
] ||| S:2858 E:2859 ||| -RRB-
.  ||| S:2859 E:2870 ||| .
E.  ||| S:2870 E:2873 ||| NNP
coli  ||| S:2873 E:2878 ||| NNS
in  ||| S:2878 E:2881 ||| IN
silico  ||| S:2881 E:2888 ||| NN
was  ||| S:2888 E:2892 ||| VBD
derived  ||| S:2892 E:2900 ||| VBN
based  ||| S:2900 E:2914 ||| VBN
on  ||| S:2914 E:2917 ||| IN
the  ||| S:2917 E:2921 ||| DT
annotated  ||| S:2921 E:2931 ||| JJ
genetic  ||| S:2931 E:2939 ||| JJ
sequence  ||| S:2939 E:2948 ||| NN
[  ||| S:2948 E:2950 ||| -LRB-
19 ||| S:2950 E:2952 ||| CD
] ||| S:2952 E:2953 ||| -RRB-
,  ||| S:2953 E:2955 ||| ,
biochemical  ||| S:2955 E:2975 ||| JJ
literature  ||| S:2975 E:2986 ||| NN
[  ||| S:2986 E:2988 ||| -LRB-
20 ||| S:2988 E:2990 ||| CD
] ||| S:2990 E:2991 ||| -RRB-
,  ||| S:2991 E:2993 ||| ,
and  ||| S:2993 E:2997 ||| CC
the  ||| S:2997 E:3001 ||| DT
online  ||| S:3001 E:3008 ||| FW
bioinformatic  ||| S:3008 E:3022 ||| FW
databases  ||| S:3022 E:3032 ||| FW
[  ||| S:3032 E:3042 ||| -LRB-
21 ||| S:3042 E:3044 ||| CD
,  ||| S:3044 E:3046 ||| ,
22 ||| S:3046 E:3048 ||| CD
,  ||| S:3048 E:3050 ||| ,
23 ||| S:3050 E:3052 ||| CD
] ||| S:3052 E:3053 ||| -RRB-
.  ||| S:3053 E:3055 ||| .
The  ||| S:3055 E:3059 ||| DT
properties  ||| S:3059 E:3070 ||| NNS
of  ||| S:3070 E:3082 ||| IN
E.  ||| S:3082 E:3085 ||| NNP
coli  ||| S:3085 E:3090 ||| NNS
in  ||| S:3090 E:3093 ||| IN
silico  ||| S:3093 E:3100 ||| NN
were  ||| S:3100 E:3105 ||| VBD
analyzed  ||| S:3105 E:3114 ||| VBN
and  ||| S:3114 E:3126 ||| CC
compared  ||| S:3126 E:3135 ||| VBN
to  ||| S:3135 E:3138 ||| TO
the  ||| S:3138 E:3151 ||| DT
in  ||| S:3151 E:3154 ||| IN
vivo  ||| S:3154 E:3159 ||| JJ
properties  ||| S:3159 E:3170 ||| NNS
of  ||| S:3170 E:3182 ||| IN
E.  ||| S:3182 E:3185 ||| NNP
coli ||| S:3185 E:3189 ||| NNS
,  ||| S:3189 E:3191 ||| ,
and  ||| S:3191 E:3195 ||| CC
it  ||| S:3195 E:3198 ||| PRP
was  ||| S:3198 E:3202 ||| VBD
shown  ||| S:3202 E:3208 ||| VBN
that  ||| S:3208 E:3222 ||| IN
E.  ||| S:3222 E:3225 ||| NNP
coli  ||| S:3225 E:3230 ||| NNS
in  ||| S:3230 E:3233 ||| IN
silico  ||| S:3233 E:3240 ||| NNS
can  ||| S:3240 E:3244 ||| MD
be  ||| S:3244 E:3247 ||| VB
used  ||| S:3247 E:3252 ||| VBN
to  ||| S:3252 E:3263 ||| TO
interpret  ||| S:3263 E:3273 ||| VB
the  ||| S:3273 E:3277 ||| DT
metabolic  ||| S:3277 E:3287 ||| JJ
phenotype  ||| S:3287 E:3297 ||| NN
of  ||| S:3297 E:3300 ||| IN
many  ||| S:3300 E:3314 ||| JJ
E.  ||| S:3314 E:3317 ||| NNP
coli  ||| S:3317 E:3322 ||| FW
mutants  ||| S:3322 E:3330 ||| FW
[  ||| S:3330 E:3332 ||| -LRB-
18 ||| S:3332 E:3334 ||| CD
] ||| S:3334 E:3335 ||| -RRB-
.  ||| S:3335 E:3337 ||| .
However ||| S:3337 E:3344 ||| RB
,  ||| S:3344 E:3346 ||| ,
the  ||| S:3346 E:3358 ||| DT
utilization  ||| S:3358 E:3370 ||| NN
of  ||| S:3370 E:3373 ||| IN
the  ||| S:3373 E:3377 ||| DT
metabolic  ||| S:3377 E:3387 ||| JJ
genes  ||| S:3387 E:3393 ||| NNS
is  ||| S:3393 E:3396 ||| VBZ
dependent  ||| S:3396 E:3406 ||| JJ
on  ||| S:3406 E:3409 ||| IN
the  ||| S:3409 E:3421 ||| DT
carbon  ||| S:3421 E:3428 ||| NN
source  ||| S:3428 E:3435 ||| NN
and  ||| S:3435 E:3439 ||| CC
the  ||| S:3439 E:3443 ||| DT
substrate  ||| S:3443 E:3453 ||| JJ
availability  ||| S:3453 E:3466 ||| NN
[  ||| S:3466 E:3468 ||| -LRB-
24 ||| S:3468 E:3470 ||| CD
,  ||| S:3470 E:3472 ||| ,
25 ||| S:3472 E:3474 ||| CD
] ||| S:3474 E:3475 ||| -RRB-
.  ||| S:3475 E:3485 ||| .
Thus ||| S:3485 E:3489 ||| RB
,  ||| S:3489 E:3491 ||| ,
the  ||| S:3491 E:3495 ||| DT
mutant  ||| S:3495 E:3502 ||| JJ
phenotype  ||| S:3502 E:3512 ||| NN
is  ||| S:3512 E:3515 ||| VBZ
also  ||| S:3515 E:3520 ||| RB
dependent  ||| S:3520 E:3530 ||| JJ
on  ||| S:3530 E:3533 ||| IN
specific  ||| S:3533 E:3550 ||| JJ
environmental  ||| S:3550 E:3564 ||| JJ
parameters ||| S:3564 E:3574 ||| NNS
.  ||| S:3574 E:3576 ||| .
Therefore ||| S:3576 E:3585 ||| RB
,  ||| S:3585 E:3587 ||| ,
herein  ||| S:3587 E:3594 ||| VBD
we  ||| S:3594 E:3597 ||| PRP
have  ||| S:3597 E:3610 ||| VBP
utilized  ||| S:3610 E:3628 ||| JJ
E.  ||| S:3628 E:3631 ||| NNP
coli  ||| S:3631 E:3636 ||| NNS
in  ||| S:3636 E:3639 ||| IN
silico  ||| S:3639 E:3646 ||| VBG
to  ||| S:3646 E:3649 ||| TO
computationally  ||| S:3649 E:3673 ||| VB
examine  ||| S:3673 E:3681 ||| VB
the  ||| S:3681 E:3685 ||| DT
condition  ||| S:3685 E:3695 ||| NN
dependent  ||| S:3695 E:3705 ||| FW
optimal  ||| S:3705 E:3713 ||| FW
metabolic  ||| S:3713 E:3723 ||| FW
pathway  ||| S:3723 E:3739 ||| FW
utilization ||| S:3739 E:3750 ||| FW
,  ||| S:3750 E:3752 ||| ,
and  ||| S:3752 E:3756 ||| CC
we  ||| S:3756 E:3759 ||| PRP
will  ||| S:3759 E:3764 ||| MD
show  ||| S:3764 E:3769 ||| VB
that  ||| S:3769 E:3774 ||| IN
the  ||| S:3774 E:3778 ||| DT
FBA  ||| S:3778 E:3782 ||| NNP
can  ||| S:3782 E:3786 ||| MD
be  ||| S:3786 E:3789 ||| VB
used  ||| S:3789 E:3794 ||| VBN
to  ||| S:3794 E:3805 ||| TO
analyze  ||| S:3805 E:3813 ||| VB
and  ||| S:3813 E:3817 ||| CC
interpret  ||| S:3817 E:3827 ||| VB
the  ||| S:3827 E:3831 ||| DT
metabolic  ||| S:3831 E:3841 ||| JJ
behavior  ||| S:3841 E:3850 ||| NN
of  ||| S:3850 E:3853 ||| IN
wildtype  ||| S:3853 E:3870 ||| NN
and  ||| S:3870 E:3874 ||| CC
mutant  ||| S:3874 E:3890 ||| JJ
E.  ||| S:3890 E:3893 ||| NNP
coli  ||| S:3893 E:3898 ||| NN
strains ||| S:3898 E:3905 ||| NNS
.  ||| S:3905 E:3929 ||| .
Materials  ||| S:3929 E:3939 ||| NNS
and  ||| S:3939 E:3943 ||| CC
Methods  ||| S:3943 E:3970 ||| NNP
Flux  ||| S:3970 E:3975 ||| NNP
balance  ||| S:3975 E:3983 ||| NN
analysis  ||| S:3983 E:4002 ||| NN
All  ||| S:4002 E:4006 ||| DT
biological  ||| S:4006 E:4017 ||| JJ
processes  ||| S:4017 E:4027 ||| NNS
are  ||| S:4027 E:4031 ||| VBP
subjected  ||| S:4031 E:4041 ||| VBN
to  ||| S:4041 E:4044 ||| TO
physico  ||| S:4044 E:4062 ||| VB
chemical  ||| S:4062 E:4071 ||| JJ
constraints  ||| S:4071 E:4083 ||| NNS
( ||| S:4083 E:4084 ||| -LRB-
such  ||| S:4084 E:4089 ||| JJ
as  ||| S:4089 E:4092 ||| IN
mass  ||| S:4092 E:4097 ||| JJ
balance ||| S:4097 E:4104 ||| NN
,  ||| S:4104 E:4106 ||| ,
osmotic  ||| S:4106 E:4124 ||| JJ
pressure ||| S:4124 E:4132 ||| NN
,  ||| S:4132 E:4134 ||| ,
electro  ||| S:4134 E:4142 ||| JJ
neutrality ||| S:4142 E:4152 ||| NN
,  ||| S:4152 E:4154 ||| ,
thermodynamic ||| S:4154 E:4167 ||| NN
,  ||| S:4167 E:4169 ||| ,
and  ||| S:4169 E:4173 ||| CC
other  ||| S:4173 E:4189 ||| JJ
constraints ||| S:4189 E:4200 ||| NNS
) ||| S:4200 E:4201 ||| -RRB-
.  ||| S:4201 E:4203 ||| .
As  ||| S:4203 E:4206 ||| IN
a  ||| S:4206 E:4208 ||| DT
result  ||| S:4208 E:4215 ||| NN
of  ||| S:4215 E:4218 ||| IN
decades  ||| S:4218 E:4226 ||| NNS
of  ||| S:4226 E:4229 ||| IN
metabolic  ||| S:4229 E:4249 ||| JJ
research  ||| S:4249 E:4258 ||| NN
and  ||| S:4258 E:4262 ||| CC
the  ||| S:4262 E:4266 ||| DT
recent  ||| S:4266 E:4273 ||| JJ
genome  ||| S:4273 E:4280 ||| JJ
sequencing  ||| S:4280 E:4291 ||| JJ
projects ||| S:4291 E:4299 ||| NNS
,  ||| S:4299 E:4301 ||| ,
the  ||| S:4301 E:4315 ||| DT
mass  ||| S:4315 E:4320 ||| JJ
balance  ||| S:4320 E:4328 ||| NN
constraints  ||| S:4328 E:4340 ||| NNS
on  ||| S:4340 E:4343 ||| IN
cellular  ||| S:4343 E:4352 ||| JJ
metabolism  ||| S:4352 E:4363 ||| NN
can  ||| S:4363 E:4367 ||| MD
be  ||| S:4367 E:4380 ||| VB
assigned  ||| S:4380 E:4389 ||| VBN
on  ||| S:4389 E:4392 ||| IN
a  ||| S:4392 E:4394 ||| DT
genome  ||| S:4394 E:4401 ||| JJ
scale  ||| S:4401 E:4407 ||| NN
for  ||| S:4407 E:4411 ||| IN
a  ||| S:4411 E:4413 ||| DT
number  ||| S:4413 E:4420 ||| NN
of  ||| S:4420 E:4423 ||| IN
organisms ||| S:4423 E:4432 ||| NNS
.  ||| S:4432 E:4444 ||| .
Methods  ||| S:4444 E:4452 ||| NNS
have  ||| S:4452 E:4457 ||| VBP
been  ||| S:4457 E:4462 ||| VBN
developed  ||| S:4462 E:4472 ||| VBN
to  ||| S:4472 E:4475 ||| TO
analyze  ||| S:4475 E:4483 ||| VB
the  ||| S:4483 E:4487 ||| DT
metabolic  ||| S:4487 E:4507 ||| JJ
capabilities  ||| S:4507 E:4520 ||| NNS
of  ||| S:4520 E:4523 ||| IN
a  ||| S:4523 E:4525 ||| DT
cellular  ||| S:4525 E:4534 ||| JJ
system  ||| S:4534 E:4541 ||| NN
based  ||| S:4541 E:4547 ||| VBN
on  ||| S:4547 E:4550 ||| IN
the  ||| S:4550 E:4554 ||| DT
mass  ||| S:4554 E:4569 ||| JJ
balance  ||| S:4569 E:4577 ||| NN
constraints  ||| S:4577 E:4589 ||| NNS
and  ||| S:4589 E:4593 ||| CC
this  ||| S:4593 E:4598 ||| DT
approach  ||| S:4598 E:4607 ||| NN
is  ||| S:4607 E:4610 ||| VBZ
known  ||| S:4610 E:4616 ||| VBN
as  ||| S:4616 E:4619 ||| IN
flux  ||| S:4619 E:4634 ||| JJ
balance  ||| S:4634 E:4642 ||| NN
analysis  ||| S:4642 E:4651 ||| NN
( ||| S:4651 E:4652 ||| -LRB-
FBA ||| S:4652 E:4655 ||| NNP
)  ||| S:4655 E:4657 ||| -RRB-
[  ||| S:4657 E:4659 ||| -LRB-
13 ||| S:4659 E:4661 ||| CD
,  ||| S:4661 E:4663 ||| ,
14 ||| S:4663 E:4665 ||| CD
,  ||| S:4665 E:4667 ||| ,
16 ||| S:4667 E:4669 ||| CD
]  ||| S:4669 E:4671 ||| -RRB-
( ||| S:4671 E:4672 ||| -LRB-
see  ||| S:4672 E:4676 ||| VB
the  ||| S:4676 E:4690 ||| DT
supplementary  ||| S:4690 E:4704 ||| JJ
information  ||| S:4704 E:4716 ||| NN
for  ||| S:4716 E:4720 ||| IN
an  ||| S:4720 E:4723 ||| DT
FBA  ||| S:4723 E:4727 ||| NNP
primer ||| S:4727 E:4733 ||| CD
) ||| S:4733 E:4734 ||| -RRB-
.  ||| S:4734 E:4736 ||| .
The  ||| S:4736 E:4740 ||| DT
mass  ||| S:4740 E:4755 ||| JJ
balance  ||| S:4755 E:4763 ||| NN
constraints  ||| S:4763 E:4775 ||| NNS
in  ||| S:4775 E:4778 ||| IN
a  ||| S:4778 E:4780 ||| DT
metabolic  ||| S:4780 E:4790 ||| JJ
network  ||| S:4790 E:4798 ||| NN
can  ||| S:4798 E:4802 ||| MD
be  ||| S:4802 E:4815 ||| VB
represented  ||| S:4815 E:4827 ||| VBN
mathematically  ||| S:4827 E:4842 ||| RB
by  ||| S:4842 E:4845 ||| IN
a  ||| S:4845 E:4847 ||| DT
matrix  ||| S:4847 E:4854 ||| JJ
equation ||| S:4854 E:4862 ||| NN
:  ||| S:4862 E:4874 ||| :
S  ||| S:4874 E:4876 ||| NNP
•  ||| S:4876 E:4878 ||| CD
v  ||| S:4878 E:4880 ||| CD
=  ||| S:4880 E:4882 ||| SYM
0  ||| S:4882 E:4884 ||| CD
Equation  ||| S:4884 E:4893 ||| CD
1  ||| S:4893 E:4905 ||| CD
The  ||| S:4905 E:4909 ||| DT
matrix  ||| S:4909 E:4927 ||| JJ
S  ||| S:4927 E:4929 ||| NNP
is  ||| S:4929 E:4932 ||| VBZ
the  ||| S:4932 E:4947 ||| DT
mxn  ||| S:4947 E:4951 ||| JJ
stoichiometric  ||| S:4951 E:4966 ||| JJ
matrix ||| S:4966 E:4972 ||| NN
,  ||| S:4972 E:4974 ||| ,
where  ||| S:4974 E:4991 ||| WRB
m  ||| S:4991 E:4993 ||| NN
is  ||| S:4993 E:4996 ||| VBZ
the  ||| S:4996 E:5000 ||| DT
number  ||| S:5000 E:5007 ||| NN
of  ||| S:5007 E:5010 ||| IN
metabolites  ||| S:5010 E:5022 ||| NN
and  ||| S:5022 E:5037 ||| CC
n  ||| S:5037 E:5039 ||| NN
is  ||| S:5039 E:5042 ||| VBZ
the  ||| S:5042 E:5046 ||| DT
number  ||| S:5046 E:5053 ||| NN
of  ||| S:5053 E:5056 ||| IN
reactions  ||| S:5056 E:5066 ||| NNS
in  ||| S:5066 E:5069 ||| IN
the  ||| S:5069 E:5083 ||| DT
network  ||| S:5083 E:5091 ||| NN
( ||| S:5091 E:5092 ||| -LRB-
The  ||| S:5092 E:5107 ||| DT
E.  ||| S:5107 E:5110 ||| NNP
coli  ||| S:5110 E:5115 ||| FW
stoichiometric  ||| S:5115 E:5130 ||| FW
matrix  ||| S:5130 E:5137 ||| FW
is  ||| S:5137 E:5150 ||| VBZ
available  ||| S:5150 E:5160 ||| JJ
in  ||| S:5160 E:5163 ||| IN
matrix  ||| S:5163 E:5170 ||| JJ
format  ||| S:5170 E:5177 ||| NN
in  ||| S:5177 E:5180 ||| IN
the  ||| S:5180 E:5184 ||| DT
supplementary  ||| S:5184 E:5208 ||| JJ
information  ||| S:5208 E:5220 ||| NN
and  ||| S:5220 E:5224 ||| CC
in  ||| S:5224 E:5227 ||| IN
a  ||| S:5227 E:5229 ||| DT
reaction  ||| S:5229 E:5238 ||| NN
list  ||| S:5238 E:5243 ||| NN
in  ||| S:5243 E:5246 ||| IN
Appendices  ||| S:5246 E:5257 ||| NNP
1-3 ||| S:5257 E:5260 ||| NNP
) ||| S:5260 E:5261 ||| -RRB-
.  ||| S:5261 E:5273 ||| .
The  ||| S:5273 E:5277 ||| DT
vector  ||| S:5277 E:5295 ||| JJ
v  ||| S:5295 E:5297 ||| NN
represents  ||| S:5297 E:5308 ||| VBZ
all  ||| S:5308 E:5312 ||| DT
fluxes  ||| S:5312 E:5319 ||| NN
in  ||| S:5319 E:5322 ||| IN
the  ||| S:5322 E:5336 ||| DT
metabolic  ||| S:5336 E:5346 ||| JJ
network ||| S:5346 E:5353 ||| NN
,  ||| S:5353 E:5355 ||| ,
including  ||| S:5355 E:5365 ||| VBG
the  ||| S:5365 E:5369 ||| DT
internal  ||| S:5369 E:5378 ||| JJ
fluxes ||| S:5378 E:5384 ||| NN
,  ||| S:5384 E:5396 ||| ,
transport  ||| S:5396 E:5406 ||| NN
fluxes  ||| S:5406 E:5413 ||| NNS
and  ||| S:5413 E:5417 ||| CC
the  ||| S:5417 E:5421 ||| DT
growth  ||| S:5421 E:5428 ||| NN
flux ||| S:5428 E:5432 ||| NN
.  ||| S:5432 E:5444 ||| .
For  ||| S:5444 E:5448 ||| IN
the  ||| S:5448 E:5463 ||| DT
E.  ||| S:5463 E:5466 ||| NNP
coli  ||| S:5466 E:5471 ||| VBD
metabolic  ||| S:5471 E:5481 ||| JJ
network  ||| S:5481 E:5499 ||| NN
represented  ||| S:5499 E:5511 ||| VBD
by  ||| S:5511 E:5514 ||| IN
Eqn.  ||| S:5514 E:5519 ||| CD
1 ||| S:5519 E:5520 ||| CD
,  ||| S:5520 E:5522 ||| ,
the  ||| S:5522 E:5526 ||| DT
number  ||| S:5526 E:5533 ||| NN
of  ||| S:5533 E:5536 ||| IN
fluxes  ||| S:5536 E:5543 ||| NN
was  ||| S:5543 E:5547 ||| VBD
greater  ||| S:5547 E:5565 ||| JJR
than  ||| S:5565 E:5570 ||| IN
the  ||| S:5570 E:5574 ||| DT
number  ||| S:5574 E:5581 ||| NN
of  ||| S:5581 E:5584 ||| IN
mass  ||| S:5584 E:5589 ||| JJ
balance  ||| S:5589 E:5597 ||| NN
constraints ||| S:5597 E:5608 ||| NNS
;  ||| S:5608 E:5610 ||| :
thus ||| S:5610 E:5614 ||| RB
,  ||| S:5614 E:5616 ||| ,
there  ||| S:5616 E:5632 ||| EX
were  ||| S:5632 E:5637 ||| VBD
multiple  ||| S:5637 E:5646 ||| JJ
feasible  ||| S:5646 E:5655 ||| JJ
flux  ||| S:5655 E:5660 ||| NN
distributions  ||| S:5660 E:5674 ||| NNS
that  ||| S:5674 E:5679 ||| WDT
satisfied  ||| S:5679 E:5699 ||| VBD
the  ||| S:5699 E:5703 ||| DT
mass  ||| S:5703 E:5708 ||| JJ
balance  ||| S:5708 E:5716 ||| NN
constraints ||| S:5716 E:5727 ||| NNS
,  ||| S:5727 E:5729 ||| ,
and  ||| S:5729 E:5733 ||| CC
the  ||| S:5733 E:5737 ||| DT
solutions  ||| S:5737 E:5747 ||| NNS
( ||| S:5747 E:5748 ||| -LRB-
or  ||| S:5748 E:5761 ||| CC
feasible  ||| S:5761 E:5770 ||| JJ
metabolic  ||| S:5770 E:5780 ||| JJ
flux  ||| S:5780 E:5785 ||| NN
distributions ||| S:5785 E:5798 ||| NNS
)  ||| S:5798 E:5800 ||| -RRB-
were  ||| S:5800 E:5805 ||| VBD
confined  ||| S:5805 E:5814 ||| VBN
to  ||| S:5814 E:5827 ||| TO
the  ||| S:5827 E:5831 ||| DT
nullspace  ||| S:5831 E:5841 ||| NN
of  ||| S:5841 E:5844 ||| IN
the  ||| S:5844 E:5848 ||| DT
matrix  ||| S:5848 E:5866 ||| JJ
S  ||| S:5866 E:5868 ||| NNP
.  ||| S:5868 E:5880 ||| .
In  ||| S:5880 E:5883 ||| IN
addition  ||| S:5883 E:5892 ||| NN
to  ||| S:5892 E:5895 ||| TO
the  ||| S:5895 E:5899 ||| DT
mass  ||| S:5899 E:5904 ||| JJ
balance  ||| S:5904 E:5912 ||| NN
constraints ||| S:5912 E:5923 ||| NNS
,  ||| S:5923 E:5925 ||| ,
we  ||| S:5925 E:5938 ||| PRP
imposed  ||| S:5938 E:5946 ||| VBD
constraints  ||| S:5946 E:5958 ||| NNS
on  ||| S:5958 E:5961 ||| IN
the  ||| S:5961 E:5965 ||| DT
magnitude  ||| S:5965 E:5975 ||| NN
of  ||| S:5975 E:5978 ||| IN
individual  ||| S:5978 E:5999 ||| JJ
metabolic  ||| S:5999 E:6009 ||| FW
fluxes.  ||| S:6009 E:6027 ||| FW
α  ||| S:6027 E:6053 ||| FW
i  ||| S:6053 E:6067 ||| FW
≤  ||| S:6067 E:6069 ||| FW
v  ||| S:6069 E:6095 ||| FW
i  ||| S:6095 E:6109 ||| FW
≤  ||| S:6109 E:6111 ||| FW
β  ||| S:6111 E:6137 ||| FW
i  ||| S:6137 E:6151 ||| FW
Equation  ||| S:6151 E:6160 ||| NNP
2  ||| S:6160 E:6172 ||| CD
The  ||| S:6172 E:6176 ||| DT
linear  ||| S:6176 E:6183 ||| JJ
inequality  ||| S:6183 E:6194 ||| NN
constraints  ||| S:6194 E:6206 ||| NNS
were  ||| S:6206 E:6211 ||| VBD
used  ||| S:6211 E:6216 ||| VBN
to  ||| S:6216 E:6219 ||| TO
enforce  ||| S:6219 E:6237 ||| VB
the  ||| S:6237 E:6241 ||| DT
reversibility  ||| S:6241 E:6255 ||| NN
of  ||| S:6255 E:6258 ||| IN
each  ||| S:6258 E:6263 ||| DT
metabolic  ||| S:6263 E:6273 ||| JJ
reaction  ||| S:6273 E:6282 ||| NN
and  ||| S:6282 E:6286 ||| CC
the  ||| S:6286 E:6300 ||| DT
maximal  ||| S:6300 E:6308 ||| JJ
flux  ||| S:6308 E:6313 ||| NN
in  ||| S:6313 E:6316 ||| IN
the  ||| S:6316 E:6320 ||| DT
transport  ||| S:6320 E:6330 ||| NN
reactions ||| S:6330 E:6339 ||| NNS
.  ||| S:6339 E:6341 ||| .
The  ||| S:6341 E:6355 ||| DT
reversibility  ||| S:6355 E:6369 ||| JJ
constraints  ||| S:6369 E:6381 ||| NNS
for  ||| S:6381 E:6385 ||| IN
each  ||| S:6385 E:6390 ||| DT
reaction  ||| S:6390 E:6399 ||| NN
are  ||| S:6399 E:6403 ||| VBP
indicated  ||| S:6403 E:6423 ||| VBN
online ||| S:6423 E:6429 ||| NN
.  ||| S:6429 E:6431 ||| .
The  ||| S:6431 E:6435 ||| DT
transport  ||| S:6435 E:6445 ||| NN
flux  ||| S:6445 E:6450 ||| NN
for  ||| S:6450 E:6454 ||| IN
inorganic  ||| S:6454 E:6464 ||| JJ
phosphate ||| S:6464 E:6473 ||| NN
,  ||| S:6473 E:6485 ||| ,
ammonia ||| S:6485 E:6492 ||| NN
,  ||| S:6492 E:6494 ||| ,
carbon  ||| S:6494 E:6501 ||| NN
dioxide ||| S:6501 E:6508 ||| NN
,  ||| S:6508 E:6510 ||| ,
sulfate ||| S:6510 E:6517 ||| NN
,  ||| S:6517 E:6519 ||| ,
potassium ||| S:6519 E:6528 ||| NN
,  ||| S:6528 E:6530 ||| ,
and  ||| S:6530 E:6534 ||| CC
sodium  ||| S:6534 E:6551 ||| NN
was  ||| S:6551 E:6555 ||| VBD
unrestrained  ||| S:6555 E:6568 ||| NNS
( ||| S:6568 E:6569 ||| -LRB-
α  ||| S:6569 E:6595 ||| FW
i  ||| S:6595 E:6609 ||| FW
=  ||| S:6609 E:6611 ||| FW
-∞  ||| S:6611 E:6614 ||| FW
and  ||| S:6614 E:6618 ||| FW
β  ||| S:6618 E:6644 ||| FW
i  ||| S:6644 E:6658 ||| FW
=  ||| S:6658 E:6660 ||| FW
∞ ||| S:6660 E:6661 ||| FW
) ||| S:6661 E:6662 ||| -RRB-
.  ||| S:6662 E:6664 ||| .
The  ||| S:6664 E:6668 ||| DT
transport  ||| S:6668 E:6678 ||| NN
flux  ||| S:6678 E:6683 ||| NN
for  ||| S:6683 E:6687 ||| IN
the  ||| S:6687 E:6691 ||| DT
other  ||| S:6691 E:6697 ||| JJ
metabolites ||| S:6697 E:6708 ||| NN
,  ||| S:6708 E:6720 ||| ,
when  ||| S:6720 E:6725 ||| WRB
available  ||| S:6725 E:6735 ||| JJ
in  ||| S:6735 E:6738 ||| IN
the  ||| S:6738 E:6753 ||| DT
in  ||| S:6753 E:6756 ||| IN
silico  ||| S:6756 E:6763 ||| JJ
medium ||| S:6763 E:6769 ||| NN
,  ||| S:6769 E:6771 ||| ,
was  ||| S:6771 E:6775 ||| VBD
constrained  ||| S:6775 E:6797 ||| VBN
between  ||| S:6797 E:6805 ||| IN
zero  ||| S:6805 E:6810 ||| CD
and  ||| S:6810 E:6814 ||| CC
the  ||| S:6814 E:6818 ||| DT
maximal  ||| S:6818 E:6826 ||| JJ
level  ||| S:6826 E:6832 ||| NN
( ||| S:6832 E:6833 ||| -LRB-
0  ||| S:6833 E:6835 ||| CD
≤  ||| S:6835 E:6837 ||| FW
v  ||| S:6837 E:6863 ||| FW
i  ||| S:6863 E:6877 ||| FW
≤  ||| S:6877 E:6879 ||| FW
v  ||| S:6879 E:6905 ||| FW
i  ||| S:6905 E:6919 ||| FW
max ||| S:6919 E:6922 ||| FW
) ||| S:6922 E:6923 ||| -RRB-
.  ||| S:6923 E:6925 ||| .
The  ||| S:6925 E:6929 ||| DT
v  ||| S:6929 E:6955 ||| FW
i  ||| S:6955 E:6980 ||| FW
max  ||| S:6980 E:6984 ||| FW
values  ||| S:6984 E:6991 ||| VBZ
used  ||| S:6991 E:6996 ||| VBN
in  ||| S:6996 E:6999 ||| IN
the  ||| S:6999 E:7003 ||| DT
simulations  ||| S:7003 E:7025 ||| NNS
are  ||| S:7025 E:7029 ||| VBP
noted  ||| S:7029 E:7035 ||| VBN
for  ||| S:7035 E:7039 ||| IN
each  ||| S:7039 E:7044 ||| DT
simulation  ||| S:7044 E:7055 ||| NN
( ||| S:7055 E:7056 ||| -LRB-
Fig.  ||| S:7056 E:7061 ||| CD
1 ||| S:7061 E:7062 ||| CD
) ||| S:7062 E:7063 ||| -RRB-
.  ||| S:7063 E:7065 ||| .
When  ||| S:7065 E:7070 ||| WRB
a  ||| S:7070 E:7072 ||| DT
metabolite  ||| S:7072 E:7093 ||| NN
was  ||| S:7093 E:7097 ||| VBD
not  ||| S:7097 E:7101 ||| RB
available  ||| S:7101 E:7111 ||| JJ
in  ||| S:7111 E:7114 ||| IN
the  ||| S:7114 E:7118 ||| DT
medium ||| S:7118 E:7124 ||| NN
,  ||| S:7124 E:7126 ||| ,
the  ||| S:7126 E:7130 ||| DT
transport  ||| S:7130 E:7140 ||| NN
flux  ||| S:7140 E:7145 ||| NN
was  ||| S:7145 E:7159 ||| VBD
constrained  ||| S:7159 E:7171 ||| VBN
to  ||| S:7171 E:7174 ||| TO
zero ||| S:7174 E:7178 ||| CD
.  ||| S:7178 E:7180 ||| .
The  ||| S:7180 E:7184 ||| DT
transport  ||| S:7184 E:7194 ||| NN
flux  ||| S:7194 E:7199 ||| NN
for  ||| S:7199 E:7203 ||| IN
metabolites  ||| S:7203 E:7225 ||| JJ
capable  ||| S:7225 E:7233 ||| JJ
of  ||| S:7233 E:7236 ||| IN
leaving  ||| S:7236 E:7244 ||| VBG
the  ||| S:7244 E:7248 ||| DT
metabolic  ||| S:7248 E:7258 ||| JJ
network  ||| S:7258 E:7266 ||| NN
( ||| S:7266 E:7267 ||| -LRB-
i.e.  ||| S:7267 E:7272 ||| FW
acetate ||| S:7272 E:7279 ||| FW
,  ||| S:7279 E:7291 ||| ,
ethanol ||| S:7291 E:7298 ||| NN
,  ||| S:7298 E:7300 ||| ,
lactate ||| S:7300 E:7307 ||| NN
,  ||| S:7307 E:7309 ||| ,
succinate ||| S:7309 E:7318 ||| NN
,  ||| S:7318 E:7320 ||| ,
formate ||| S:7320 E:7327 ||| NN
,  ||| S:7327 E:7329 ||| ,
and  ||| S:7329 E:7333 ||| CC
pyruvate ||| S:7333 E:7341 ||| CD
)  ||| S:7341 E:7343 ||| -RRB-
was  ||| S:7343 E:7357 ||| VBD
always  ||| S:7357 E:7364 ||| RB
unconstrained  ||| S:7364 E:7378 ||| VBN
in  ||| S:7378 E:7381 ||| IN
the  ||| S:7381 E:7385 ||| DT
net  ||| S:7385 E:7389 ||| JJ
outward  ||| S:7389 E:7397 ||| JJ
direction ||| S:7397 E:7406 ||| NN
.  ||| S:7406 E:7418 ||| .
The  ||| S:7418 E:7422 ||| DT
intersection  ||| S:7422 E:7435 ||| NN
of  ||| S:7435 E:7438 ||| IN
the  ||| S:7438 E:7442 ||| DT
nullspace  ||| S:7442 E:7452 ||| NN
and  ||| S:7452 E:7456 ||| CC
the  ||| S:7456 E:7460 ||| DT
region  ||| S:7460 E:7477 ||| NN
defined  ||| S:7477 E:7485 ||| VBN
by  ||| S:7485 E:7488 ||| IN
the  ||| S:7488 E:7492 ||| DT
linear  ||| S:7492 E:7499 ||| JJ
inequalities  ||| S:7499 E:7512 ||| NNS
defined  ||| S:7512 E:7520 ||| VBD
a  ||| S:7520 E:7522 ||| DT
region  ||| S:7522 E:7529 ||| NN
in  ||| S:7529 E:7542 ||| IN
flux  ||| S:7542 E:7547 ||| JJ
space  ||| S:7547 E:7553 ||| NN
that  ||| S:7553 E:7558 ||| IN
we  ||| S:7558 E:7561 ||| PRP
will  ||| S:7561 E:7566 ||| MD
refer  ||| S:7566 E:7572 ||| VB
to  ||| S:7572 E:7575 ||| TO
as  ||| S:7575 E:7578 ||| IN
the  ||| S:7578 E:7582 ||| DT
feasible  ||| S:7582 E:7591 ||| JJ
set ||| S:7591 E:7594 ||| NN
,  ||| S:7594 E:7596 ||| ,
and  ||| S:7596 E:7610 ||| CC
the  ||| S:7610 E:7614 ||| DT
feasible  ||| S:7614 E:7623 ||| JJ
set  ||| S:7623 E:7627 ||| NN
defined  ||| S:7627 E:7635 ||| VBD
the  ||| S:7635 E:7639 ||| DT
capabilities  ||| S:7639 E:7652 ||| NNS
of  ||| S:7652 E:7655 ||| IN
the  ||| S:7655 E:7669 ||| DT
metabolic  ||| S:7669 E:7679 ||| JJ
network  ||| S:7679 E:7687 ||| NN
subject  ||| S:7687 E:7695 ||| NN
to  ||| S:7695 E:7698 ||| TO
the  ||| S:7698 E:7702 ||| DT
imposed  ||| S:7702 E:7710 ||| VBN
cellular  ||| S:7710 E:7729 ||| JJ
constraints ||| S:7729 E:7740 ||| NNS
.  ||| S:7740 E:7742 ||| .
It  ||| S:7742 E:7745 ||| PRP
should  ||| S:7745 E:7752 ||| MD
be  ||| S:7752 E:7755 ||| VB
noted  ||| S:7755 E:7761 ||| VBN
that  ||| S:7761 E:7766 ||| IN
every  ||| S:7766 E:7772 ||| DT
vector  ||| S:7772 E:7790 ||| JJ
v  ||| S:7790 E:7792 ||| NN
within  ||| S:7792 E:7799 ||| IN
the  ||| S:7799 E:7803 ||| DT
feasible  ||| S:7803 E:7812 ||| JJ
set  ||| S:7812 E:7816 ||| NN
is  ||| S:7816 E:7819 ||| VBZ
not  ||| S:7819 E:7833 ||| RB
reachable  ||| S:7833 E:7843 ||| VBN
by  ||| S:7843 E:7846 ||| IN
the  ||| S:7846 E:7850 ||| DT
cell  ||| S:7850 E:7855 ||| NN
under  ||| S:7855 E:7861 ||| IN
a  ||| S:7861 E:7863 ||| DT
given  ||| S:7863 E:7869 ||| VBN
condition  ||| S:7869 E:7879 ||| NN
due  ||| S:7879 E:7883 ||| JJ
to  ||| S:7883 E:7896 ||| TO
other  ||| S:7896 E:7902 ||| JJ
constraints  ||| S:7902 E:7914 ||| NNS
not  ||| S:7914 E:7918 ||| RB
considered  ||| S:7918 E:7929 ||| VBN
in  ||| S:7929 E:7932 ||| IN
the  ||| S:7932 E:7936 ||| DT
analysis  ||| S:7936 E:7945 ||| NN
( ||| S:7945 E:7946 ||| -LRB-
i.e.  ||| S:7946 E:7961 ||| FW
maximal  ||| S:7961 E:7969 ||| FW
internal  ||| S:7969 E:7978 ||| JJ
fluxes  ||| S:7978 E:7985 ||| NN
and  ||| S:7985 E:7989 ||| CC
gene  ||| S:7989 E:7994 ||| NN
regulation ||| S:7994 E:8004 ||| NN
) ||| S:8004 E:8005 ||| -RRB-
.  ||| S:8005 E:8007 ||| .
The  ||| S:8007 E:8021 ||| DT
feasible  ||| S:8021 E:8030 ||| JJ
set  ||| S:8030 E:8034 ||| NN
can  ||| S:8034 E:8038 ||| MD
be  ||| S:8038 E:8041 ||| VB
further  ||| S:8041 E:8049 ||| RB
reduced  ||| S:8049 E:8057 ||| VBN
by  ||| S:8057 E:8060 ||| IN
imposing  ||| S:8060 E:8079 ||| VBG
additional  ||| S:8079 E:8090 ||| JJ
constraints  ||| S:8090 E:8102 ||| NNS
( ||| S:8102 E:8103 ||| -LRB-
i.e.  ||| S:8103 E:8108 ||| FW
kinetic  ||| S:8108 E:8116 ||| FW
or  ||| S:8116 E:8119 ||| CC
gene  ||| S:8119 E:8124 ||| NN
regulatory  ||| S:8124 E:8145 ||| JJ
constraints ||| S:8145 E:8156 ||| NNS
) ||| S:8156 E:8157 ||| -RRB-
,  ||| S:8157 E:8159 ||| ,
and  ||| S:8159 E:8163 ||| CC
in  ||| S:8163 E:8166 ||| IN
the  ||| S:8166 E:8170 ||| DT
limiting  ||| S:8170 E:8179 ||| JJ
condition  ||| S:8179 E:8189 ||| NN
where  ||| S:8189 E:8195 ||| WRB
all  ||| S:8195 E:8209 ||| DT
constraints  ||| S:8209 E:8221 ||| NNS
are  ||| S:8221 E:8225 ||| VBP
known ||| S:8225 E:8230 ||| VBN
,  ||| S:8230 E:8232 ||| ,
the  ||| S:8232 E:8236 ||| DT
feasible  ||| S:8236 E:8245 ||| JJ
set  ||| S:8245 E:8249 ||| NN
may  ||| S:8249 E:8253 ||| MD
reduce  ||| S:8253 E:8260 ||| VB
to  ||| S:8260 E:8263 ||| TO
a  ||| S:8263 E:8275 ||| DT
single  ||| S:8275 E:8282 ||| JJ
point ||| S:8282 E:8287 ||| NN
.  ||| S:8287 E:8299 ||| .
A  ||| S:8299 E:8301 ||| DT
particular  ||| S:8301 E:8312 ||| JJ
metabolic  ||| S:8312 E:8322 ||| JJ
flux  ||| S:8322 E:8327 ||| JJ
distribution  ||| S:8327 E:8340 ||| NN
within  ||| S:8340 E:8347 ||| IN
the  ||| S:8347 E:8361 ||| DT
feasible  ||| S:8361 E:8370 ||| JJ
set  ||| S:8370 E:8374 ||| NN
( ||| S:8374 E:8375 ||| -LRB-
vector  ||| S:8375 E:8393 ||| JJ
v  ||| S:8393 E:8395 ||| NN
which  ||| S:8395 E:8401 ||| WDT
satisfies  ||| S:8401 E:8411 ||| VBZ
the  ||| S:8411 E:8415 ||| DT
constraints  ||| S:8415 E:8427 ||| NNS
in  ||| S:8427 E:8440 ||| IN
Eqns.  ||| S:8440 E:8446 ||| CD
1  ||| S:8446 E:8448 ||| CD
and  ||| S:8448 E:8452 ||| CC
2 ||| S:8452 E:8453 ||| LS
)  ||| S:8453 E:8455 ||| -RRB-
was  ||| S:8455 E:8459 ||| VBD
found  ||| S:8459 E:8465 ||| VBN
using  ||| S:8465 E:8471 ||| VBG
linear  ||| S:8471 E:8478 ||| JJ
programming  ||| S:8478 E:8490 ||| NN
( ||| S:8490 E:8491 ||| -LRB-
LP ||| S:8491 E:8493 ||| NNP
) ||| S:8493 E:8494 ||| -RRB-
.  ||| S:8494 E:8496 ||| .
A  ||| S:8496 E:8508 ||| DT
commercially  ||| S:8508 E:8521 ||| JJ
available  ||| S:8521 E:8531 ||| JJ
LP  ||| S:8531 E:8534 ||| NNP
package  ||| S:8534 E:8542 ||| NN
was  ||| S:8542 E:8546 ||| VBD
used  ||| S:8546 E:8551 ||| VBN
( ||| S:8551 E:8552 ||| -LRB-
LINDO ||| S:8552 E:8557 ||| NNP
,  ||| S:8557 E:8559 ||| ,
Lindo  ||| S:8559 E:8575 ||| NNP
Systems  ||| S:8575 E:8583 ||| NNPS
Inc. ||| S:8583 E:8587 ||| NNP
,  ||| S:8587 E:8589 ||| ,
Chicago ||| S:8589 E:8596 ||| NNP
,  ||| S:8596 E:8598 ||| ,
II ||| S:8598 E:8600 ||| NNP
) ||| S:8600 E:8601 ||| -RRB-
.  ||| S:8601 E:8603 ||| .
LP  ||| S:8603 E:8606 ||| NNP
identified  ||| S:8606 E:8617 ||| VBD
a  ||| S:8617 E:8619 ||| DT
solution  ||| S:8619 E:8628 ||| NN
that  ||| S:8628 E:8643 ||| IN
minimized  ||| S:8643 E:8653 ||| VBG
a  ||| S:8653 E:8655 ||| DT
metabolic  ||| S:8655 E:8665 ||| JJ
objective  ||| S:8665 E:8675 ||| NN
function  ||| S:8675 E:8684 ||| NN
( ||| S:8684 E:8685 ||| -LRB-
subject  ||| S:8685 E:8693 ||| JJ
to  ||| S:8693 E:8696 ||| TO
the  ||| S:8696 E:8710 ||| DT
imposed  ||| S:8710 E:8718 ||| VBN
constraints-  ||| S:8718 E:8731 ||| JJ
Eqns.  ||| S:8731 E:8737 ||| CD
1  ||| S:8737 E:8739 ||| CD
and  ||| S:8739 E:8743 ||| CC
2 ||| S:8743 E:8744 ||| LS
)  ||| S:8744 E:8746 ||| -RRB-
[  ||| S:8746 E:8748 ||| -LRB-
16 ||| S:8748 E:8750 ||| CD
,  ||| S:8750 E:8752 ||| ,
48 ||| S:8752 E:8754 ||| CD
,  ||| S:8754 E:8756 ||| ,
49 ||| S:8756 E:8758 ||| CD
] ||| S:8758 E:8759 ||| -RRB-
,  ||| S:8759 E:8761 ||| ,
and  ||| S:8761 E:8775 ||| CC
was  ||| S:8775 E:8779 ||| VBD
formulated  ||| S:8779 E:8790 ||| VBN
as  ||| S:8790 E:8793 ||| RB
shown  ||| S:8793 E:8799 ||| VBN
below ||| S:8799 E:8804 ||| IN
:  ||| S:8804 E:8816 ||| :
Minimize  ||| S:8816 E:8825 ||| NNP
-Z  ||| S:8825 E:8838 ||| NNP
where  ||| S:8838 E:8855 ||| WRB
Z  ||| S:8855 E:8857 ||| NNP
=  ||| S:8857 E:8859 ||| SYM
Σ  ||| S:8859 E:8872 ||| FW
c  ||| S:8872 E:8898 ||| FW
i  ||| S:8898 E:8912 ||| FW
v  ||| S:8912 E:8938 ||| FW
i  ||| S:8938 E:8952 ||| FW
=  ||| S:8952 E:8955 ||| FW
Equation  ||| S:8955 E:8964 ||| NNP
3  ||| S:8964 E:8976 ||| CD
The  ||| S:8976 E:8980 ||| DT
vector  ||| S:8980 E:8998 ||| JJ
c  ||| S:8998 E:9000 ||| NN
was  ||| S:9000 E:9004 ||| VBD
used  ||| S:9004 E:9009 ||| VBN
to  ||| S:9009 E:9012 ||| TO
select  ||| S:9012 E:9019 ||| VB
a  ||| S:9019 E:9021 ||| DT
linear  ||| S:9021 E:9038 ||| JJ
combination  ||| S:9038 E:9050 ||| NN
of  ||| S:9050 E:9053 ||| IN
metabolic  ||| S:9053 E:9063 ||| JJ
fluxes  ||| S:9063 E:9070 ||| NN
to  ||| S:9070 E:9073 ||| TO
include  ||| S:9073 E:9081 ||| VB
in  ||| S:9081 E:9084 ||| IN
the  ||| S:9084 E:9098 ||| DT
objective  ||| S:9098 E:9108 ||| JJ
function  ||| S:9108 E:9117 ||| NN
[  ||| S:9117 E:9119 ||| -LRB-
50 ||| S:9119 E:9121 ||| CD
] ||| S:9121 E:9122 ||| -RRB-
.  ||| S:9122 E:9124 ||| .
Herein ||| S:9124 E:9130 ||| NNP
,  ||| S:9130 E:9143 ||| ,
c  ||| S:9143 E:9145 ||| NN
was  ||| S:9145 E:9149 ||| VBD
defined  ||| S:9149 E:9157 ||| VBN
as  ||| S:9157 E:9160 ||| IN
the  ||| S:9160 E:9164 ||| DT
unit  ||| S:9164 E:9169 ||| NN
vector  ||| S:9169 E:9176 ||| NN
in  ||| S:9176 E:9189 ||| IN
the  ||| S:9189 E:9193 ||| DT
direction  ||| S:9193 E:9203 ||| NN
of  ||| S:9203 E:9206 ||| IN
the  ||| S:9206 E:9210 ||| DT
growth  ||| S:9210 E:9217 ||| NN
flux ||| S:9217 E:9221 ||| NN
,  ||| S:9221 E:9223 ||| ,
and  ||| S:9223 E:9227 ||| CC
the  ||| S:9227 E:9231 ||| DT
growth  ||| S:9231 E:9238 ||| NN
flux  ||| S:9238 E:9243 ||| NN
was  ||| S:9243 E:9257 ||| VBD
defined  ||| S:9257 E:9265 ||| VBN
in  ||| S:9265 E:9268 ||| IN
terms  ||| S:9268 E:9274 ||| NNS
of  ||| S:9274 E:9277 ||| IN
the  ||| S:9277 E:9281 ||| DT
biosynthetic  ||| S:9281 E:9294 ||| JJ
requirements ||| S:9294 E:9306 ||| NNS
:  ||| S:9306 E:9318 ||| :
( ||| S:9318 E:9319 ||| -LRB-
Equation  ||| S:9319 E:9328 ||| NNP
4 ||| S:9328 E:9329 ||| CD
)  ||| S:9329 E:9341 ||| -RRB-
where  ||| S:9341 E:9358 ||| WRB
d  ||| S:9358 E:9384 ||| JJ
m  ||| S:9384 E:9398 ||| NN
is  ||| S:9398 E:9401 ||| VBZ
the  ||| S:9401 E:9405 ||| DT
biomass  ||| S:9405 E:9413 ||| JJ
composition  ||| S:9413 E:9425 ||| NN
of  ||| S:9425 E:9428 ||| IN
metabolite  ||| S:9428 E:9439 ||| JJ
X  ||| S:9439 E:9465 ||| NN
m  ||| S:9465 E:9479 ||| NNS
( ||| S:9479 E:9480 ||| -LRB-
we  ||| S:9480 E:9483 ||| PRP
used  ||| S:9483 E:9488 ||| VBD
a  ||| S:9488 E:9490 ||| DT
constant  ||| S:9490 E:9499 ||| JJ
biomass  ||| S:9499 E:9507 ||| NNS
composition  ||| S:9507 E:9519 ||| VBP
defined  ||| S:9519 E:9527 ||| VBN
from  ||| S:9527 E:9542 ||| IN
the  ||| S:9542 E:9546 ||| DT
literature  ||| S:9546 E:9557 ||| NN
[  ||| S:9557 E:9559 ||| -LRB-
51 ||| S:9559 E:9561 ||| CD
]  ||| S:9561 E:9563 ||| -RRB-
( ||| S:9563 E:9564 ||| -LRB-
see  ||| S:9564 E:9568 ||| VB
Appendix  ||| S:9568 E:9577 ||| NNP
4 ||| S:9577 E:9578 ||| CD
) ||| S:9578 E:9579 ||| -RRB-
) ||| S:9579 E:9580 ||| -RRB-
,  ||| S:9580 E:9582 ||| ,
and  ||| S:9582 E:9586 ||| CC
the  ||| S:9586 E:9590 ||| DT
growth  ||| S:9590 E:9607 ||| NN
flux  ||| S:9607 E:9612 ||| NN
was  ||| S:9612 E:9616 ||| VBD
modeled  ||| S:9616 E:9624 ||| VBN
as  ||| S:9624 E:9627 ||| IN
a  ||| S:9627 E:9629 ||| DT
single  ||| S:9629 E:9636 ||| JJ
reaction  ||| S:9636 E:9645 ||| NN
that  ||| S:9645 E:9650 ||| WDT
converts  ||| S:9650 E:9659 ||| VBZ
all  ||| S:9659 E:9673 ||| PDT
the  ||| S:9673 E:9677 ||| DT
biosynthetic  ||| S:9677 E:9690 ||| JJ
precursors  ||| S:9690 E:9701 ||| NN
into  ||| S:9701 E:9706 ||| IN
biomass ||| S:9706 E:9713 ||| NN
.  ||| S:9713 E:9743 ||| .
Phenotype  ||| S:9743 E:9753 ||| NNP
Phase  ||| S:9753 E:9759 ||| NNP
Plane  ||| S:9759 E:9765 ||| NNP
Analysis  ||| S:9765 E:9784 ||| NNP
All  ||| S:9784 E:9788 ||| DT
feasible  ||| S:9788 E:9808 ||| JJ
E.  ||| S:9808 E:9811 ||| NNP
coli  ||| S:9811 E:9816 ||| NNS
in  ||| S:9816 E:9819 ||| IN
silico  ||| S:9819 E:9826 ||| JJ
metabolic  ||| S:9826 E:9836 ||| JJ
flux  ||| S:9836 E:9851 ||| NN
distributions  ||| S:9851 E:9865 ||| NNS
are  ||| S:9865 E:9869 ||| VBP
mathematically  ||| S:9869 E:9884 ||| RB
confined  ||| S:9884 E:9893 ||| VBN
to  ||| S:9893 E:9896 ||| TO
the  ||| S:9896 E:9900 ||| DT
feasible  ||| S:9900 E:9919 ||| JJ
set ||| S:9919 E:9922 ||| NN
,  ||| S:9922 E:9924 ||| ,
which  ||| S:9924 E:9930 ||| WDT
is  ||| S:9930 E:9933 ||| VBZ
a  ||| S:9933 E:9935 ||| DT
region  ||| S:9935 E:9942 ||| NN
in  ||| S:9942 E:9945 ||| IN
flux  ||| S:9945 E:9950 ||| JJ
space  ||| S:9950 E:9956 ||| NN
(  ||| S:9956 E:9958 ||| -LRB-
n ||| S:9958 E:9959 ||| LS
) ||| S:9959 E:9960 ||| -RRB-
,  ||| S:9960 E:9962 ||| ,
where  ||| S:9962 E:9968 ||| WRB
each  ||| S:9968 E:9983 ||| DT
solution  ||| S:9983 E:9992 ||| NN
in  ||| S:9992 E:9995 ||| IN
this  ||| S:9995 E:10000 ||| DT
space  ||| S:10000 E:10006 ||| NN
corresponds  ||| S:10006 E:10018 ||| NN
to  ||| S:10018 E:10021 ||| TO
a  ||| S:10021 E:10023 ||| DT
feasible  ||| S:10023 E:10042 ||| JJ
metabolic  ||| S:10042 E:10052 ||| JJ
flux  ||| S:10052 E:10057 ||| JJ
distribution ||| S:10057 E:10069 ||| NN
.  ||| S:10069 E:10081 ||| .
Phenotype  ||| S:10081 E:10091 ||| NNP
Phase  ||| S:10091 E:10097 ||| NNP
Plane  ||| S:10097 E:10103 ||| NNP
( ||| S:10103 E:10104 ||| -LRB-
PhPP ||| S:10104 E:10108 ||| NNP
) ||| S:10108 E:10109 ||| -RRB-
:  ||| S:10109 E:10111 ||| :
A  ||| S:10111 E:10113 ||| DT
PhPP  ||| S:10113 E:10118 ||| NN
is  ||| S:10118 E:10121 ||| VBZ
a  ||| S:10121 E:10133 ||| DT
two-dimensional  ||| S:10133 E:10149 ||| JJ
projection  ||| S:10149 E:10160 ||| NN
of  ||| S:10160 E:10163 ||| IN
the  ||| S:10163 E:10167 ||| DT
feasible  ||| S:10167 E:10176 ||| JJ
set ||| S:10176 E:10179 ||| NN
,  ||| S:10179 E:10181 ||| ,
and  ||| S:10181 E:10185 ||| CC
below  ||| S:10185 E:10201 ||| IN
we  ||| S:10201 E:10204 ||| PRP
will  ||| S:10204 E:10209 ||| MD
briefly  ||| S:10209 E:10217 ||| RB
discuss  ||| S:10217 E:10225 ||| VB
the  ||| S:10225 E:10229 ||| DT
formalism  ||| S:10229 E:10239 ||| NN
for  ||| S:10239 E:10243 ||| IN
constructing  ||| S:10243 E:10266 ||| VBG
the  ||| S:10266 E:10270 ||| DT
PhPP ||| S:10270 E:10274 ||| JJ
.  ||| S:10274 E:10276 ||| .
Two  ||| S:10276 E:10280 ||| CD
parameters  ||| S:10280 E:10291 ||| NNS
that  ||| S:10291 E:10296 ||| WDT
describe  ||| S:10296 E:10305 ||| VBP
the  ||| S:10305 E:10309 ||| DT
growth  ||| S:10309 E:10326 ||| NN
conditions  ||| S:10326 E:10337 ||| NNS
( ||| S:10337 E:10338 ||| -LRB-
such  ||| S:10338 E:10343 ||| JJ
as  ||| S:10343 E:10346 ||| IN
substrate  ||| S:10346 E:10356 ||| NN
and  ||| S:10356 E:10360 ||| CC
oxygen  ||| S:10360 E:10367 ||| JJ
uptake  ||| S:10367 E:10374 ||| JJ
rates ||| S:10374 E:10379 ||| NNS
)  ||| S:10379 E:10391 ||| -RRB-
were  ||| S:10391 E:10396 ||| VBD
defined  ||| S:10396 E:10404 ||| VBN
as  ||| S:10404 E:10407 ||| IN
the  ||| S:10407 E:10411 ||| DT
two  ||| S:10411 E:10415 ||| CD
axes  ||| S:10415 E:10420 ||| NN
of  ||| S:10420 E:10423 ||| IN
the  ||| S:10423 E:10427 ||| DT
two  ||| S:10427 E:10431 ||| CD
dimensional  ||| S:10431 E:10453 ||| JJ
space ||| S:10453 E:10458 ||| NN
.  ||| S:10458 E:10460 ||| .
The  ||| S:10460 E:10464 ||| DT
optimal  ||| S:10464 E:10472 ||| JJ
flux  ||| S:10472 E:10477 ||| JJ
distribution  ||| S:10477 E:10490 ||| NN
was  ||| S:10490 E:10494 ||| VBD
calculated  ||| S:10494 E:10515 ||| VBN
( ||| S:10515 E:10516 ||| -LRB-
using  ||| S:10516 E:10522 ||| VBG
LP ||| S:10522 E:10524 ||| NNP
)  ||| S:10524 E:10526 ||| -RRB-
for  ||| S:10526 E:10530 ||| IN
all  ||| S:10530 E:10534 ||| DT
points  ||| S:10534 E:10541 ||| NNS
in  ||| S:10541 E:10544 ||| IN
this  ||| S:10544 E:10549 ||| DT
plane  ||| S:10549 E:10555 ||| NN
by  ||| S:10555 E:10558 ||| IN
solving  ||| S:10558 E:10566 ||| VBG
the  ||| S:10566 E:10570 ||| DT
LP  ||| S:10570 E:10583 ||| NNP
problem  ||| S:10583 E:10591 ||| NN
while  ||| S:10591 E:10597 ||| IN
adjusting  ||| S:10597 E:10607 ||| VBG
the  ||| S:10607 E:10611 ||| DT
exchange  ||| S:10611 E:10620 ||| NN
flux  ||| S:10620 E:10625 ||| NN
constraints  ||| S:10625 E:10647 ||| NNS
( ||| S:10647 E:10648 ||| -LRB-
defining  ||| S:10648 E:10657 ||| VB
the  ||| S:10657 E:10661 ||| DT
two-dimensional  ||| S:10661 E:10677 ||| JJ
space ||| S:10677 E:10682 ||| NN
) ||| S:10682 E:10683 ||| -RRB-
.  ||| S:10683 E:10685 ||| .
A  ||| S:10685 E:10687 ||| DT
finite  ||| S:10687 E:10694 ||| JJ
number  ||| S:10694 E:10701 ||| NN
of  ||| S:10701 E:10714 ||| IN
qualitatively  ||| S:10714 E:10728 ||| JJ
different  ||| S:10728 E:10738 ||| JJ
patterns  ||| S:10738 E:10747 ||| NNS
of  ||| S:10747 E:10750 ||| IN
metabolic  ||| S:10750 E:10760 ||| JJ
pathway  ||| S:10760 E:10778 ||| JJ
utilization  ||| S:10778 E:10790 ||| NN
were  ||| S:10790 E:10795 ||| VBD
identified  ||| S:10795 E:10806 ||| VBN
in  ||| S:10806 E:10809 ||| IN
such  ||| S:10809 E:10814 ||| PDT
a  ||| S:10814 E:10816 ||| DT
plane ||| S:10816 E:10821 ||| NN
,  ||| S:10821 E:10823 ||| ,
and  ||| S:10823 E:10827 ||| CC
lines  ||| S:10827 E:10843 ||| NNS
were  ||| S:10843 E:10848 ||| VBD
drawn  ||| S:10848 E:10854 ||| VBN
to  ||| S:10854 E:10857 ||| TO
demarcate  ||| S:10857 E:10867 ||| VB
these  ||| S:10867 E:10873 ||| DT
regions ||| S:10873 E:10880 ||| NNS
.  ||| S:10880 E:10882 ||| .
Each  ||| S:10882 E:10887 ||| DT
region  ||| S:10887 E:10894 ||| NN
is  ||| S:10894 E:10907 ||| VBZ
denoted  ||| S:10907 E:10915 ||| VBN
by  ||| S:10915 E:10918 ||| IN
Pn  ||| S:10918 E:10932 ||| NNP
x ||| S:10932 E:10933 ||| NN
,  ||| S:10933 E:10935 ||| ,
y  ||| S:10935 E:10937 ||| NN
,  ||| S:10937 E:10939 ||| ,
where  ||| S:10939 E:10945 ||| NN
' ||| S:10945 E:10946 ||| POS
P ||| S:10946 E:10947 ||| NN
'  ||| S:10947 E:10949 ||| ''
indicates  ||| S:10949 E:10959 ||| VBZ
that  ||| S:10959 E:10964 ||| IN
the  ||| S:10964 E:10978 ||| DT
region  ||| S:10978 E:10985 ||| NN
was  ||| S:10985 E:10989 ||| VBD
defined  ||| S:10989 E:10997 ||| VBN
by  ||| S:10997 E:11000 ||| IN
a  ||| S:11000 E:11002 ||| DT
phenotype  ||| S:11002 E:11012 ||| JJ
phase  ||| S:11012 E:11018 ||| NN
plane  ||| S:11018 E:11024 ||| NN
analysis ||| S:11024 E:11032 ||| NN
,  ||| S:11032 E:11044 ||| ,
' ||| S:11044 E:11045 ||| ''
n ||| S:11045 E:11046 ||| NN
'  ||| S:11046 E:11048 ||| POS
denotes  ||| S:11048 E:11056 ||| VBG
the  ||| S:11056 E:11060 ||| DT
number  ||| S:11060 E:11067 ||| NN
of  ||| S:11067 E:11070 ||| IN
the  ||| S:11070 E:11074 ||| DT
demarcated  ||| S:11074 E:11085 ||| JJ
phase  ||| S:11085 E:11091 ||| NN
( ||| S:11091 E:11092 ||| -LRB-
as  ||| S:11092 E:11095 ||| RB
shown  ||| S:11095 E:11111 ||| VBN
in  ||| S:11111 E:11114 ||| IN
a  ||| S:11114 E:11116 ||| DT
particular  ||| S:11116 E:11127 ||| JJ
PhPP  ||| S:11127 E:11132 ||| JJ
figure ||| S:11132 E:11138 ||| NN
) ||| S:11138 E:11139 ||| -RRB-
,  ||| S:11139 E:11141 ||| ,
and  ||| S:11141 E:11145 ||| CC
' ||| S:11145 E:11146 ||| :
x ||| S:11146 E:11147 ||| LS
,  ||| S:11147 E:11149 ||| ,
y ||| S:11149 E:11150 ||| NN
'  ||| S:11150 E:11152 ||| POS
denotes  ||| S:11152 E:11160 ||| VBG
the  ||| S:11160 E:11164 ||| DT
two  ||| S:11164 E:11178 ||| CD
uptake  ||| S:11178 E:11185 ||| CD
rates  ||| S:11185 E:11191 ||| NNS
on  ||| S:11191 E:11194 ||| IN
the  ||| S:11194 E:11198 ||| DT
axis  ||| S:11198 E:11203 ||| NN
of  ||| S:11203 E:11206 ||| IN
the  ||| S:11206 E:11210 ||| DT
PhPP ||| S:11210 E:11214 ||| JJ
.  ||| S:11214 E:11216 ||| .
PhPPs  ||| S:11216 E:11222 ||| NNP
were  ||| S:11222 E:11227 ||| VBD
also  ||| S:11227 E:11242 ||| RB
generated  ||| S:11242 E:11252 ||| VBN
for  ||| S:11252 E:11256 ||| IN
mutant  ||| S:11256 E:11263 ||| JJ
genotypes ||| S:11263 E:11272 ||| NN
;  ||| S:11272 E:11274 ||| :
represented  ||| S:11274 E:11286 ||| VBN
as  ||| S:11286 E:11289 ||| IN
P  ||| S:11289 E:11291 ||| NN
genen  ||| S:11291 E:11308 ||| NN
x ||| S:11308 E:11309 ||| NN
,  ||| S:11309 E:11311 ||| ,
y  ||| S:11311 E:11313 ||| NN
.  ||| S:11313 E:11325 ||| .
One  ||| S:11325 E:11329 ||| CD
demarcation  ||| S:11329 E:11341 ||| JJ
line  ||| S:11341 E:11346 ||| NN
in  ||| S:11346 E:11349 ||| IN
the  ||| S:11349 E:11353 ||| DT
PhPP  ||| S:11353 E:11358 ||| NN
was  ||| S:11358 E:11362 ||| VBD
defined  ||| S:11362 E:11370 ||| VBN
as  ||| S:11370 E:11373 ||| IN
the  ||| S:11373 E:11387 ||| DT
line  ||| S:11387 E:11392 ||| NN
of  ||| S:11392 E:11395 ||| IN
optimality  ||| S:11395 E:11406 ||| NNS
( ||| S:11406 E:11407 ||| -LRB-
LO ||| S:11407 E:11409 ||| NNP
) ||| S:11409 E:11410 ||| -RRB-
.  ||| S:11410 E:11412 ||| .
The  ||| S:11412 E:11416 ||| DT
LO  ||| S:11416 E:11419 ||| NNP
represents  ||| S:11419 E:11430 ||| VBZ
the  ||| S:11430 E:11434 ||| DT
optimal  ||| S:11434 E:11452 ||| JJ
relation  ||| S:11452 E:11461 ||| NN
between  ||| S:11461 E:11469 ||| IN
exchange  ||| S:11469 E:11478 ||| NN
fluxes  ||| S:11478 E:11485 ||| VBZ
defined  ||| S:11485 E:11493 ||| VBN
on  ||| S:11493 E:11496 ||| IN
the  ||| S:11496 E:11500 ||| DT
axes  ||| S:11500 E:11505 ||| NN
of  ||| S:11505 E:11518 ||| IN
the  ||| S:11518 E:11522 ||| DT
PhPP ||| S:11522 E:11526 ||| JJ
.  ||| S:11526 E:11556 ||| .
Alterations  ||| S:11556 E:11568 ||| NNP
of  ||| S:11568 E:11571 ||| IN
the  ||| S:11571 E:11575 ||| DT
genotype  ||| S:11575 E:11594 ||| JJ
FBA  ||| S:11594 E:11598 ||| NNP
and  ||| S:11598 E:11613 ||| CC
E.  ||| S:11613 E:11616 ||| NNP
coli  ||| S:11616 E:11621 ||| NNS
in  ||| S:11621 E:11624 ||| IN
silico  ||| S:11624 E:11631 ||| NN
were  ||| S:11631 E:11636 ||| VBD
used  ||| S:11636 E:11641 ||| VBN
to  ||| S:11641 E:11654 ||| TO
examine  ||| S:11654 E:11662 ||| VB
the  ||| S:11662 E:11666 ||| DT
systemic  ||| S:11666 E:11675 ||| JJ
effects  ||| S:11675 E:11683 ||| NNS
of  ||| S:11683 E:11686 ||| IN
in  ||| S:11686 E:11700 ||| IN
silico  ||| S:11700 E:11707 ||| JJ
gene  ||| S:11707 E:11712 ||| NN
deletions ||| S:11712 E:11721 ||| NNS
.  ||| S:11721 E:11723 ||| .
The  ||| S:11723 E:11727 ||| DT
genes  ||| S:11727 E:11743 ||| NNS
involved  ||| S:11743 E:11752 ||| VBN
in  ||| S:11752 E:11755 ||| IN
the  ||| S:11755 E:11759 ||| DT
central  ||| S:11759 E:11767 ||| JJ
metabolic  ||| S:11767 E:11777 ||| JJ
pathways  ||| S:11777 E:11786 ||| NNS
( ||| S:11786 E:11787 ||| -LRB-
glycolysis ||| S:11787 E:11797 ||| UH
,  ||| S:11797 E:11809 ||| ,
pentose  ||| S:11809 E:11817 ||| FW
phosphate  ||| S:11817 E:11827 ||| FW
pathway ||| S:11827 E:11834 ||| FW
,  ||| S:11834 E:11836 ||| ,
TCA  ||| S:11836 E:11840 ||| NNP
cycle ||| S:11840 E:11845 ||| NN
,  ||| S:11845 E:11847 ||| ,
electron  ||| S:11847 E:11856 ||| JJ
transport ||| S:11856 E:11865 ||| NN
)  ||| S:11865 E:11877 ||| -RRB-
were  ||| S:11877 E:11882 ||| VBD
subjected  ||| S:11882 E:11892 ||| VBN
to  ||| S:11892 E:11895 ||| TO
removal  ||| S:11895 E:11903 ||| NN
from  ||| S:11903 E:11919 ||| IN
E.  ||| S:11919 E:11922 ||| NNP
coli  ||| S:11922 E:11927 ||| NNS
in  ||| S:11927 E:11930 ||| IN
silico ||| S:11930 E:11936 ||| NN
.  ||| S:11936 E:11938 ||| .
To  ||| S:11938 E:11941 ||| TO
simulate  ||| S:11941 E:11950 ||| VB
a  ||| S:11950 E:11962 ||| DT
gene  ||| S:11962 E:11967 ||| NN
deletion ||| S:11967 E:11975 ||| NN
,  ||| S:11975 E:11977 ||| ,
all  ||| S:11977 E:11981 ||| DT
metabolic  ||| S:11981 E:11991 ||| JJ
reactions  ||| S:11991 E:12001 ||| NNS
catalyzed  ||| S:12001 E:12011 ||| VBN
by  ||| S:12011 E:12014 ||| IN
a  ||| S:12014 E:12026 ||| DT
given  ||| S:12026 E:12032 ||| VBN
gene  ||| S:12032 E:12037 ||| NN
product  ||| S:12037 E:12045 ||| NN
were  ||| S:12045 E:12050 ||| VBD
simultaneously  ||| S:12050 E:12065 ||| RB
constrained  ||| S:12065 E:12077 ||| VBN
to  ||| S:12077 E:12090 ||| TO
zero ||| S:12090 E:12094 ||| CD
.  ||| S:12094 E:12096 ||| .
Some  ||| S:12096 E:12101 ||| DT
metabolic  ||| S:12101 E:12111 ||| JJ
reactions  ||| S:12111 E:12121 ||| NNS
were  ||| S:12121 E:12126 ||| VBD
catalyzed  ||| S:12126 E:12136 ||| VBN
by  ||| S:12136 E:12139 ||| IN
more  ||| S:12139 E:12154 ||| JJR
than  ||| S:12154 E:12159 ||| IN
one  ||| S:12159 E:12163 ||| CD
enzyme ||| S:12163 E:12169 ||| NN
,  ||| S:12169 E:12171 ||| ,
and  ||| S:12171 E:12175 ||| CC
all  ||| S:12175 E:12179 ||| DT
genes  ||| S:12179 E:12185 ||| NNS
that  ||| S:12185 E:12190 ||| IN
code  ||| S:12190 E:12195 ||| NN
for  ||| S:12195 E:12199 ||| IN
enzymes  ||| S:12199 E:12207 ||| NNS
that  ||| S:12207 E:12222 ||| WDT
catalyze  ||| S:12222 E:12231 ||| VBZ
a  ||| S:12231 E:12233 ||| DT
given  ||| S:12233 E:12239 ||| VBN
reaction  ||| S:12239 E:12248 ||| NN
were  ||| S:12248 E:12253 ||| VBD
simultaneously  ||| S:12253 E:12268 ||| RB
removed  ||| S:12268 E:12286 ||| VBN
( ||| S:12286 E:12287 ||| -LRB-
i.e.  ||| S:12287 E:12303 ||| FW
rpiAB  ||| S:12303 E:12309 ||| FW
) ||| S:12309 E:12310 ||| -RRB-
.  ||| S:12310 E:12312 ||| .
Furthermore ||| S:12312 E:12323 ||| RB
,  ||| S:12323 E:12325 ||| ,
all  ||| S:12325 E:12329 ||| DT
genes  ||| S:12329 E:12345 ||| NNS
that  ||| S:12345 E:12350 ||| WDT
make  ||| S:12350 E:12355 ||| VBP
up  ||| S:12355 E:12358 ||| RP
an  ||| S:12358 E:12361 ||| DT
enzyme  ||| S:12361 E:12368 ||| JJ
complex  ||| S:12368 E:12376 ||| NN
were  ||| S:12376 E:12381 ||| VBD
also  ||| S:12381 E:12386 ||| RB
simultaneously  ||| S:12386 E:12411 ||| RB
removed  ||| S:12411 E:12419 ||| VBN
( ||| S:12419 E:12420 ||| -LRB-
i.e.  ||| S:12420 E:12436 ||| FW
sdhABCD  ||| S:12436 E:12444 ||| FW
) ||| S:12444 E:12445 ||| -RRB-
.  ||| S:12445 E:12457 ||| .
The  ||| S:12457 E:12461 ||| DT
optimal  ||| S:12461 E:12469 ||| JJ
metabolic  ||| S:12469 E:12479 ||| JJ
flux  ||| S:12479 E:12484 ||| JJ
distribution  ||| S:12484 E:12497 ||| NN
for  ||| S:12497 E:12501 ||| IN
the  ||| S:12501 E:12515 ||| DT
generation  ||| S:12515 E:12526 ||| NN
of  ||| S:12526 E:12529 ||| IN
biomass  ||| S:12529 E:12537 ||| NN
was  ||| S:12537 E:12541 ||| VBD
calculated  ||| S:12541 E:12552 ||| VBN
for  ||| S:12552 E:12556 ||| IN
each  ||| S:12556 E:12572 ||| DT
in  ||| S:12572 E:12575 ||| IN
silico  ||| S:12575 E:12582 ||| JJ
deletion  ||| S:12582 E:12591 ||| JJ
strain ||| S:12591 E:12597 ||| NN
.  ||| S:12597 E:12599 ||| .
The  ||| S:12599 E:12614 ||| DT
in  ||| S:12614 E:12617 ||| IN
silico  ||| S:12617 E:12624 ||| JJ
gene  ||| S:12624 E:12629 ||| NN
deletion  ||| S:12629 E:12638 ||| NN
analysis  ||| S:12638 E:12657 ||| NN
was  ||| S:12657 E:12661 ||| VBD
performed  ||| S:12661 E:12671 ||| VBN
with  ||| S:12671 E:12676 ||| IN
the  ||| S:12676 E:12680 ||| DT
transport  ||| S:12680 E:12690 ||| NN
flux  ||| S:12690 E:12695 ||| NN
constraints  ||| S:12695 E:12707 ||| NNS
defined  ||| S:12707 E:12725 ||| VBN
by  ||| S:12725 E:12728 ||| IN
the  ||| S:12728 E:12732 ||| DT
wild-type  ||| S:12732 E:12742 ||| JJ
PhPP ||| S:12742 E:12746 ||| NN
.  ||| S:12746 E:12748 ||| .
The  ||| S:12748 E:12752 ||| DT
constraints  ||| S:12752 E:12764 ||| NNS
imposed  ||| S:12764 E:12772 ||| VBN
for  ||| S:12772 E:12776 ||| IN
each  ||| S:12776 E:12791 ||| DT
simulation  ||| S:12791 E:12802 ||| NNS
are  ||| S:12802 E:12806 ||| VBP
noted  ||| S:12806 E:12812 ||| VBN
in  ||| S:12812 E:12815 ||| IN
Fig.  ||| S:12815 E:12820 ||| CD
1 ||| S:12820 E:12821 ||| CD
.  ||| S:12821 E:12833 ||| .
For  ||| S:12833 E:12837 ||| IN
each  ||| S:12837 E:12853 ||| DT
in  ||| S:12853 E:12856 ||| IN
silico  ||| S:12856 E:12863 ||| JJ
deletion  ||| S:12863 E:12872 ||| JJ
strain ||| S:12872 E:12878 ||| NN
,  ||| S:12878 E:12880 ||| ,
the  ||| S:12880 E:12894 ||| DT
optimal  ||| S:12894 E:12902 ||| JJ
production  ||| S:12902 E:12913 ||| NN
of  ||| S:12913 E:12916 ||| IN
the  ||| S:12916 E:12920 ||| DT
twelve  ||| S:12920 E:12927 ||| JJ
biosynthetic  ||| S:12927 E:12940 ||| JJ
precursors  ||| S:12940 E:12961 ||| NN
and  ||| S:12961 E:12965 ||| CC
the  ||| S:12965 E:12969 ||| DT
metabolic  ||| S:12969 E:12979 ||| JJ
cofactors  ||| S:12979 E:12989 ||| NN
was  ||| S:12989 E:12993 ||| VBD
also  ||| S:12993 E:12998 ||| RB
calculated  ||| S:12998 E:13009 ||| VBN
to  ||| S:13009 E:13022 ||| TO
identify  ||| S:13022 E:13031 ||| VB
auxotrophic  ||| S:13031 E:13043 ||| JJ
requirements  ||| S:13043 E:13056 ||| NNS
and  ||| S:13056 E:13060 ||| CC
impaired  ||| S:13060 E:13069 ||| JJ
functions  ||| S:13069 E:13089 ||| NNS
in  ||| S:13089 E:13092 ||| IN
the  ||| S:13092 E:13096 ||| DT
metabolic  ||| S:13096 E:13106 ||| JJ
network  ||| S:13106 E:13114 ||| NN
( ||| S:13114 E:13115 ||| -LRB-
Table  ||| S:13115 E:13121 ||| NNP
1 ||| S:13121 E:13122 ||| CD
) ||| S:13122 E:13123 ||| -RRB-
.  ||| S:13123 E:13125 ||| .
The  ||| S:13125 E:13129 ||| DT
optimal  ||| S:13129 E:13147 ||| JJ
production  ||| S:13147 E:13158 ||| NN
of  ||| S:13158 E:13161 ||| IN
the  ||| S:13161 E:13165 ||| DT
biosynthetic  ||| S:13165 E:13178 ||| JJ
precursors  ||| S:13178 E:13189 ||| NN
was  ||| S:13189 E:13193 ||| VBD
calculated  ||| S:13193 E:13214 ||| VBN
by  ||| S:13214 E:13217 ||| IN
setting  ||| S:13217 E:13225 ||| VBG
the  ||| S:13225 E:13229 ||| DT
objective  ||| S:13229 E:13239 ||| JJ
function  ||| S:13239 E:13248 ||| NN
to  ||| S:13248 E:13251 ||| TO
the  ||| S:13251 E:13255 ||| DT
drain  ||| S:13255 E:13261 ||| NN
of  ||| S:13261 E:13264 ||| IN
a  ||| S:13264 E:13276 ||| DT
single  ||| S:13276 E:13283 ||| JJ
metabolite  ||| S:13283 E:13294 ||| NNS
( ||| S:13294 E:13295 ||| -LRB-
i.e. ||| S:13295 E:13299 ||| FW
,  ||| S:13299 E:13301 ||| ,
ATP  ||| S:13301 E:13305 ||| FW
→  ||| S:13305 E:13307 ||| FW
ADP  ||| S:13307 E:13311 ||| FW
+  ||| S:13311 E:13313 ||| FW
P  ||| S:13313 E:13326 ||| FW
i  ||| S:13326 E:13328 ||| FW
,  ||| S:13328 E:13330 ||| ,
or  ||| S:13330 E:13333 ||| CC
PEP  ||| S:13333 E:13337 ||| NNP
→ ||| S:13337 E:13338 ||| NNP
) ||| S:13338 E:13339 ||| -RRB-
.  ||| S:13339 E:13341 ||| .
The  ||| S:13341 E:13345 ||| DT
numerical  ||| S:13345 E:13355 ||| JJ
value  ||| S:13355 E:13361 ||| NN
of  ||| S:13361 E:13374 ||| IN
the  ||| S:13374 E:13378 ||| DT
objective  ||| S:13378 E:13388 ||| JJ
function  ||| S:13388 E:13397 ||| NN
for  ||| S:13397 E:13401 ||| IN
each  ||| S:13401 E:13417 ||| DT
in  ||| S:13417 E:13420 ||| IN
silico  ||| S:13420 E:13427 ||| JJ
deletion  ||| S:13427 E:13436 ||| JJ
strain  ||| S:13436 E:13443 ||| NN
was  ||| S:13443 E:13457 ||| VBD
reported  ||| S:13457 E:13466 ||| VBN
as  ||| S:13466 E:13469 ||| IN
a  ||| S:13469 E:13471 ||| DT
fraction  ||| S:13471 E:13480 ||| NN
of  ||| S:13480 E:13483 ||| IN
the  ||| S:13483 E:13487 ||| DT
wild-type  ||| S:13487 E:13497 ||| JJ
optimal  ||| S:13497 E:13505 ||| JJ
value  ||| S:13505 E:13521 ||| NN
( ||| S:13521 E:13522 ||| -LRB-
Table  ||| S:13522 E:13528 ||| NNP
1 ||| S:13528 E:13529 ||| CD
) ||| S:13529 E:13530 ||| -RRB-
.  ||| S:13530 E:13563 ||| .
Results  ||| S:13563 E:13579 ||| NNS
We  ||| S:13579 E:13582 ||| PRP
have  ||| S:13582 E:13587 ||| VBP
previously  ||| S:13587 E:13598 ||| RB
described  ||| S:13598 E:13608 ||| VBD
the  ||| S:13608 E:13612 ||| DT
construction  ||| S:13612 E:13625 ||| NN
of  ||| S:13625 E:13636 ||| IN
phenotype  ||| S:13636 E:13646 ||| JJ
phase  ||| S:13646 E:13652 ||| NN
planes  ||| S:13652 E:13659 ||| NNS
( ||| S:13659 E:13660 ||| -LRB-
PhPPs ||| S:13660 E:13665 ||| NNP
)  ||| S:13665 E:13667 ||| -RRB-
( ||| S:13667 E:13668 ||| -LRB-
see  ||| S:13668 E:13672 ||| VB
materials  ||| S:13672 E:13682 ||| NNS
and  ||| S:13682 E:13686 ||| CC
methods ||| S:13686 E:13693 ||| NNS
)  ||| S:13693 E:13703 ||| -RRB-
and  ||| S:13703 E:13707 ||| CC
the  ||| S:13707 E:13711 ||| DT
analysis  ||| S:13711 E:13720 ||| NN
of  ||| S:13720 E:13723 ||| IN
the  ||| S:13723 E:13727 ||| DT
glucose-oxygen  ||| S:13727 E:13742 ||| JJ
PhPP ||| S:13742 E:13746 ||| NN
.  ||| S:13746 E:13748 ||| .
We  ||| S:13748 E:13751 ||| PRP
have  ||| S:13751 E:13764 ||| VBP
previously  ||| S:13764 E:13775 ||| RB
described  ||| S:13775 E:13785 ||| VBD
the  ||| S:13785 E:13789 ||| DT
effect  ||| S:13789 E:13796 ||| NN
of  ||| S:13796 E:13808 ||| IN
in  ||| S:13808 E:13811 ||| IN
silico  ||| S:13811 E:13818 ||| NN
' ||| S:13818 E:13819 ||| POS
gene  ||| S:13819 E:13824 ||| NN
deletions ||| S:13824 E:13833 ||| NNS
'  ||| S:13833 E:13835 ||| ''
on  ||| S:13835 E:13838 ||| IN
the  ||| S:13838 E:13850 ||| DT
ability  ||| S:13850 E:13858 ||| NN
of  ||| S:13858 E:13870 ||| IN
E.  ||| S:13870 E:13873 ||| NNP
coli  ||| S:13873 E:13878 ||| NNS
in  ||| S:13878 E:13881 ||| IN
silico  ||| S:13881 E:13888 ||| VBG
to  ||| S:13888 E:13891 ||| TO
' ||| S:13891 E:13892 ||| ''
grow ||| S:13892 E:13896 ||| VB
'  ||| S:13896 E:13898 ||| ''
under  ||| S:13898 E:13904 ||| IN
a  ||| S:13904 E:13914 ||| DT
single  ||| S:13914 E:13921 ||| JJ
condition  ||| S:13921 E:13931 ||| NN
[  ||| S:13931 E:13933 ||| -LRB-
18 ||| S:13933 E:13935 ||| CD
] ||| S:13935 E:13936 ||| -RRB-
.  ||| S:13936 E:13938 ||| .
Since  ||| S:13938 E:13944 ||| IN
the  ||| S:13944 E:13948 ||| DT
utilization  ||| S:13948 E:13960 ||| NN
of  ||| S:13960 E:13963 ||| IN
the  ||| S:13963 E:13975 ||| DT
metabolic  ||| S:13975 E:13985 ||| JJ
pathways  ||| S:13985 E:13994 ||| NN
is  ||| S:13994 E:13997 ||| VBZ
condition  ||| S:13997 E:14007 ||| NN
dependent ||| S:14007 E:14016 ||| NN
,  ||| S:14016 E:14018 ||| ,
herein ||| S:14018 E:14024 ||| NN
,  ||| S:14024 E:14026 ||| ,
we  ||| S:14026 E:14029 ||| PRP
have  ||| S:14029 E:14042 ||| VBP
investigated  ||| S:14042 E:14055 ||| VBN
the  ||| S:14055 E:14059 ||| DT
link  ||| S:14059 E:14064 ||| NN
between  ||| S:14064 E:14072 ||| IN
the  ||| S:14072 E:14076 ||| DT
environmental  ||| S:14076 E:14090 ||| JJ
conditions  ||| S:14090 E:14109 ||| NNS
and  ||| S:14109 E:14113 ||| CC
the  ||| S:14113 E:14117 ||| DT
optimal  ||| S:14117 E:14125 ||| JJ
metabolic  ||| S:14125 E:14135 ||| JJ
pathway  ||| S:14135 E:14143 ||| JJ
utilization  ||| S:14143 E:14164 ||| NN
in  ||| S:14164 E:14167 ||| IN
silico  ||| S:14167 E:14174 ||| NN
by ||| S:14174 E:14176 ||| IN
:  ||| S:14176 E:14178 ||| :
1.  ||| S:14178 E:14181 ||| CD
studying  ||| S:14181 E:14190 ||| VBG
the  ||| S:14190 E:14194 ||| DT
effects  ||| S:14194 E:14210 ||| NNS
of  ||| S:14210 E:14213 ||| IN
gene  ||| S:14213 E:14218 ||| NN
deletions  ||| S:14218 E:14228 ||| NNS
in  ||| S:14228 E:14231 ||| IN
all  ||| S:14231 E:14235 ||| DT
phases  ||| S:14235 E:14242 ||| NNS
of  ||| S:14242 E:14245 ||| IN
the  ||| S:14245 E:14249 ||| DT
glucose-oxygen  ||| S:14249 E:14264 ||| JJ
PhPP ||| S:14264 E:14268 ||| NN
,  ||| S:14268 E:14278 ||| ,
and  ||| S:14278 E:14282 ||| CC
2.  ||| S:14282 E:14285 ||| RB
broadening  ||| S:14285 E:14296 ||| VBG
the  ||| S:14296 E:14300 ||| DT
analysis  ||| S:14300 E:14309 ||| NN
of  ||| S:14309 E:14321 ||| IN
in  ||| S:14321 E:14324 ||| IN
silico  ||| S:14324 E:14331 ||| JJ
deletion  ||| S:14331 E:14340 ||| NN
strains  ||| S:14340 E:14348 ||| NNS
by  ||| S:14348 E:14359 ||| IN
comparing  ||| S:14359 E:14369 ||| VBG
PhPPs  ||| S:14369 E:14375 ||| JJ
from  ||| S:14375 E:14380 ||| IN
isogenic  ||| S:14380 E:14398 ||| NN
in  ||| S:14398 E:14401 ||| IN
silico  ||| S:14401 E:14408 ||| JJ
strains ||| S:14408 E:14415 ||| NNS
.  ||| S:14415 E:14434 ||| .
Gene  ||| S:14434 E:14439 ||| NNP
Deletions  ||| S:14439 E:14449 ||| NNP
:  ||| S:14449 E:14451 ||| :
A  ||| S:14451 E:14453 ||| DT
point  ||| S:14453 E:14459 ||| NN
within  ||| S:14459 E:14466 ||| IN
each  ||| S:14466 E:14479 ||| DT
phase  ||| S:14479 E:14485 ||| NN
of  ||| S:14485 E:14488 ||| IN
the  ||| S:14488 E:14492 ||| DT
glucose-oxygen  ||| S:14492 E:14507 ||| JJ
PhPP  ||| S:14507 E:14512 ||| NN
was  ||| S:14512 E:14516 ||| VBD
chosen  ||| S:14516 E:14523 ||| VBN
to  ||| S:14523 E:14526 ||| TO
define  ||| S:14526 E:14533 ||| VB
the  ||| S:14533 E:14545 ||| DT
transport  ||| S:14545 E:14555 ||| NN
flux  ||| S:14555 E:14560 ||| NN
constraints  ||| S:14560 E:14572 ||| NNS
( ||| S:14572 E:14573 ||| -LRB-
indicated  ||| S:14573 E:14583 ||| VBN
in  ||| S:14583 E:14586 ||| IN
Fig.  ||| S:14586 E:14591 ||| CD
1 ||| S:14591 E:14592 ||| CD
)  ||| S:14592 E:14594 ||| -RRB-
for  ||| S:14594 E:14598 ||| IN
the  ||| S:14598 E:14610 ||| DT
FBA  ||| S:14610 E:14614 ||| NNP
simulations ||| S:14614 E:14625 ||| NNS
.  ||| S:14625 E:14627 ||| .
At  ||| S:14627 E:14630 ||| IN
each  ||| S:14630 E:14635 ||| DT
point ||| S:14635 E:14640 ||| NN
,  ||| S:14640 E:14642 ||| ,
the  ||| S:14642 E:14646 ||| DT
growth  ||| S:14646 E:14653 ||| NN
characteristics  ||| S:14653 E:14677 ||| NNS
of  ||| S:14677 E:14680 ||| IN
all  ||| S:14680 E:14693 ||| DT
in  ||| S:14693 E:14696 ||| IN
silico  ||| S:14696 E:14703 ||| JJ
gene  ||| S:14703 E:14708 ||| NN
deletion  ||| S:14708 E:14717 ||| NN
strains  ||| S:14717 E:14725 ||| NNS
( ||| S:14725 E:14726 ||| -LRB-
of  ||| S:14726 E:14737 ||| IN
central  ||| S:14737 E:14745 ||| JJ
metabolic  ||| S:14745 E:14755 ||| JJ
pathway  ||| S:14755 E:14763 ||| JJ
genes ||| S:14763 E:14768 ||| NNS
)  ||| S:14768 E:14770 ||| -RRB-
were  ||| S:14770 E:14775 ||| VBD
examined ||| S:14775 E:14783 ||| VBN
.  ||| S:14783 E:14785 ||| .
Based  ||| S:14785 E:14791 ||| VBN
on  ||| S:14791 E:14802 ||| IN
the  ||| S:14802 E:14806 ||| DT
results ||| S:14806 E:14813 ||| NNS
,  ||| S:14813 E:14815 ||| ,
the  ||| S:14815 E:14819 ||| DT
genes  ||| S:14819 E:14825 ||| NNS
were  ||| S:14825 E:14830 ||| VBD
categorized  ||| S:14830 E:14842 ||| VBN
as ||| S:14842 E:14844 ||| RB
;  ||| S:14844 E:14855 ||| :
essential  ||| S:14855 E:14865 ||| JJ
( ||| S:14865 E:14866 ||| -LRB-
growth  ||| S:14866 E:14873 ||| NN
under  ||| S:14873 E:14879 ||| IN
the  ||| S:14879 E:14883 ||| DT
defined  ||| S:14883 E:14899 ||| JJ
condition  ||| S:14899 E:14909 ||| NN
requires  ||| S:14909 E:14918 ||| VBZ
the  ||| S:14918 E:14922 ||| DT
activity  ||| S:14922 E:14931 ||| NN
of  ||| S:14931 E:14934 ||| IN
the  ||| S:14934 E:14938 ||| DT
corresponding  ||| S:14938 E:14952 ||| JJ
gene  ||| S:14952 E:14965 ||| NN
product ||| S:14965 E:14972 ||| NN
) ||| S:14972 E:14973 ||| -RRB-
,  ||| S:14973 E:14984 ||| ,
critical  ||| S:14984 E:14993 ||| JJ
( ||| S:14993 E:14994 ||| -LRB-
growth  ||| S:14994 E:15001 ||| NN
at  ||| S:15001 E:15004 ||| IN
a  ||| S:15004 E:15006 ||| DT
reduced  ||| S:15006 E:15014 ||| JJ
yield  ||| S:15014 E:15028 ||| NN
(  ||| S:15028 E:15029 ||| -LRB-
< ||| S:15029 E:15031 ||| SYM
95 ||| S:15031 E:15033 ||| CD
%  ||| S:15033 E:15035 ||| NN
of  ||| S:15035 E:15038 ||| IN
wild-type ||| S:15038 E:15047 ||| NNP
) ||| S:15047 E:15048 ||| -RRB-
) ||| S:15048 E:15049 ||| -RRB-
,  ||| S:15049 E:15051 ||| ,
or  ||| S:15051 E:15063 ||| CC
non-essential  ||| S:15063 E:15077 ||| NNP
( ||| S:15077 E:15078 ||| -LRB-
growth  ||| S:15078 E:15085 ||| NN
at  ||| S:15085 E:15088 ||| IN
near  ||| S:15088 E:15101 ||| JJ
wild-type  ||| S:15101 E:15111 ||| JJ
yield  ||| S:15111 E:15117 ||| NN
( ||| S:15117 E:15118 ||| -LRB-
>  ||| S:15118 E:15120 ||| CD
95 ||| S:15120 E:15122 ||| CD
% ||| S:15122 E:15123 ||| NN
) ||| S:15123 E:15124 ||| -RRB-
) ||| S:15124 E:15125 ||| -RRB-
.  ||| S:15125 E:15127 ||| .
The  ||| S:15127 E:15131 ||| DT
effects  ||| S:15131 E:15139 ||| NNS
of  ||| S:15139 E:15142 ||| IN
the  ||| S:15142 E:15155 ||| DT
in  ||| S:15155 E:15158 ||| IN
silico  ||| S:15158 E:15165 ||| JJ
gene  ||| S:15165 E:15170 ||| NN
deletions  ||| S:15170 E:15180 ||| NNS
were  ||| S:15180 E:15193 ||| VBD
phase-dependent ||| S:15193 E:15208 ||| JJ
,  ||| S:15208 E:15210 ||| ,
allowing  ||| S:15210 E:15219 ||| VBG
us  ||| S:15219 E:15222 ||| PRP
to  ||| S:15222 E:15225 ||| TO
identify  ||| S:15225 E:15234 ||| VB
optimal  ||| S:15234 E:15242 ||| JJ
growth  ||| S:15242 E:15257 ||| NN
phenotypes  ||| S:15257 E:15268 ||| NN
for  ||| S:15268 E:15272 ||| IN
each  ||| S:15272 E:15277 ||| DT
growth  ||| S:15277 E:15284 ||| NN
condition ||| S:15284 E:15293 ||| NN
.  ||| S:15293 E:15295 ||| .
Additionally ||| S:15295 E:15307 ||| RB
,  ||| S:15307 E:15309 ||| ,
the  ||| S:15309 E:15321 ||| DT
optimal  ||| S:15321 E:15329 ||| JJ
production  ||| S:15329 E:15340 ||| NN
of  ||| S:15340 E:15343 ||| IN
the  ||| S:15343 E:15347 ||| DT
12  ||| S:15347 E:15350 ||| CD
biosynthetic  ||| S:15350 E:15363 ||| JJ
precursors ||| S:15363 E:15373 ||| NN
,  ||| S:15373 E:15383 ||| ,
high-energy  ||| S:15383 E:15395 ||| JJ
phosphate  ||| S:15395 E:15405 ||| JJ
bonds ||| S:15405 E:15410 ||| NNS
,  ||| S:15410 E:15412 ||| ,
and  ||| S:15412 E:15416 ||| CC
redox  ||| S:15416 E:15422 ||| JJ
potential  ||| S:15422 E:15432 ||| NN
was  ||| S:15432 E:15444 ||| VBD
calculated  ||| S:15444 E:15455 ||| VBN
for  ||| S:15455 E:15459 ||| IN
each  ||| S:15459 E:15473 ||| DT
in  ||| S:15473 E:15476 ||| IN
silico  ||| S:15476 E:15483 ||| JJ
deletion  ||| S:15483 E:15492 ||| JJ
strain  ||| S:15492 E:15499 ||| NN
( ||| S:15499 E:15500 ||| -LRB-
Table  ||| S:15500 E:15506 ||| NNP
1 ||| S:15506 E:15507 ||| CD
)  ||| S:15507 E:15517 ||| -RRB-
to  ||| S:15517 E:15520 ||| TO
determine  ||| S:15520 E:15530 ||| VB
the  ||| S:15530 E:15534 ||| DT
specific  ||| S:15534 E:15543 ||| JJ
effect  ||| S:15543 E:15550 ||| NN
of  ||| S:15550 E:15553 ||| IN
the  ||| S:15553 E:15557 ||| DT
gene  ||| S:15557 E:15562 ||| NN
deletion  ||| S:15562 E:15571 ||| NN
on  ||| S:15571 E:15582 ||| IN
the  ||| S:15582 E:15586 ||| DT
metabolic  ||| S:15586 E:15596 ||| JJ
capabilities ||| S:15596 E:15608 ||| NNS
.  ||| S:15608 E:15610 ||| .
For  ||| S:15610 E:15614 ||| IN
instance ||| S:15614 E:15622 ||| NN
,  ||| S:15622 E:15624 ||| ,
the  ||| S:15624 E:15637 ||| DT
in  ||| S:15637 E:15640 ||| IN
silico  ||| S:15640 E:15647 ||| JJ
acnAB ||| S:15647 E:15652 ||| NN
'  ||| S:15652 E:15654 ||| POS
strain  ||| S:15654 E:15661 ||| NN
was  ||| S:15661 E:15665 ||| VBD
unable  ||| S:15665 E:15672 ||| JJ
to  ||| S:15672 E:15683 ||| TO
synthesize  ||| S:15683 E:15694 ||| VB
α-ketoglutarate  ||| S:15694 E:15710 ||| JJ
under  ||| S:15710 E:15716 ||| IN
all  ||| S:15716 E:15720 ||| DT
simulated  ||| S:15720 E:15730 ||| JJ
growth  ||| S:15730 E:15745 ||| NN
conditions ||| S:15745 E:15755 ||| NNS
,  ||| S:15755 E:15757 ||| ,
and  ||| S:15757 E:15761 ||| CC
thus ||| S:15761 E:15765 ||| RB
,  ||| S:15765 E:15776 ||| ,
acnAB  ||| S:15776 E:15782 ||| NNP
was  ||| S:15782 E:15786 ||| VBD
defined  ||| S:15786 E:15794 ||| VBN
as  ||| S:15794 E:15797 ||| IN
essential  ||| S:15797 E:15807 ||| JJ
for  ||| S:15807 E:15819 ||| IN
growth  ||| S:15819 E:15826 ||| NN
in  ||| S:15826 E:15829 ||| IN
a  ||| S:15829 E:15831 ||| DT
glucose  ||| S:15831 E:15839 ||| JJ
minimal  ||| S:15839 E:15847 ||| JJ
media  ||| S:15847 E:15853 ||| NNS
( ||| S:15853 E:15854 ||| -LRB-
Table  ||| S:15854 E:15860 ||| NNP
1 ||| S:15860 E:15861 ||| CD
) ||| S:15861 E:15862 ||| -RRB-
.  ||| S:15862 E:15872 ||| .
The  ||| S:15872 E:15876 ||| DT
optimal  ||| S:15876 E:15884 ||| JJ
utilization  ||| S:15884 E:15896 ||| NN
of  ||| S:15896 E:15899 ||| IN
the  ||| S:15899 E:15903 ||| DT
metabolic  ||| S:15903 E:15913 ||| JJ
pathways  ||| S:15913 E:15922 ||| NN
was  ||| S:15922 E:15934 ||| VBD
dependent  ||| S:15934 E:15944 ||| JJ
on  ||| S:15944 E:15947 ||| IN
the  ||| S:15947 E:15951 ||| DT
specific  ||| S:15951 E:15960 ||| JJ
transport  ||| S:15960 E:15970 ||| NN
flux  ||| S:15970 E:15975 ||| NN
constraints ||| S:15975 E:15986 ||| NNS
,  ||| S:15986 E:15988 ||| ,
and  ||| S:15988 E:16000 ||| CC
the  ||| S:16000 E:16004 ||| DT
qualitative  ||| S:16004 E:16016 ||| JJ
shifts  ||| S:16016 E:16023 ||| NNS
in  ||| S:16023 E:16026 ||| IN
optimal  ||| S:16026 E:16034 ||| JJ
metabolic  ||| S:16034 E:16044 ||| JJ
behavior  ||| S:16044 E:16053 ||| NN
as  ||| S:16053 E:16056 ||| IN
a  ||| S:16056 E:16066 ||| DT
function  ||| S:16066 E:16075 ||| NN
of  ||| S:16075 E:16078 ||| IN
two  ||| S:16078 E:16082 ||| CD
transport  ||| S:16082 E:16092 ||| NN
fluxes  ||| S:16092 E:16099 ||| NNS
are  ||| S:16099 E:16103 ||| VBP
shown  ||| S:16103 E:16109 ||| VBN
in  ||| S:16109 E:16112 ||| IN
the  ||| S:16112 E:16116 ||| DT
PhPP ||| S:16116 E:16120 ||| JJ
.  ||| S:16120 E:16122 ||| .
The  ||| S:16122 E:16134 ||| DT
optimal  ||| S:16134 E:16142 ||| JJ
biomass  ||| S:16142 E:16150 ||| JJ
yield  ||| S:16150 E:16156 ||| NN
and  ||| S:16156 E:16160 ||| CC
biosynthetic  ||| S:16160 E:16173 ||| JJ
precursor  ||| S:16173 E:16183 ||| JJ
production  ||| S:16183 E:16202 ||| NN
capabilities  ||| S:16202 E:16215 ||| NNS
were  ||| S:16215 E:16220 ||| VBD
calculated  ||| S:16220 E:16231 ||| VBN
for  ||| S:16231 E:16235 ||| IN
each  ||| S:16235 E:16249 ||| DT
E.  ||| S:16249 E:16252 ||| NNP
coli  ||| S:16252 E:16257 ||| NNS
in  ||| S:16257 E:16260 ||| IN
silico  ||| S:16260 E:16267 ||| JJ
deletion  ||| S:16267 E:16276 ||| JJ
strain  ||| S:16276 E:16283 ||| NN
for  ||| S:16283 E:16295 ||| IN
a  ||| S:16295 E:16297 ||| DT
point  ||| S:16297 E:16303 ||| NN
within  ||| S:16303 E:16310 ||| IN
each  ||| S:16310 E:16315 ||| DT
region  ||| S:16315 E:16322 ||| NN
of  ||| S:16322 E:16325 ||| IN
the  ||| S:16325 E:16329 ||| DT
PhPP ||| S:16329 E:16333 ||| JJ
,  ||| S:16333 E:16335 ||| ,
and  ||| S:16335 E:16339 ||| CC
the  ||| S:16339 E:16343 ||| DT
optimal  ||| S:16343 E:16359 ||| JJ
values  ||| S:16359 E:16366 ||| NNS
were  ||| S:16366 E:16371 ||| VBD
normalized  ||| S:16371 E:16382 ||| VBN
to  ||| S:16382 E:16385 ||| TO
the  ||| S:16385 E:16389 ||| DT
wild-type  ||| S:16389 E:16399 ||| JJ
( ||| S:16399 E:16400 ||| -LRB-
Fig.  ||| S:16400 E:16405 ||| CD
1 ||| S:16405 E:16406 ||| CD
) ||| S:16406 E:16407 ||| -RRB-
.  ||| S:16407 E:16409 ||| .
The  ||| S:16409 E:16421 ||| DT
condition  ||| S:16421 E:16431 ||| NN
dependent  ||| S:16431 E:16441 ||| JJ
metabolic  ||| S:16441 E:16451 ||| JJ
phenotypes  ||| S:16451 E:16462 ||| NN
were  ||| S:16462 E:16475 ||| VBD
computationally  ||| S:16475 E:16491 ||| JJ
analyzed ||| S:16491 E:16499 ||| NN
,  ||| S:16499 E:16501 ||| ,
and  ||| S:16501 E:16505 ||| CC
the  ||| S:16505 E:16509 ||| DT
results  ||| S:16509 E:16517 ||| NNS
are  ||| S:16517 E:16521 ||| VBP
organized  ||| S:16521 E:16531 ||| VBN
by  ||| S:16531 E:16542 ||| IN
the  ||| S:16542 E:16546 ||| DT
overall  ||| S:16546 E:16554 ||| JJ
metabolic  ||| S:16554 E:16564 ||| JJ
phenotype ||| S:16564 E:16573 ||| NN
;  ||| S:16573 E:16584 ||| :
essential ||| S:16584 E:16593 ||| JJ
,  ||| S:16593 E:16595 ||| ,
conditionally  ||| S:16595 E:16617 ||| RB
essential ||| S:16617 E:16626 ||| JJ
,  ||| S:16626 E:16628 ||| ,
or  ||| S:16628 E:16640 ||| CC
non-essential  ||| S:16640 E:16654 ||| JJ
genes ||| S:16654 E:16659 ||| NNS
.  ||| S:16659 E:16679 ||| .
Essential  ||| S:16679 E:16689 ||| JJ
genes  ||| S:16689 E:16695 ||| NNS
:  ||| S:16695 E:16697 ||| :
The  ||| S:16697 E:16701 ||| DT
gene  ||| S:16701 E:16706 ||| NN
products  ||| S:16706 E:16723 ||| NNS
that  ||| S:16723 E:16728 ||| WDT
were  ||| S:16728 E:16733 ||| VBD
essential  ||| S:16733 E:16743 ||| JJ
for  ||| S:16743 E:16747 ||| IN
growth  ||| S:16747 E:16754 ||| NN
with  ||| S:16754 E:16759 ||| IN
conditions  ||| S:16759 E:16770 ||| NNS
defined  ||| S:16770 E:16778 ||| VBN
by  ||| S:16778 E:16789 ||| IN
the  ||| S:16789 E:16793 ||| DT
line  ||| S:16793 E:16798 ||| NN
of  ||| S:16798 E:16801 ||| IN
optimality  ||| S:16801 E:16812 ||| NNS
( ||| S:16812 E:16813 ||| -LRB-
LO ||| S:16813 E:16815 ||| NNP
)  ||| S:16815 E:16817 ||| -RRB-
( ||| S:16817 E:16818 ||| -LRB-
see  ||| S:16818 E:16822 ||| VB
materials  ||| S:16822 E:16832 ||| NNS
and  ||| S:16832 E:16836 ||| CC
methods ||| S:16836 E:16843 ||| NNS
)  ||| S:16843 E:16853 ||| -RRB-
were  ||| S:16853 E:16858 ||| VBD
also  ||| S:16858 E:16863 ||| RB
identified  ||| S:16863 E:16874 ||| VBN
as  ||| S:16874 E:16877 ||| IN
essential  ||| S:16877 E:16887 ||| JJ
within  ||| S:16887 E:16894 ||| IN
all  ||| S:16894 E:16898 ||| DT
other  ||| S:16898 E:16904 ||| JJ
phases  ||| S:16904 E:16911 ||| NNS
(  ||| S:16911 E:16930 ||| -LRB-
acnAB ||| S:16930 E:16935 ||| NNP
,  ||| S:16935 E:16937 ||| ,
gapAC ||| S:16937 E:16942 ||| NNP
,  ||| S:16942 E:16944 ||| ,
gltA ||| S:16944 E:16948 ||| NNP
,  ||| S:16948 E:16950 ||| ,
icdA ||| S:16950 E:16954 ||| NNP
,  ||| S:16954 E:16956 ||| ,
pgk ||| S:16956 E:16959 ||| NN
,  ||| S:16959 E:16961 ||| ,
rpiAB ||| S:16961 E:16966 ||| NNP
,  ||| S:16966 E:16976 ||| ,
tktAB  ||| S:16976 E:16982 ||| NNP
) ||| S:16982 E:16983 ||| -RRB-
.  ||| S:16983 E:16985 ||| .
Specifically ||| S:16985 E:16997 ||| RB
,  ||| S:16997 E:16999 ||| ,
the  ||| S:16999 E:17012 ||| DT
gltA  ||| S:17012 E:17017 ||| JJ
- ||| S:17017 E:17018 ||| :
,  ||| S:17018 E:17029 ||| ,
icdA  ||| S:17029 E:17034 ||| JJ
- ||| S:17034 E:17035 ||| :
,  ||| S:17035 E:17037 ||| ,
and  ||| S:17037 E:17050 ||| CC
acnAB  ||| S:17050 E:17056 ||| JJ
-  ||| S:17056 E:17067 ||| :
in  ||| S:17067 E:17070 ||| IN
silico  ||| S:17070 E:17077 ||| JJ
deletion  ||| S:17077 E:17086 ||| NN
strains  ||| S:17086 E:17094 ||| NNS
were  ||| S:17094 E:17107 ||| VBD
unable  ||| S:17107 E:17114 ||| JJ
to  ||| S:17114 E:17117 ||| TO
produce  ||| S:17117 E:17125 ||| VB
one  ||| S:17125 E:17129 ||| CD
biosynthetic  ||| S:17129 E:17142 ||| CD
precursor  ||| S:17142 E:17160 ||| NNS
( ||| S:17160 E:17161 ||| -LRB-
α-ketoglutarate ||| S:17161 E:17176 ||| NNP
,  ||| S:17176 E:17178 ||| ,
Table  ||| S:17178 E:17184 ||| NNP
1 ||| S:17184 E:17185 ||| CD
) ||| S:17185 E:17186 ||| -RRB-
,  ||| S:17186 E:17188 ||| ,
and  ||| S:17188 E:17192 ||| CC
retained  ||| S:17192 E:17201 ||| VBD
the  ||| S:17201 E:17205 ||| DT
capability  ||| S:17205 E:17216 ||| NN
to  ||| S:17216 E:17227 ||| TO
synthesize  ||| S:17227 E:17238 ||| VB
the  ||| S:17238 E:17242 ||| DT
remaining  ||| S:17242 E:17252 ||| JJ
biosynthetic  ||| S:17252 E:17265 ||| JJ
precursors  ||| S:17265 E:17276 ||| NN
and  ||| S:17276 E:17288 ||| CC
cofactors  ||| S:17288 E:17298 ||| VBP
nearly  ||| S:17298 E:17305 ||| RB
equivalent  ||| S:17305 E:17316 ||| JJ
to  ||| S:17316 E:17319 ||| TO
the  ||| S:17319 E:17323 ||| DT
wild-type ||| S:17323 E:17332 ||| JJ
.  ||| S:17332 E:17334 ||| .
This  ||| S:17334 E:17347 ||| DT
prediction  ||| S:17347 E:17358 ||| NN
is  ||| S:17358 E:17361 ||| VBZ
consistent  ||| S:17361 E:17372 ||| JJ
with  ||| S:17372 E:17377 ||| IN
the  ||| S:17377 E:17381 ||| DT
defined  ||| S:17381 E:17389 ||| JJ
media  ||| S:17389 E:17395 ||| NNS
required  ||| S:17395 E:17412 ||| VBN
for  ||| S:17412 E:17416 ||| IN
the  ||| S:17416 E:17420 ||| DT
cultivation  ||| S:17420 E:17432 ||| NN
of  ||| S:17432 E:17444 ||| IN
aglt  ||| S:17444 E:17449 ||| NNS
-  ||| S:17449 E:17460 ||| :
E.  ||| S:17460 E:17463 ||| NNP
coli  ||| S:17463 E:17468 ||| FW
mutant  ||| S:17468 E:17475 ||| FW
strain  ||| S:17475 E:17482 ||| FW
( ||| S:17482 E:17483 ||| -LRB-
glucose  ||| S:17483 E:17499 ||| JJ
minimal  ||| S:17499 E:17507 ||| JJ
media  ||| S:17507 E:17513 ||| NNS
supplemented  ||| S:17513 E:17526 ||| VBN
with  ||| S:17526 E:17531 ||| IN
glutamine  ||| S:17531 E:17541 ||| NN
or  ||| S:17541 E:17544 ||| CC
proline ||| S:17544 E:17551 ||| CD
)  ||| S:17551 E:17553 ||| -RRB-
[  ||| S:17553 E:17563 ||| -LRB-
26 ||| S:17563 E:17565 ||| CD
] ||| S:17565 E:17566 ||| -RRB-
.  ||| S:17566 E:17568 ||| .
Furthermore ||| S:17568 E:17579 ||| RB
,  ||| S:17579 E:17581 ||| ,
the  ||| S:17581 E:17585 ||| DT
essential  ||| S:17585 E:17595 ||| JJ
glycolytic  ||| S:17595 E:17606 ||| JJ
gene  ||| S:17606 E:17611 ||| NN
products  ||| S:17611 E:17620 ||| NNS
(  ||| S:17620 E:17631 ||| -LRB-
pgk ||| S:17631 E:17634 ||| UH
,  ||| S:17634 E:17636 ||| ,
gapAC  ||| S:17636 E:17642 ||| NNP
)  ||| S:17642 E:17644 ||| -RRB-
were  ||| S:17644 E:17649 ||| VBD
required  ||| S:17649 E:17658 ||| VBN
for  ||| S:17658 E:17662 ||| IN
the  ||| S:17662 E:17674 ||| DT
synthesis  ||| S:17674 E:17684 ||| NN
of  ||| S:17684 E:17687 ||| IN
oxaloacetate ||| S:17687 E:17699 ||| NN
,  ||| S:17699 E:17701 ||| ,
succinyl-CoA ||| S:17701 E:17713 ||| NNP
,  ||| S:17713 E:17715 ||| ,
α-ketoglutarate ||| S:17715 E:17730 ||| NNP
,  ||| S:17730 E:17740 ||| ,
pyruvate ||| S:17740 E:17748 ||| NN
,  ||| S:17748 E:17750 ||| ,
phosphoenolpyruvate  ||| S:17750 E:17770 ||| NNS
( ||| S:17770 E:17771 ||| -LRB-
PEP ||| S:17771 E:17774 ||| NNP
) ||| S:17774 E:17775 ||| -RRB-
,  ||| S:17775 E:17777 ||| ,
and  ||| S:17777 E:17781 ||| CC
3-phosphoglycerate  ||| S:17781 E:17808 ||| CD
within  ||| S:17808 E:17815 ||| IN
all  ||| S:17815 E:17819 ||| DT
conditions ||| S:17819 E:17829 ||| NNS
,  ||| S:17829 E:17831 ||| ,
and  ||| S:17831 E:17835 ||| CC
were  ||| S:17835 E:17840 ||| VBD
unable  ||| S:17840 E:17847 ||| JJ
to  ||| S:17847 E:17850 ||| TO
synthesize  ||| S:17850 E:17861 ||| VB
all  ||| S:17861 E:17873 ||| DT
biosynthetic  ||| S:17873 E:17886 ||| JJ
precursors  ||| S:17886 E:17897 ||| NN
under  ||| S:17897 E:17903 ||| IN
anaerobic  ||| S:17903 E:17913 ||| JJ
growth  ||| S:17913 E:17920 ||| NN
conditions ||| S:17920 E:17930 ||| NNS
.  ||| S:17930 E:17940 ||| .
The  ||| S:17940 E:17944 ||| DT
remaining  ||| S:17944 E:17954 ||| JJ
two  ||| S:17954 E:17958 ||| CD
essential  ||| S:17958 E:17968 ||| JJ
gene  ||| S:17968 E:17973 ||| NN
products  ||| S:17973 E:17982 ||| NNS
were  ||| S:17982 E:17987 ||| VBD
in  ||| S:17987 E:17990 ||| IN
the  ||| S:17990 E:18002 ||| DT
pentosephosphate  ||| S:18002 E:18019 ||| JJ
pathway  ||| S:18019 E:18027 ||| NNS
(  ||| S:18027 E:18038 ||| -LRB-
tktAB ||| S:18038 E:18043 ||| NNP
,  ||| S:18043 E:18045 ||| ,
rpiAB  ||| S:18045 E:18051 ||| NNP
) ||| S:18051 E:18052 ||| -RRB-
.  ||| S:18052 E:18054 ||| .
The  ||| S:18054 E:18067 ||| DT
tktAB  ||| S:18067 E:18073 ||| JJ
and  ||| S:18073 E:18086 ||| CC
rpiAB  ||| S:18086 E:18092 ||| JJ
gene  ||| S:18092 E:18097 ||| NN
products  ||| S:18097 E:18106 ||| NNS
were  ||| S:18106 E:18111 ||| VBD
required  ||| S:18111 E:18120 ||| VBN
for  ||| S:18120 E:18132 ||| IN
the  ||| S:18132 E:18136 ||| DT
synthesis  ||| S:18136 E:18146 ||| NN
of  ||| S:18146 E:18149 ||| IN
erythrose  ||| S:18149 E:18159 ||| JJ
4-phosphate  ||| S:18159 E:18171 ||| NN
in  ||| S:18171 E:18174 ||| IN
all  ||| S:18174 E:18178 ||| DT
phases  ||| S:18178 E:18193 ||| NNS
( ||| S:18193 E:18194 ||| -LRB-
aromatic  ||| S:18194 E:18203 ||| FW
amino  ||| S:18203 E:18209 ||| FW
acid  ||| S:18209 E:18214 ||| FW
supplement  ||| S:18214 E:18225 ||| FW
required  ||| S:18225 E:18234 ||| VBN
for  ||| S:18234 E:18238 ||| IN
the  ||| S:18238 E:18250 ||| DT
cultivation  ||| S:18250 E:18262 ||| NN
of  ||| S:18262 E:18274 ||| IN
tkt  ||| S:18274 E:18278 ||| NNS
-  ||| S:18278 E:18289 ||| :
E.  ||| S:18289 E:18292 ||| NNP
coli  ||| S:18292 E:18297 ||| FW
mutant  ||| S:18297 E:18304 ||| FW
strains  ||| S:18304 E:18312 ||| FW
[  ||| S:18312 E:18314 ||| -LRB-
27 ||| S:18314 E:18316 ||| CD
] ||| S:18316 E:18317 ||| CD
) ||| S:18317 E:18318 ||| -RRB-
.  ||| S:18318 E:18328 ||| .
Additionally ||| S:18328 E:18340 ||| RB
,  ||| S:18340 E:18351 ||| ,
rpiAB  ||| S:18351 E:18357 ||| JJ
-strains  ||| S:18357 E:18366 ||| NN
were  ||| S:18366 E:18371 ||| VBD
identified  ||| S:18371 E:18382 ||| VBN
as  ||| S:18382 E:18393 ||| IN
ribose  ||| S:18393 E:18400 ||| JJ
auxotrophs  ||| S:18400 E:18411 ||| NN
by  ||| S:18411 E:18414 ||| IN
the  ||| S:18414 E:18427 ||| DT
in  ||| S:18427 E:18430 ||| IN
silico  ||| S:18430 E:18437 ||| JJ
analysis ||| S:18437 E:18445 ||| NN
,  ||| S:18445 E:18447 ||| ,
which  ||| S:18447 E:18453 ||| WDT
was  ||| S:18453 E:18465 ||| VBD
consistent  ||| S:18465 E:18476 ||| JJ
with  ||| S:18476 E:18481 ||| IN
experimental  ||| S:18481 E:18494 ||| JJ
data  ||| S:18494 E:18499 ||| NNS
[  ||| S:18499 E:18501 ||| -LRB-
28 ||| S:18501 E:18503 ||| CD
] ||| S:18503 E:18504 ||| -RRB-
.  ||| S:18504 E:18523 ||| .
Conditionally  ||| S:18523 E:18537 ||| RB
essential  ||| S:18537 E:18547 ||| JJ
genes  ||| S:18547 E:18553 ||| NNS
:  ||| S:18553 E:18563 ||| :
During  ||| S:18563 E:18570 ||| IN
the  ||| S:18570 E:18574 ||| DT
growth  ||| S:18574 E:18581 ||| NN
simulations  ||| S:18581 E:18593 ||| NNS
with  ||| S:18593 E:18598 ||| IN
external  ||| S:18598 E:18607 ||| JJ
parameters  ||| S:18607 E:18626 ||| NNS
defined  ||| S:18626 E:18634 ||| VBN
by  ||| S:18634 E:18637 ||| IN
the  ||| S:18637 E:18641 ||| DT
LO ||| S:18641 E:18643 ||| NNP
,  ||| S:18643 E:18645 ||| ,
there  ||| S:18645 E:18651 ||| EX
were  ||| S:18651 E:18656 ||| VBD
genes  ||| S:18656 E:18662 ||| NNS
defined  ||| S:18662 E:18670 ||| VBN
as  ||| S:18670 E:18673 ||| IN
critical  ||| S:18673 E:18682 ||| JJ
for  ||| S:18682 E:18694 ||| IN
growth ||| S:18694 E:18700 ||| NN
;  ||| S:18700 E:18702 ||| :
however ||| S:18702 E:18709 ||| RB
,  ||| S:18709 E:18711 ||| ,
many  ||| S:18711 E:18716 ||| JJ
of  ||| S:18716 E:18719 ||| IN
these  ||| S:18719 E:18725 ||| DT
genes  ||| S:18725 E:18731 ||| NNS
were  ||| S:18731 E:18736 ||| VBD
essential  ||| S:18736 E:18746 ||| JJ
for  ||| S:18746 E:18758 ||| IN
cellular  ||| S:18758 E:18767 ||| JJ
growth  ||| S:18767 E:18774 ||| NN
upon  ||| S:18774 E:18779 ||| IN
oxygen  ||| S:18779 E:18786 ||| NN
limitations  ||| S:18786 E:18798 ||| NNS
(  ||| S:18798 E:18809 ||| -LRB-
fba ||| S:18809 E:18812 ||| UH
,  ||| S:18812 E:18814 ||| ,
pfkAB ||| S:18814 E:18819 ||| NNP
,  ||| S:18819 E:18821 ||| ,
tpiA ||| S:18821 E:18825 ||| NNP
,  ||| S:18825 E:18827 ||| ,
eno ||| S:18827 E:18830 ||| NN
,  ||| S:18830 E:18832 ||| ,
gpmAB  ||| S:18832 E:18838 ||| NNP
) ||| S:18838 E:18839 ||| -RRB-
.  ||| S:18839 E:18841 ||| .
These  ||| S:18841 E:18855 ||| DT
genes  ||| S:18855 E:18861 ||| NNS
were  ||| S:18861 E:18866 ||| VBD
termed  ||| S:18866 E:18873 ||| VBN
conditionally  ||| S:18873 E:18887 ||| RB
essential ||| S:18887 E:18896 ||| JJ
.  ||| S:18896 E:18898 ||| .
The  ||| S:18898 E:18911 ||| DT
fba  ||| S:18911 E:18915 ||| NN
- ||| S:18915 E:18916 ||| :
,  ||| S:18916 E:18927 ||| ,
pfkAB  ||| S:18927 E:18933 ||| JJ
- ||| S:18933 E:18934 ||| :
,  ||| S:18934 E:18936 ||| ,
and  ||| S:18936 E:18949 ||| CC
tpiA  ||| S:18949 E:18954 ||| JJ
-  ||| S:18954 E:18965 ||| :
in  ||| S:18965 E:18968 ||| IN
silico  ||| S:18968 E:18975 ||| JJ
deletion  ||| S:18975 E:18984 ||| NN
strains  ||| S:18984 E:18992 ||| NNS
had  ||| S:18992 E:18996 ||| VBD
a  ||| S:18996 E:19006 ||| DT
limited  ||| S:19006 E:19014 ||| JJ
capability  ||| S:19014 E:19025 ||| NN
to  ||| S:19025 E:19028 ||| TO
synthesize  ||| S:19028 E:19039 ||| VB
glyceraldehyde  ||| S:19039 E:19062 ||| JJ
3-phosphate ||| S:19062 E:19073 ||| NN
,  ||| S:19073 E:19075 ||| ,
3-phosphoglycerate ||| S:19075 E:19093 ||| NNP
,  ||| S:19093 E:19095 ||| ,
phosphoenolpyruvate ||| S:19095 E:19114 ||| NN
,  ||| S:19114 E:19124 ||| ,
pyruvate ||| S:19124 E:19132 ||| NN
,  ||| S:19132 E:19134 ||| ,
acetyl-CoA ||| S:19134 E:19144 ||| NNP
,  ||| S:19144 E:19146 ||| ,
α-ketoglutarate ||| S:19146 E:19161 ||| NNP
,  ||| S:19161 E:19163 ||| ,
succinyl-CoA ||| S:19163 E:19175 ||| NNP
,  ||| S:19175 E:19185 ||| ,
oxaloacetate ||| S:19185 E:19197 ||| NN
,  ||| S:19197 E:19199 ||| ,
and  ||| S:19199 E:19203 ||| CC
high-energy  ||| S:19203 E:19215 ||| JJ
phosphate  ||| S:19215 E:19225 ||| JJ
bonds  ||| S:19225 E:19231 ||| NNS
in  ||| S:19231 E:19234 ||| IN
all  ||| S:19234 E:19246 ||| DT
phases ||| S:19246 E:19252 ||| NNS
,  ||| S:19252 E:19254 ||| ,
and  ||| S:19254 E:19258 ||| CC
were  ||| S:19258 E:19263 ||| VBD
completely  ||| S:19263 E:19274 ||| RB
unable  ||| S:19274 E:19281 ||| JJ
to  ||| S:19281 E:19284 ||| TO
synthesize  ||| S:19284 E:19295 ||| VB
many  ||| S:19295 E:19300 ||| JJ
of  ||| S:19300 E:19311 ||| IN
the  ||| S:19311 E:19315 ||| DT
biosynthetic  ||| S:19315 E:19328 ||| JJ
precursors  ||| S:19328 E:19339 ||| NN
in  ||| S:19339 E:19342 ||| IN
phases  ||| S:19342 E:19349 ||| CD
46  ||| S:19349 E:19352 ||| CD
( ||| S:19352 E:19353 ||| -LRB-
Table  ||| S:19353 E:19359 ||| NNP
1 ||| S:19359 E:19360 ||| CD
)  ||| S:19360 E:19362 ||| -RRB-
(  ||| S:19362 E:19373 ||| -LRB-
tpi  ||| S:19373 E:19377 ||| NN
-  ||| S:19377 E:19388 ||| :
in  ||| S:19388 E:19391 ||| IN
silico  ||| S:19391 E:19398 ||| JJ
strain  ||| S:19398 E:19405 ||| NN
discussed  ||| S:19405 E:19415 ||| VBN
below ||| S:19415 E:19420 ||| IN
) ||| S:19420 E:19421 ||| -RRB-
.  ||| S:19421 E:19431 ||| .
The  ||| S:19431 E:19435 ||| DT
growth  ||| S:19435 E:19442 ||| NN
potential  ||| S:19442 E:19452 ||| NN
of  ||| S:19452 E:19455 ||| IN
the  ||| S:19455 E:19468 ||| DT
eno  ||| S:19468 E:19472 ||| JJ
-and  ||| S:19472 E:19486 ||| JJ
gpmAB  ||| S:19486 E:19492 ||| NN
-  ||| S:19492 E:19503 ||| :
in  ||| S:19503 E:19506 ||| IN
silico  ||| S:19506 E:19513 ||| JJ
deletion  ||| S:19513 E:19522 ||| NN
strains  ||| S:19522 E:19530 ||| NNS
was  ||| S:19530 E:19542 ||| VBD
theoretically  ||| S:19542 E:19556 ||| VBN
maintained  ||| S:19556 E:19567 ||| VBN
under  ||| S:19567 E:19573 ||| IN
aerobic  ||| S:19573 E:19581 ||| JJ
conditions  ||| S:19581 E:19592 ||| NNS
by  ||| S:19592 E:19595 ||| IN
the  ||| S:19595 E:19607 ||| DT
synthesis  ||| S:19607 E:19617 ||| NN
and  ||| S:19617 E:19621 ||| CC
degradation  ||| S:19621 E:19633 ||| NN
of  ||| S:19633 E:19636 ||| IN
serine ||| S:19636 E:19642 ||| NN
,  ||| S:19642 E:19644 ||| ,
and  ||| S:19644 E:19648 ||| CC
without  ||| S:19648 E:19656 ||| IN
the  ||| S:19656 E:19660 ||| DT
serine  ||| S:19660 E:19675 ||| JJ
degradation  ||| S:19675 E:19687 ||| JJ
pathway ||| S:19687 E:19694 ||| NN
,  ||| S:19694 E:19696 ||| ,
the  ||| S:19696 E:19709 ||| DT
eno  ||| S:19709 E:19713 ||| JJ
-and  ||| S:19713 E:19727 ||| JJ
gpmAB  ||| S:19727 E:19733 ||| JJ
-gene  ||| S:19733 E:19739 ||| JJ
products  ||| S:19739 E:19748 ||| NNS
were  ||| S:19748 E:19753 ||| VBD
defined  ||| S:19753 E:19761 ||| VBN
as  ||| S:19761 E:19772 ||| IN
essential ||| S:19772 E:19781 ||| JJ
.  ||| S:19781 E:19783 ||| .
However ||| S:19783 E:19790 ||| RB
,  ||| S:19790 E:19792 ||| ,
the  ||| S:19792 E:19805 ||| DT
eno  ||| S:19805 E:19809 ||| JJ
-and  ||| S:19809 E:19823 ||| JJ
gpmAB  ||| S:19823 E:19829 ||| NN
-  ||| S:19829 E:19840 ||| :
in  ||| S:19840 E:19843 ||| IN
silico  ||| S:19843 E:19850 ||| JJ
deletion  ||| S:19850 E:19859 ||| NN
strains  ||| S:19859 E:19867 ||| NNS
were  ||| S:19867 E:19880 ||| VBD
limited  ||| S:19880 E:19888 ||| VBN
in  ||| S:19888 E:19891 ||| IN
their  ||| S:19891 E:19897 ||| PRP$
production  ||| S:19897 E:19908 ||| NN
capability  ||| S:19908 E:19919 ||| NN
of  ||| S:19919 E:19922 ||| IN
high-energy  ||| S:19922 E:19942 ||| JJ
phosphate  ||| S:19942 E:19952 ||| JJ
bonds  ||| S:19952 E:19958 ||| NNS
under  ||| S:19958 E:19964 ||| IN
all  ||| S:19964 E:19968 ||| DT
conditions ||| S:19968 E:19978 ||| NNS
,  ||| S:19978 E:19980 ||| ,
and  ||| S:19980 E:19984 ||| CC
were  ||| S:19984 E:19989 ||| VBD
unable  ||| S:19989 E:19996 ||| JJ
to  ||| S:19996 E:20007 ||| TO
produce  ||| S:20007 E:20015 ||| VB
any  ||| S:20015 E:20019 ||| DT
of  ||| S:20019 E:20022 ||| IN
the  ||| S:20022 E:20026 ||| DT
biosynthetic  ||| S:20026 E:20039 ||| JJ
precursors  ||| S:20039 E:20050 ||| NN
in  ||| S:20050 E:20053 ||| IN
phase  ||| S:20053 E:20059 ||| NN
6  ||| S:20059 E:20061 ||| CD
even  ||| S:20061 E:20074 ||| RB
with  ||| S:20074 E:20079 ||| IN
the  ||| S:20079 E:20083 ||| DT
serine  ||| S:20083 E:20090 ||| JJ
degradation  ||| S:20090 E:20102 ||| JJ
pathway ||| S:20102 E:20109 ||| NN
.  ||| S:20109 E:20119 ||| .
Additionally ||| S:20119 E:20131 ||| RB
,  ||| S:20131 E:20133 ||| ,
several  ||| S:20133 E:20141 ||| JJ
LO  ||| S:20141 E:20144 ||| NNP
non-essential  ||| S:20144 E:20158 ||| JJ
gene  ||| S:20158 E:20163 ||| NN
products  ||| S:20163 E:20180 ||| NNS
were  ||| S:20180 E:20185 ||| VBD
essential  ||| S:20185 E:20195 ||| JJ
(  ||| S:20195 E:20206 ||| -LRB-
sdhABCD ||| S:20206 E:20213 ||| NNP
,  ||| S:20213 E:20215 ||| ,
ppc ||| S:20215 E:20218 ||| NN
,  ||| S:20218 E:20220 ||| ,
frdABCD  ||| S:20220 E:20228 ||| NNP
)  ||| S:20228 E:20230 ||| -RRB-
for  ||| S:20230 E:20234 ||| IN
growth  ||| S:20234 E:20249 ||| NN
within  ||| S:20249 E:20256 ||| IN
other  ||| S:20256 E:20262 ||| JJ
phases ||| S:20262 E:20268 ||| NNS
.  ||| S:20268 E:20270 ||| .
The  ||| S:20270 E:20283 ||| DT
in  ||| S:20283 E:20286 ||| IN
silico  ||| S:20286 E:20293 ||| JJ
analysis  ||| S:20293 E:20302 ||| NN
suggested  ||| S:20302 E:20312 ||| VBD
that  ||| S:20312 E:20317 ||| IN
the  ||| S:20317 E:20338 ||| DT
sdhABCD  ||| S:20338 E:20346 ||| JJ
and  ||| S:20346 E:20359 ||| CC
frdABCD  ||| S:20359 E:20367 ||| JJ
gene  ||| S:20367 E:20372 ||| NN
products  ||| S:20372 E:20381 ||| NNS
were  ||| S:20381 E:20386 ||| VBD
required  ||| S:20386 E:20403 ||| VBN
for  ||| S:20403 E:20407 ||| IN
anaerobic  ||| S:20407 E:20417 ||| JJ
pyrimidine  ||| S:20417 E:20428 ||| JJ
biosynthesis ||| S:20428 E:20440 ||| NN
.  ||| S:20440 E:20442 ||| .
Additionally ||| S:20442 E:20454 ||| RB
,  ||| S:20454 E:20456 ||| ,
the  ||| S:20456 E:20469 ||| DT
frdABCD  ||| S:20469 E:20477 ||| JJ
gene  ||| S:20477 E:20482 ||| NN
products  ||| S:20482 E:20491 ||| NNS
were  ||| S:20491 E:20496 ||| VBD
essential  ||| S:20496 E:20514 ||| JJ
for  ||| S:20514 E:20518 ||| IN
the  ||| S:20518 E:20522 ||| DT
anaerobic  ||| S:20522 E:20532 ||| JJ
synthesis  ||| S:20532 E:20542 ||| NN
of  ||| S:20542 E:20545 ||| IN
the  ||| S:20545 E:20549 ||| DT
NAD  ||| S:20549 E:20553 ||| NNP
cofactor ||| S:20553 E:20561 ||| NN
.  ||| S:20561 E:20563 ||| .
However ||| S:20563 E:20570 ||| RB
,  ||| S:20570 E:20580 ||| ,
these  ||| S:20580 E:20595 ||| DT
in  ||| S:20595 E:20598 ||| IN
silico  ||| S:20598 E:20605 ||| JJ
results  ||| S:20605 E:20613 ||| NNS
could  ||| S:20613 E:20619 ||| MD
be  ||| S:20619 E:20622 ||| VB
due  ||| S:20622 E:20626 ||| JJ
to  ||| S:20626 E:20637 ||| TO
inaccurate  ||| S:20637 E:20648 ||| VB
stoichiometric  ||| S:20648 E:20663 ||| JJ
information  ||| S:20663 E:20675 ||| NN
with  ||| S:20675 E:20680 ||| IN
respect  ||| S:20680 E:20688 ||| NN
to  ||| S:20688 E:20699 ||| TO
cofactor  ||| S:20699 E:20708 ||| VB
utilization  ||| S:20708 E:20720 ||| NN
and  ||| S:20720 E:20724 ||| CC
should  ||| S:20724 E:20731 ||| MD
be  ||| S:20731 E:20734 ||| VB
critically  ||| S:20734 E:20745 ||| RB
examined ||| S:20745 E:20753 ||| VBN
.  ||| S:20753 E:20763 ||| .
Finally ||| S:20763 E:20770 ||| RB
,  ||| S:20770 E:20772 ||| ,
the  ||| S:20772 E:20785 ||| DT
ppc  ||| S:20785 E:20789 ||| JJ
gene  ||| S:20789 E:20794 ||| NN
product  ||| S:20794 E:20802 ||| NN
was  ||| S:20802 E:20806 ||| VBD
required  ||| S:20806 E:20815 ||| VBN
for  ||| S:20815 E:20819 ||| IN
the  ||| S:20819 E:20831 ||| DT
anaerobic  ||| S:20831 E:20841 ||| JJ
synthesis  ||| S:20841 E:20851 ||| NN
of  ||| S:20851 E:20854 ||| IN
oxaloacetate  ||| S:20854 E:20867 ||| NN
and  ||| S:20867 E:20871 ||| CC
α-ketoglutarate ||| S:20871 E:20886 ||| JJ
,  ||| S:20886 E:20896 ||| ,
but  ||| S:20896 E:20900 ||| CC
the  ||| S:20900 E:20913 ||| DT
in  ||| S:20913 E:20916 ||| IN
silico  ||| S:20916 E:20923 ||| JJ
analysis  ||| S:20923 E:20932 ||| NN
suggests  ||| S:20932 E:20941 ||| VBZ
that  ||| S:20941 E:20946 ||| IN
this  ||| S:20946 E:20959 ||| DT
gene  ||| S:20959 E:20964 ||| NN
product  ||| S:20964 E:20972 ||| NN
is  ||| S:20972 E:20975 ||| VBZ
not  ||| S:20975 E:20979 ||| RB
essential  ||| S:20979 E:20989 ||| JJ
for  ||| S:20989 E:20993 ||| IN
growth  ||| S:20993 E:21000 ||| NN
in  ||| S:21000 E:21003 ||| IN
aerobic  ||| S:21003 E:21019 ||| JJ
conditions  ||| S:21019 E:21030 ||| NNS
where  ||| S:21030 E:21036 ||| WRB
the  ||| S:21036 E:21040 ||| DT
glyoxylate  ||| S:21040 E:21051 ||| JJ
by-pass  ||| S:21051 E:21059 ||| NN
has  ||| S:21059 E:21063 ||| VBZ
the  ||| S:21063 E:21067 ||| DT
potential  ||| S:21067 E:21085 ||| JJ
to  ||| S:21085 E:21088 ||| TO
replenish  ||| S:21088 E:21098 ||| VB
the  ||| S:21098 E:21102 ||| DT
biosynthetic  ||| S:21102 E:21115 ||| JJ
precursors  ||| S:21115 E:21126 ||| NNS
[  ||| S:21126 E:21128 ||| -LRB-
29 ||| S:21128 E:21130 ||| CD
] ||| S:21130 E:21131 ||| -RRB-
.  ||| S:21131 E:21150 ||| .
Non-essential  ||| S:21150 E:21164 ||| JJ
genes  ||| S:21164 E:21170 ||| NNS
:  ||| S:21170 E:21172 ||| :
Several  ||| S:21172 E:21180 ||| JJ
genes  ||| S:21180 E:21194 ||| NNS
that  ||| S:21194 E:21199 ||| WDT
are  ||| S:21199 E:21203 ||| VBP
critical  ||| S:21203 E:21212 ||| JJ
for  ||| S:21212 E:21216 ||| IN
growth  ||| S:21216 E:21223 ||| NN
in  ||| S:21223 E:21226 ||| IN
conditions  ||| S:21226 E:21237 ||| NNS
defined  ||| S:21237 E:21245 ||| VBN
by  ||| S:21245 E:21248 ||| IN
the  ||| S:21248 E:21260 ||| DT
LO  ||| S:21260 E:21263 ||| NNP
were  ||| S:21263 E:21268 ||| VBD
non-essential  ||| S:21268 E:21282 ||| JJ
for  ||| S:21282 E:21286 ||| IN
growth  ||| S:21286 E:21293 ||| NN
in  ||| S:21293 E:21296 ||| IN
other  ||| S:21296 E:21302 ||| JJ
phases  ||| S:21302 E:21309 ||| NNS
(  ||| S:21309 E:21320 ||| -LRB-
nuo  ||| S:21320 E:21324 ||| UH
,  ||| S:21324 E:21335 ||| ,
cyoABCD ||| S:21335 E:21342 ||| NNP
,  ||| S:21342 E:21344 ||| ,
fumABC  ||| S:21344 E:21351 ||| NNP
) ||| S:21351 E:21352 ||| -RRB-
.  ||| S:21352 E:21354 ||| .
The  ||| S:21354 E:21367 ||| DT
in  ||| S:21367 E:21370 ||| IN
silico  ||| S:21370 E:21377 ||| JJ
nuo  ||| S:21377 E:21381 ||| JJ
-and  ||| S:21381 E:21395 ||| JJ
cyoABCD  ||| S:21395 E:21403 ||| JJ
-deletion  ||| S:21403 E:21413 ||| JJ
strains  ||| S:21413 E:21421 ||| NNS
were  ||| S:21421 E:21434 ||| VBD
limited  ||| S:21434 E:21442 ||| VBN
in  ||| S:21442 E:21445 ||| IN
their  ||| S:21445 E:21451 ||| PRP$
production  ||| S:21451 E:21462 ||| NN
capabilities  ||| S:21462 E:21475 ||| NNS
of  ||| S:21475 E:21478 ||| IN
high-energy  ||| S:21478 E:21498 ||| JJ
phosphate  ||| S:21498 E:21508 ||| JJ
bonds  ||| S:21508 E:21514 ||| NNS
for  ||| S:21514 E:21518 ||| IN
aerobic  ||| S:21518 E:21526 ||| JJ
growth ||| S:21526 E:21532 ||| NN
;  ||| S:21532 E:21534 ||| :
however ||| S:21534 E:21541 ||| RB
,  ||| S:21541 E:21543 ||| ,
under  ||| S:21543 E:21557 ||| IN
anaerobic  ||| S:21557 E:21567 ||| JJ
conditions  ||| S:21567 E:21578 ||| NNS
high-energy  ||| S:21578 E:21590 ||| JJ
phosphate  ||| S:21590 E:21600 ||| JJ
bonds  ||| S:21600 E:21606 ||| NNS
were  ||| S:21606 E:21619 ||| VBD
produced  ||| S:21619 E:21628 ||| VBN
by  ||| S:21628 E:21631 ||| IN
substrate  ||| S:21631 E:21641 ||| JJ
level  ||| S:21641 E:21647 ||| NN
phosphorylation ||| S:21647 E:21662 ||| NN
.  ||| S:21662 E:21664 ||| .
The  ||| S:21664 E:21668 ||| DT
production  ||| S:21668 E:21687 ||| NN
capabilities  ||| S:21687 E:21700 ||| NNS
of  ||| S:21700 E:21703 ||| IN
the  ||| S:21703 E:21716 ||| DT
fumABC  ||| S:21716 E:21723 ||| JJ
-  ||| S:21723 E:21734 ||| :
in  ||| S:21734 E:21737 ||| IN
silico  ||| S:21737 E:21744 ||| JJ
deletion  ||| S:21744 E:21753 ||| JJ
strain  ||| S:21753 E:21760 ||| NN
was  ||| S:21760 E:21764 ||| VBD
not  ||| S:21764 E:21776 ||| RB
limited  ||| S:21776 E:21784 ||| VBN
with  ||| S:21784 E:21789 ||| IN
respect  ||| S:21789 E:21797 ||| NN
to  ||| S:21797 E:21800 ||| TO
the  ||| S:21800 E:21804 ||| DT
biosynthetic  ||| S:21804 E:21817 ||| JJ
precursors  ||| S:21817 E:21828 ||| NNS
shown  ||| S:21828 E:21842 ||| VBN
in  ||| S:21842 E:21845 ||| IN
the  ||| S:21845 E:21849 ||| DT
table  ||| S:21849 E:21855 ||| NN
( ||| S:21855 E:21856 ||| -LRB-
other  ||| S:21856 E:21862 ||| JJ
than  ||| S:21862 E:21867 ||| IN
a  ||| S:21867 E:21869 ||| DT
slight  ||| S:21869 E:21876 ||| JJ
limitation  ||| S:21876 E:21887 ||| NN
of  ||| S:21887 E:21890 ||| IN
ATP  ||| S:21890 E:21902 ||| NNP
production  ||| S:21902 E:21913 ||| NN
in  ||| S:21913 E:21916 ||| IN
P1  ||| S:21916 E:21928 ||| CD
glucose ||| S:21928 E:21935 ||| NN
,  ||| S:21935 E:21937 ||| ,
oxygen  ||| S:21937 E:21944 ||| NN
) ||| S:21944 E:21945 ||| -RRB-
.  ||| S:21945 E:21947 ||| .
However ||| S:21947 E:21954 ||| RB
,  ||| S:21954 E:21956 ||| ,
the  ||| S:21956 E:21969 ||| DT
fumABC  ||| S:21969 E:21976 ||| JJ
-  ||| S:21976 E:21987 ||| :
in  ||| S:21987 E:21990 ||| IN
silico  ||| S:21990 E:21997 ||| JJ
deletion  ||| S:21997 E:22006 ||| JJ
strain  ||| S:22006 E:22013 ||| NN
was  ||| S:22013 E:22017 ||| VBD
limited  ||| S:22017 E:22033 ||| VBN
in  ||| S:22033 E:22036 ||| IN
its  ||| S:22036 E:22040 ||| PRP$
production  ||| S:22040 E:22051 ||| NN
capabilities  ||| S:22051 E:22064 ||| NNS
of  ||| S:22064 E:22067 ||| IN
several  ||| S:22067 E:22075 ||| JJ
amino  ||| S:22075 E:22081 ||| JJ
acids  ||| S:22081 E:22087 ||| NNS
( ||| S:22087 E:22088 ||| -LRB-
arg ||| S:22088 E:22091 ||| UH
,  ||| S:22091 E:22101 ||| ,
gly ||| S:22101 E:22104 ||| NN
,  ||| S:22104 E:22106 ||| ,
his-  ||| S:22106 E:22111 ||| NNP
not  ||| S:22111 E:22115 ||| RB
shown  ||| S:22115 E:22121 ||| VBN
in  ||| S:22121 E:22124 ||| IN
table ||| S:22124 E:22129 ||| NN
) ||| S:22129 E:22130 ||| -RRB-
,  ||| S:22130 E:22132 ||| ,
but  ||| S:22132 E:22136 ||| CC
under  ||| S:22136 E:22142 ||| IN
anaerobic  ||| S:22142 E:22160 ||| JJ
conditions ||| S:22160 E:22170 ||| NNS
,  ||| S:22170 E:22172 ||| ,
these  ||| S:22172 E:22178 ||| DT
capabilities  ||| S:22178 E:22191 ||| NNS
were  ||| S:22191 E:22196 ||| VBD
not  ||| S:22196 E:22200 ||| RB
limited  ||| S:22200 E:22208 ||| VBN
with  ||| S:22208 E:22221 ||| IN
respect  ||| S:22221 E:22229 ||| NN
to  ||| S:22229 E:22232 ||| TO
the  ||| S:22232 E:22236 ||| DT
wild-type ||| S:22236 E:22245 ||| JJ
.  ||| S:22245 E:22255 ||| .
Several  ||| S:22255 E:22263 ||| JJ
LO  ||| S:22263 E:22266 ||| NNP
non-essential  ||| S:22266 E:22280 ||| JJ
gene  ||| S:22280 E:22285 ||| NN
products  ||| S:22285 E:22294 ||| NNS
were  ||| S:22294 E:22299 ||| VBD
critical  ||| S:22299 E:22308 ||| JJ
(  ||| S:22308 E:22319 ||| -LRB-
pgi ||| S:22319 E:22322 ||| UH
,  ||| S:22322 E:22324 ||| ,
pta ||| S:22324 E:22327 ||| NN
,  ||| S:22327 E:22329 ||| ,
ackAB  ||| S:22329 E:22335 ||| NNP
)  ||| S:22335 E:22337 ||| -RRB-
for  ||| S:22337 E:22341 ||| IN
growth  ||| S:22341 E:22348 ||| NN
within  ||| S:22348 E:22363 ||| IN
other  ||| S:22363 E:22369 ||| JJ
phases ||| S:22369 E:22375 ||| NNS
.  ||| S:22375 E:22377 ||| .
The  ||| S:22377 E:22390 ||| DT
in  ||| S:22390 E:22393 ||| IN
silico  ||| S:22393 E:22400 ||| JJ
pgi  ||| S:22400 E:22404 ||| JJ
deletion  ||| S:22404 E:22413 ||| JJ
strain  ||| S:22413 E:22420 ||| NN
had  ||| S:22420 E:22424 ||| VBD
a  ||| S:22424 E:22434 ||| DT
reduced  ||| S:22434 E:22442 ||| JJ
capacity  ||| S:22442 E:22451 ||| NN
to  ||| S:22451 E:22454 ||| TO
produce  ||| S:22454 E:22462 ||| VB
all  ||| S:22462 E:22466 ||| PDT
the  ||| S:22466 E:22470 ||| DT
biosynthetic  ||| S:22470 E:22483 ||| JJ
precursors  ||| S:22483 E:22502 ||| NN
under  ||| S:22502 E:22508 ||| IN
oxygen  ||| S:22508 E:22515 ||| JJ
limitation ||| S:22515 E:22525 ||| NN
,  ||| S:22525 E:22527 ||| ,
and  ||| S:22527 E:22531 ||| CC
this  ||| S:22531 E:22536 ||| DT
resulted  ||| S:22536 E:22545 ||| VBN
in  ||| S:22545 E:22548 ||| IN
a  ||| S:22548 E:22550 ||| DT
decreased  ||| S:22550 E:22568 ||| JJ
normalized  ||| S:22568 E:22579 ||| JJ
growth  ||| S:22579 E:22586 ||| NN
yield  ||| S:22586 E:22592 ||| NN
of  ||| S:22592 E:22595 ||| IN
this  ||| S:22595 E:22609 ||| DT
in  ||| S:22609 E:22612 ||| IN
silico  ||| S:22612 E:22619 ||| JJ
deletion  ||| S:22619 E:22628 ||| JJ
strain ||| S:22628 E:22634 ||| NN
.  ||| S:22634 E:22636 ||| .
The  ||| S:22636 E:22649 ||| DT
pta  ||| S:22649 E:22653 ||| NN
and  ||| S:22653 E:22666 ||| CC
ackAB  ||| S:22666 E:22672 ||| JJ
gene  ||| S:22672 E:22677 ||| NN
products  ||| S:22677 E:22686 ||| NNS
participate  ||| S:22686 E:22698 ||| VBP
in  ||| S:22698 E:22709 ||| IN
the  ||| S:22709 E:22713 ||| DT
metabolic  ||| S:22713 E:22723 ||| JJ
pathway  ||| S:22723 E:22731 ||| NNS
leading  ||| S:22731 E:22739 ||| VBG
to  ||| S:22739 E:22742 ||| TO
the  ||| S:22742 E:22746 ||| DT
formation  ||| S:22746 E:22756 ||| NN
of  ||| S:22756 E:22759 ||| IN
acetate ||| S:22759 E:22766 ||| NN
.  ||| S:22766 E:22776 ||| .
Acetate  ||| S:22776 E:22784 ||| NNP
was  ||| S:22784 E:22788 ||| VBD
predicted  ||| S:22788 E:22798 ||| VBN
as  ||| S:22798 E:22801 ||| IN
a  ||| S:22801 E:22803 ||| DT
metabolic  ||| S:22803 E:22813 ||| JJ
by-product  ||| S:22813 E:22824 ||| NN
upon  ||| S:22824 E:22829 ||| IN
oxygen  ||| S:22829 E:22844 ||| NN
limitations  ||| S:22844 E:22856 ||| NNS
( ||| S:22856 E:22857 ||| -LRB-
all  ||| S:22857 E:22861 ||| DT
phases  ||| S:22861 E:22868 ||| NNS
below  ||| S:22868 E:22874 ||| IN
the  ||| S:22874 E:22878 ||| DT
LO ||| S:22878 E:22880 ||| NNP
) ||| S:22880 E:22881 ||| -RRB-
.  ||| S:22881 E:22883 ||| .
Under  ||| S:22883 E:22889 ||| IN
conditions  ||| S:22889 E:22908 ||| NNS
defined  ||| S:22908 E:22916 ||| VBN
by  ||| S:22916 E:22919 ||| IN
P5-6  ||| S:22919 E:22933 ||| CD
glucose ||| S:22933 E:22940 ||| NN
,  ||| S:22940 E:22942 ||| ,
oxygen  ||| S:22942 E:22949 ||| NN
,  ||| S:22949 E:22951 ||| ,
the  ||| S:22951 E:22955 ||| DT
production  ||| S:22955 E:22974 ||| NN
capabilities  ||| S:22974 E:22987 ||| NNS
of  ||| S:22987 E:22990 ||| IN
several  ||| S:22990 E:22998 ||| JJ
of  ||| S:22998 E:23001 ||| IN
the  ||| S:23001 E:23005 ||| DT
biosynthetic  ||| S:23005 E:23018 ||| JJ
precursors  ||| S:23018 E:23037 ||| NNS
( ||| S:23037 E:23038 ||| -LRB-
glucose  ||| S:23038 E:23046 ||| FW
6-phosphate ||| S:23046 E:23057 ||| FW
,  ||| S:23057 E:23059 ||| ,
fructose  ||| S:23059 E:23068 ||| CD
6-phosphate ||| S:23068 E:23079 ||| CD
,  ||| S:23079 E:23081 ||| ,
ribose  ||| S:23081 E:23096 ||| CD
5-phosphate ||| S:23096 E:23107 ||| CD
,  ||| S:23107 E:23109 ||| ,
erythrose  ||| S:23109 E:23119 ||| CD
5-phosphate ||| S:23119 E:23130 ||| CD
,  ||| S:23130 E:23132 ||| ,
glyceraldehyde  ||| S:23132 E:23155 ||| CD
3-phosphate ||| S:23155 E:23166 ||| CD
)  ||| S:23166 E:23168 ||| -RRB-
were  ||| S:23168 E:23173 ||| VBD
limited  ||| S:23173 E:23181 ||| VBN
in  ||| S:23181 E:23184 ||| IN
the  ||| S:23184 E:23197 ||| DT
pta  ||| S:23197 E:23201 ||| NN
and  ||| S:23201 E:23214 ||| CC
ackAB  ||| S:23214 E:23220 ||| JJ
in  ||| S:23220 E:23223 ||| IN
silico  ||| S:23223 E:23230 ||| JJ
deletion  ||| S:23230 E:23239 ||| NN
strains  ||| S:23239 E:23247 ||| NNS
(  ||| S:23247 E:23258 ||| -LRB-
pta  ||| S:23258 E:23262 ||| NN
-  ||| S:23262 E:23273 ||| :
In  ||| S:23273 E:23276 ||| IN
silico  ||| S:23276 E:23283 ||| JJ
deletion  ||| S:23283 E:23292 ||| NNS
strain  ||| S:23292 E:23299 ||| VBP
discussed  ||| S:23299 E:23317 ||| VBN
below ||| S:23317 E:23322 ||| IN
) ||| S:23322 E:23323 ||| -RRB-
.  ||| S:23323 E:23333 ||| .
This  ||| S:23333 E:23338 ||| DT
sub-section  ||| S:23338 E:23350 ||| NN
illustrated  ||| S:23350 E:23362 ||| VBD
the  ||| S:23362 E:23366 ||| DT
condition-dependent  ||| S:23366 E:23394 ||| JJ
effect  ||| S:23394 E:23401 ||| NN
of  ||| S:23401 E:23404 ||| IN
gene  ||| S:23404 E:23409 ||| NN
deletions  ||| S:23409 E:23419 ||| NNS
on  ||| S:23419 E:23422 ||| IN
the  ||| S:23422 E:23426 ||| DT
metabolic  ||| S:23426 E:23444 ||| JJ
genotype-phenotype  ||| S:23444 E:23463 ||| JJ
relation ||| S:23463 E:23471 ||| NN
.  ||| S:23471 E:23473 ||| .
The  ||| S:23473 E:23477 ||| DT
results  ||| S:23477 E:23485 ||| NNS
covered  ||| S:23485 E:23493 ||| VBN
the  ||| S:23493 E:23497 ||| DT
range  ||| S:23497 E:23511 ||| NN
of  ||| S:23511 E:23514 ||| IN
substrate  ||| S:23514 E:23524 ||| JJ
uptake  ||| S:23524 E:23531 ||| JJ
rates  ||| S:23531 E:23537 ||| NNS
and  ||| S:23537 E:23541 ||| CC
defined  ||| S:23541 E:23549 ||| VBN
the  ||| S:23549 E:23553 ||| DT
optimal  ||| S:23553 E:23561 ||| JJ
metabolic  ||| S:23561 E:23579 ||| JJ
pathway  ||| S:23579 E:23587 ||| JJ
utilization  ||| S:23587 E:23599 ||| NN
of  ||| S:23599 E:23602 ||| IN
isogenic  ||| S:23602 E:23611 ||| JJ
strains  ||| S:23611 E:23628 ||| NNS
in  ||| S:23628 E:23631 ||| IN
silico  ||| S:23631 E:23638 ||| NN
under  ||| S:23638 E:23644 ||| IN
different  ||| S:23644 E:23662 ||| JJ
combinations  ||| S:23662 E:23675 ||| NNS
of  ||| S:23675 E:23678 ||| IN
environmental  ||| S:23678 E:23692 ||| JJ
parameters ||| S:23692 E:23702 ||| NNS
.  ||| S:23702 E:23704 ||| .
The  ||| S:23704 E:23708 ||| DT
optimal  ||| S:23708 E:23724 ||| JJ
utilization  ||| S:23724 E:23736 ||| NN
of  ||| S:23736 E:23739 ||| IN
the  ||| S:23739 E:23743 ||| DT
metabolic  ||| S:23743 E:23753 ||| JJ
pathways  ||| S:23753 E:23762 ||| NN
was  ||| S:23762 E:23766 ||| VBD
dependent  ||| S:23766 E:23776 ||| JJ
on  ||| S:23776 E:23779 ||| IN
the  ||| S:23779 E:23791 ||| DT
metabolic  ||| S:23791 E:23801 ||| JJ
genotype ||| S:23801 E:23809 ||| NN
;  ||| S:23809 E:23811 ||| :
thus ||| S:23811 E:23815 ||| RB
,  ||| S:23815 E:23817 ||| ,
different  ||| S:23817 E:23827 ||| JJ
metabolic  ||| S:23827 E:23837 ||| JJ
genotypes  ||| S:23837 E:23847 ||| NNS
are  ||| S:23847 E:23859 ||| VBP
characterized  ||| S:23859 E:23873 ||| VBN
by  ||| S:23873 E:23876 ||| IN
different  ||| S:23876 E:23886 ||| JJ
PhPPs ||| S:23886 E:23891 ||| NN
.  ||| S:23891 E:23893 ||| .
The  ||| S:23893 E:23897 ||| DT
results  ||| S:23897 E:23905 ||| NNS
presented  ||| S:23905 E:23923 ||| VBD
above  ||| S:23923 E:23929 ||| RB
provide  ||| S:23929 E:23937 ||| VB
insight  ||| S:23937 E:23945 ||| VBN
into  ||| S:23945 E:23950 ||| IN
the  ||| S:23950 E:23954 ||| DT
genotype  ||| S:23954 E:23963 ||| JJ
phenotype  ||| S:23963 E:23973 ||| JJ
relation ||| S:23973 E:23981 ||| NN
.  ||| S:23981 E:23991 ||| .
Next ||| S:23991 E:23995 ||| JJ
,  ||| S:23995 E:23997 ||| ,
we  ||| S:23997 E:24000 ||| PRP
will  ||| S:24000 E:24005 ||| MD
compare  ||| S:24005 E:24013 ||| VB
the  ||| S:24013 E:24017 ||| DT
PhPPs  ||| S:24017 E:24023 ||| JJ
from  ||| S:24023 E:24037 ||| IN
in  ||| S:24037 E:24040 ||| IN
silico  ||| S:24040 E:24047 ||| JJ
deletion  ||| S:24047 E:24056 ||| NN
strains  ||| S:24056 E:24064 ||| NNS
to  ||| S:24064 E:24067 ||| TO
the  ||| S:24067 E:24079 ||| DT
wild-type  ||| S:24079 E:24089 ||| JJ
to  ||| S:24089 E:24092 ||| TO
provide  ||| S:24092 E:24100 ||| VB
a  ||| S:24100 E:24102 ||| DT
more  ||| S:24102 E:24107 ||| RBR
complete  ||| S:24107 E:24116 ||| JJ
definition  ||| S:24116 E:24127 ||| NN
of  ||| S:24127 E:24130 ||| IN
optimal  ||| S:24130 E:24146 ||| JJ
phenotypes.  ||| S:24146 E:24175 ||| NN
in  ||| S:24175 E:24178 ||| IN
silico  ||| S:24178 E:24185 ||| JJ
Deletion  ||| S:24185 E:24194 ||| NNP
Strain  ||| S:24194 E:24201 ||| NNP
Phenotype  ||| S:24201 E:24211 ||| NNP
Phase  ||| S:24211 E:24225 ||| NNP
Plane  ||| S:24225 E:24231 ||| NNP
Analysis  ||| S:24231 E:24240 ||| NNP
:  ||| S:24240 E:24242 ||| :
Comparative  ||| S:24242 E:24254 ||| NNP
analysis  ||| S:24254 E:24263 ||| NN
of  ||| S:24263 E:24266 ||| IN
the  ||| S:24266 E:24270 ||| DT
phase  ||| S:24270 E:24284 ||| NN
planes  ||| S:24284 E:24291 ||| NNS
for  ||| S:24291 E:24295 ||| IN
several  ||| S:24295 E:24303 ||| JJ
mutant  ||| S:24303 E:24310 ||| JJ
strains  ||| S:24310 E:24318 ||| NNS
(  ||| S:24318 E:24329 ||| -LRB-
tpi  ||| S:24329 E:24333 ||| NN
-  ||| S:24333 E:24344 ||| :
,  ||| S:24344 E:24346 ||| ,
pta  ||| S:24346 E:24350 ||| NNS
-  ||| S:24350 E:24361 ||| :
,  ||| S:24361 E:24363 ||| ,
and  ||| S:24363 E:24376 ||| CC
zwf  ||| S:24376 E:24380 ||| CD
)  ||| S:24380 E:24382 ||| -RRB-
were  ||| S:24382 E:24387 ||| VBD
performed ||| S:24387 E:24396 ||| VBN
.  ||| S:24396 E:24398 ||| .
These  ||| S:24398 E:24404 ||| DT
case  ||| S:24404 E:24417 ||| NN
studies  ||| S:24417 E:24425 ||| NNS
were  ||| S:24425 E:24430 ||| VBD
chosen  ||| S:24430 E:24437 ||| VBN
to  ||| S:24437 E:24440 ||| TO
further  ||| S:24440 E:24448 ||| RB
investigate  ||| S:24448 E:24460 ||| VB
the  ||| S:24460 E:24464 ||| DT
metabolic  ||| S:24464 E:24482 ||| JJ
genotype-phenotype  ||| S:24482 E:24501 ||| JJ
relation  ||| S:24501 E:24519 ||| NN
in  ||| S:24519 E:24522 ||| IN
silico  ||| S:24522 E:24529 ||| NN
and  ||| S:24529 E:24533 ||| CC
to  ||| S:24533 E:24536 ||| TO
demonstrate  ||| S:24536 E:24548 ||| VB
the  ||| S:24548 E:24552 ||| DT
use  ||| S:24552 E:24564 ||| NN
of  ||| S:24564 E:24567 ||| IN
FBA  ||| S:24567 E:24571 ||| NNP
to  ||| S:24571 E:24574 ||| TO
interpret  ||| S:24574 E:24584 ||| VB
and  ||| S:24584 E:24588 ||| CC
analyze  ||| S:24588 E:24596 ||| VB
cellular  ||| S:24596 E:24605 ||| JJ
metabolism.  ||| S:24605 E:24634 ||| CD
tpi  ||| S:24634 E:24638 ||| NNS
:  ||| S:24638 E:24640 ||| :
The  ||| S:24640 E:24653 ||| DT
tpi  ||| S:24653 E:24657 ||| JJ
-PhPP  ||| S:24657 E:24663 ||| NN
showed  ||| S:24663 E:24670 ||| VBD
3  ||| S:24670 E:24672 ||| CD
distinct  ||| S:24672 E:24681 ||| JJ
optimal  ||| S:24681 E:24697 ||| NNS
metabolic  ||| S:24697 E:24707 ||| VBP
phenotypes-  ||| S:24707 E:24719 ||| JJ
one  ||| S:24719 E:24723 ||| CD
glucose  ||| S:24723 E:24731 ||| CD
limited  ||| S:24731 E:24739 ||| JJ
phase  ||| S:24739 E:24745 ||| NN
( ||| S:24745 E:24746 ||| -LRB-
P  ||| S:24746 E:24757 ||| NN
tpi  ||| S:24757 E:24761 ||| VBD
2  ||| S:24761 E:24772 ||| CD
glucose ||| S:24772 E:24779 ||| NN
,  ||| S:24779 E:24781 ||| ,
oxygen  ||| S:24781 E:24788 ||| NN
) ||| S:24788 E:24789 ||| -RRB-
,  ||| S:24789 E:24791 ||| ,
and  ||| S:24791 E:24795 ||| CC
two  ||| S:24795 E:24799 ||| CD
futile  ||| S:24799 E:24806 ||| JJ
phases  ||| S:24806 E:24821 ||| NNS
( ||| S:24821 E:24822 ||| -LRB-
Fig.  ||| S:24822 E:24827 ||| NNP
2A ||| S:24827 E:24829 ||| NNP
) ||| S:24829 E:24830 ||| -RRB-
.  ||| S:24830 E:24832 ||| .
Futile  ||| S:24832 E:24839 ||| JJ
phases  ||| S:24839 E:24846 ||| NNS
are  ||| S:24846 E:24850 ||| VBP
characterized  ||| S:24850 E:24864 ||| VBN
by  ||| S:24864 E:24867 ||| IN
a  ||| S:24867 E:24869 ||| DT
negative  ||| S:24869 E:24886 ||| JJ
effect  ||| S:24886 E:24893 ||| NN
of  ||| S:24893 E:24896 ||| IN
one  ||| S:24896 E:24900 ||| CD
of  ||| S:24900 E:24903 ||| IN
the  ||| S:24903 E:24907 ||| DT
substrates  ||| S:24907 E:24918 ||| NN
on  ||| S:24918 E:24921 ||| IN
the  ||| S:24921 E:24925 ||| DT
objective  ||| S:24925 E:24935 ||| JJ
function ||| S:24935 E:24943 ||| NN
.  ||| S:24943 E:24953 ||| .
One  ||| S:24953 E:24957 ||| CD
of  ||| S:24957 E:24960 ||| IN
the  ||| S:24960 E:24964 ||| DT
futile  ||| S:24964 E:24971 ||| JJ
phases  ||| S:24971 E:24978 ||| NNS
was  ||| S:24978 E:24982 ||| VBD
due  ||| S:24982 E:24986 ||| JJ
to  ||| S:24986 E:24989 ||| TO
excess  ||| S:24989 E:24996 ||| JJ
oxygen  ||| S:24996 E:25003 ||| NN
( ||| S:25003 E:25004 ||| -LRB-
P  ||| S:25004 E:25015 ||| NN
tpi  ||| S:25015 E:25019 ||| VBD
1  ||| S:25019 E:25030 ||| CD
glucose ||| S:25030 E:25037 ||| NN
,  ||| S:25037 E:25039 ||| ,
oxygen  ||| S:25039 E:25046 ||| NN
)  ||| S:25046 E:25048 ||| -RRB-
and  ||| S:25048 E:25052 ||| CC
the  ||| S:25052 E:25056 ||| DT
other  ||| S:25056 E:25062 ||| JJ
was  ||| S:25062 E:25066 ||| VBD
due  ||| S:25066 E:25078 ||| JJ
to  ||| S:25078 E:25081 ||| TO
excess  ||| S:25081 E:25088 ||| JJ
glucose  ||| S:25088 E:25096 ||| NNS
( ||| S:25096 E:25097 ||| -LRB-
P  ||| S:25097 E:25108 ||| NN
tpi  ||| S:25108 E:25112 ||| VBD
3  ||| S:25112 E:25123 ||| CD
glucose ||| S:25123 E:25130 ||| NN
,  ||| S:25130 E:25132 ||| ,
oxygen  ||| S:25132 E:25139 ||| NN
) ||| S:25139 E:25140 ||| -RRB-
.  ||| S:25140 E:25142 ||| .
Although  ||| S:25142 E:25151 ||| IN
the  ||| S:25151 E:25164 ||| DT
tpi  ||| S:25164 E:25168 ||| NN
-  ||| S:25168 E:25179 ||| :
in  ||| S:25179 E:25182 ||| IN
silico  ||| S:25182 E:25189 ||| FW
metabolic  ||| S:25189 E:25199 ||| FW
genotype  ||| S:25199 E:25216 ||| FW
theoretically  ||| S:25216 E:25230 ||| FW
supported  ||| S:25230 E:25240 ||| FW
biomass  ||| S:25240 E:25248 ||| FW
production ||| S:25248 E:25258 ||| NN
,  ||| S:25258 E:25260 ||| ,
the  ||| S:25260 E:25264 ||| DT
feasible  ||| S:25264 E:25281 ||| JJ
steady  ||| S:25281 E:25288 ||| JJ
states  ||| S:25288 E:25295 ||| NNS
were  ||| S:25295 E:25300 ||| VBD
restricted  ||| S:25300 E:25311 ||| VBN
to  ||| S:25311 E:25314 ||| TO
a  ||| S:25314 E:25316 ||| DT
limited  ||| S:25316 E:25324 ||| JJ
phase  ||| S:25324 E:25330 ||| NN
of  ||| S:25330 E:25333 ||| IN
the  ||| S:25333 E:25345 ||| DT
phase  ||| S:25345 E:25351 ||| NN
plane  ||| S:25351 E:25357 ||| NN
and  ||| S:25357 E:25361 ||| CC
the  ||| S:25361 E:25365 ||| DT
flexibility  ||| S:25365 E:25377 ||| NN
of  ||| S:25377 E:25380 ||| IN
the  ||| S:25380 E:25384 ||| DT
metabolic  ||| S:25384 E:25394 ||| JJ
network  ||| S:25394 E:25410 ||| NN
was  ||| S:25410 E:25414 ||| VBD
reduced  ||| S:25414 E:25422 ||| VBN
to  ||| S:25422 E:25425 ||| TO
one  ||| S:25425 E:25429 ||| CD
dimension ||| S:25429 E:25438 ||| NN
.  ||| S:25438 E:25448 ||| .
The  ||| S:25448 E:25452 ||| DT
optimal  ||| S:25452 E:25460 ||| JJ
utilization  ||| S:25460 E:25472 ||| NN
of  ||| S:25472 E:25484 ||| IN
the  ||| S:25484 E:25488 ||| DT
tpi  ||| S:25488 E:25492 ||| JJ
-metabolic  ||| S:25492 E:25503 ||| JJ
network  ||| S:25503 E:25511 ||| NN
under  ||| S:25511 E:25525 ||| IN
environmental  ||| S:25525 E:25539 ||| JJ
conditions  ||| S:25539 E:25550 ||| NNS
defined  ||| S:25550 E:25558 ||| VBN
by  ||| S:25558 E:25561 ||| IN
the  ||| S:25561 E:25565 ||| DT
LO  ||| S:25565 E:25577 ||| NNP
tpi  ||| S:25577 E:25581 ||| NN
was  ||| S:25581 E:25585 ||| VBD
characterized  ||| S:25585 E:25599 ||| VBN
by  ||| S:25599 E:25602 ||| IN
increased  ||| S:25602 E:25620 ||| JJ
PPP  ||| S:25620 E:25624 ||| NNP
fluxes  ||| S:25624 E:25631 ||| VBD
to  ||| S:25631 E:25634 ||| TO
bypass  ||| S:25634 E:25641 ||| VB
the  ||| S:25641 E:25645 ||| DT
TPI  ||| S:25645 E:25649 ||| NNP
block ||| S:25649 E:25654 ||| NN
.  ||| S:25654 E:25656 ||| .
The  ||| S:25656 E:25660 ||| DT
PPP  ||| S:25660 E:25664 ||| NNP
operated  ||| S:25664 E:25681 ||| VBD
cyclically ||| S:25681 E:25691 ||| VBN
;  ||| S:25691 E:25693 ||| :
thus ||| S:25693 E:25697 ||| RB
,  ||| S:25697 E:25699 ||| ,
leading  ||| S:25699 E:25707 ||| VBG
to  ||| S:25707 E:25710 ||| TO
a  ||| S:25710 E:25712 ||| DT
high  ||| S:25712 E:25717 ||| JJ
production  ||| S:25717 E:25728 ||| NN
of  ||| S:25728 E:25731 ||| IN
NADPH ||| S:25731 E:25736 ||| NNP
.  ||| S:25736 E:25746 ||| .
Due  ||| S:25746 E:25750 ||| JJ
to  ||| S:25750 E:25753 ||| TO
the  ||| S:25753 E:25757 ||| DT
high  ||| S:25757 E:25762 ||| JJ
NADPH  ||| S:25762 E:25768 ||| NNP
production  ||| S:25768 E:25779 ||| NN
in  ||| S:25779 E:25782 ||| IN
the  ||| S:25782 E:25786 ||| DT
PPP ||| S:25786 E:25789 ||| NNP
,  ||| S:25789 E:25791 ||| ,
the  ||| S:25791 E:25795 ||| DT
TCA  ||| S:25795 E:25799 ||| NNP
cycle  ||| S:25799 E:25813 ||| NN
flux  ||| S:25813 E:25818 ||| NN
was  ||| S:25818 E:25822 ||| VBD
optimally  ||| S:25822 E:25832 ||| VBN
reduced  ||| S:25832 E:25840 ||| VBN
and  ||| S:25840 E:25844 ||| CC
functioned  ||| S:25844 E:25855 ||| VBD
only  ||| S:25855 E:25860 ||| RB
to  ||| S:25860 E:25863 ||| TO
produce  ||| S:25863 E:25879 ||| VB
the  ||| S:25879 E:25883 ||| DT
biosynthetic  ||| S:25883 E:25896 ||| JJ
precursors ||| S:25896 E:25906 ||| NN
.  ||| S:25906 E:25916 ||| .
The  ||| S:25916 E:25929 ||| DT
in  ||| S:25929 E:25932 ||| IN
silico  ||| S:25932 E:25939 ||| JJ
analysis  ||| S:25939 E:25948 ||| NN
suggests  ||| S:25948 E:25957 ||| VBZ
that  ||| S:25957 E:25962 ||| IN
the  ||| S:25962 E:25975 ||| DT
tpi  ||| S:25975 E:25979 ||| JJ
-metabolic  ||| S:25979 E:25990 ||| JJ
network  ||| S:25990 E:25998 ||| NN
was  ||| S:25998 E:26002 ||| VBD
restricted  ||| S:26002 E:26021 ||| VBN
by  ||| S:26021 E:26024 ||| IN
the  ||| S:26024 E:26028 ||| DT
ability  ||| S:26028 E:26036 ||| NN
to  ||| S:26036 E:26039 ||| TO
regenerate  ||| S:26039 E:26050 ||| VB
phosphoenolpyruvate  ||| S:26050 E:26070 ||| NNS
( ||| S:26070 E:26071 ||| -LRB-
PE ||| S:26071 E:26073 ||| NNP
)  ||| S:26073 E:26075 ||| -RRB-
for  ||| S:26075 E:26087 ||| IN
the  ||| S:26087 E:26091 ||| DT
PTS ||| S:26091 E:26094 ||| NNP
,  ||| S:26094 E:26096 ||| ,
and  ||| S:26096 E:26100 ||| CC
the  ||| S:26100 E:26113 ||| DT
in  ||| S:26113 E:26116 ||| IN
silico  ||| S:26116 E:26123 ||| JJ
analysis  ||| S:26123 E:26132 ||| NN
identified  ||| S:26132 E:26143 ||| VBD
3  ||| S:26143 E:26153 ||| CD
metabolic  ||| S:26153 E:26163 ||| NN
' ||| S:26163 E:26164 ||| POS
routes ||| S:26164 E:26170 ||| NNS
'  ||| S:26170 E:26172 ||| ''
for  ||| S:26172 E:26176 ||| IN
the  ||| S:26176 E:26180 ||| DT
regeneration  ||| S:26180 E:26193 ||| NN
of  ||| S:26193 E:26196 ||| IN
PEP ||| S:26196 E:26199 ||| NNP
.  ||| S:26199 E:26201 ||| .
Two  ||| S:26201 E:26205 ||| CD
of  ||| S:26205 E:26208 ||| IN
the  ||| S:26208 E:26220 ||| DT
' ||| S:26220 E:26221 ||| POS
routes ||| S:26221 E:26227 ||| NNS
'  ||| S:26227 E:26229 ||| ''
were  ||| S:26229 E:26234 ||| VBD
equivalent  ||| S:26234 E:26245 ||| JJ
( ||| S:26245 E:26246 ||| -LRB-
alternate  ||| S:26246 E:26256 ||| JJ
optimal  ||| S:26256 E:26264 ||| JJ
solutions ||| S:26264 E:26273 ||| NNS
) ||| S:26273 E:26274 ||| -RRB-
,  ||| S:26274 E:26276 ||| ,
( ||| S:26276 E:26277 ||| -LRB-
1 ||| S:26277 E:26278 ||| LS
)  ||| S:26278 E:26288 ||| -RRB-
The  ||| S:26288 E:26292 ||| DT
PEP  ||| S:26292 E:26296 ||| NNP
was  ||| S:26296 E:26300 ||| VBD
regenerated  ||| S:26300 E:26312 ||| VBN
by  ||| S:26312 E:26315 ||| IN
the  ||| S:26315 E:26319 ||| DT
phosphoenolpyruvate  ||| S:26319 E:26339 ||| JJ
synthase  ||| S:26339 E:26356 ||| NNS
( ||| S:26356 E:26357 ||| -LRB-
PPS ||| S:26357 E:26360 ||| NNP
) ||| S:26360 E:26361 ||| -RRB-
,  ||| S:26361 E:26363 ||| ,
or  ||| S:26363 E:26366 ||| CC
( ||| S:26366 E:26367 ||| -LRB-
2 ||| S:26367 E:26368 ||| LS
)  ||| S:26368 E:26370 ||| -RRB-
the  ||| S:26370 E:26374 ||| DT
glactose  ||| S:26374 E:26383 ||| JJ
transporter  ||| S:26383 E:26395 ||| NN
was  ||| S:26395 E:26399 ||| VBD
used  ||| S:26399 E:26404 ||| VBN
for  ||| S:26404 E:26408 ||| IN
the  ||| S:26408 E:26420 ||| DT
transport  ||| S:26420 E:26430 ||| NN
of  ||| S:26430 E:26433 ||| IN
glucose  ||| S:26433 E:26441 ||| NN
which  ||| S:26441 E:26447 ||| WDT
was  ||| S:26447 E:26451 ||| VBD
subsequently  ||| S:26451 E:26464 ||| RB
phosphorylated  ||| S:26464 E:26487 ||| VBN
by  ||| S:26487 E:26490 ||| IN
the  ||| S:26490 E:26494 ||| DT
glucokinase  ||| S:26494 E:26506 ||| JJ
reaction ||| S:26506 E:26514 ||| NN
.  ||| S:26514 E:26516 ||| .
These  ||| S:26516 E:26522 ||| DT
two  ||| S:26522 E:26526 ||| CD
routes  ||| S:26526 E:26533 ||| NNS
were  ||| S:26533 E:26546 ||| VBD
equivalent  ||| S:26546 E:26557 ||| NN
with  ||| S:26557 E:26562 ||| IN
respect  ||| S:26562 E:26570 ||| NN
to  ||| S:26570 E:26573 ||| TO
the  ||| S:26573 E:26577 ||| DT
objective  ||| S:26577 E:26587 ||| JJ
function  ||| S:26587 E:26596 ||| NN
( ||| S:26596 E:26597 ||| -LRB-
although  ||| S:26597 E:26614 ||| IN
they  ||| S:26614 E:26619 ||| PRP
were  ||| S:26619 E:26624 ||| VBD
structurally  ||| S:26624 E:26637 ||| RB
different ||| S:26637 E:26646 ||| JJ
) ||| S:26646 E:26647 ||| -RRB-
.  ||| S:26647 E:26649 ||| .
The  ||| S:26649 E:26653 ||| DT
third  ||| S:26653 E:26659 ||| JJ
PEP  ||| S:26659 E:26671 ||| NNP
regeneration  ||| S:26671 E:26684 ||| JJ
route  ||| S:26684 E:26690 ||| NN
involved  ||| S:26690 E:26699 ||| VBD
the  ||| S:26699 E:26703 ||| DT
glyoxylate  ||| S:26703 E:26714 ||| JJ
bypass  ||| S:26714 E:26721 ||| NN
and  ||| S:26721 E:26725 ||| CC
the  ||| S:26725 E:26737 ||| DT
phosphoenolpyruvate  ||| S:26737 E:26757 ||| JJ
carboxykinase ||| S:26757 E:26770 ||| NN
,  ||| S:26770 E:26772 ||| ,
and  ||| S:26772 E:26776 ||| CC
this  ||| S:26776 E:26781 ||| DT
route  ||| S:26781 E:26787 ||| NN
was  ||| S:26787 E:26799 ||| VBD
characterized  ||| S:26799 E:26813 ||| VBN
by  ||| S:26813 E:26816 ||| IN
a  ||| S:26816 E:26818 ||| DT
38 ||| S:26818 E:26820 ||| CD
%  ||| S:26820 E:26822 ||| NN
reduction  ||| S:26822 E:26832 ||| NN
in  ||| S:26832 E:26835 ||| IN
the  ||| S:26835 E:26839 ||| DT
optimal  ||| S:26839 E:26847 ||| JJ
biomass  ||| S:26847 E:26863 ||| JJ
yield ||| S:26863 E:26868 ||| NN
.  ||| S:26868 E:26870 ||| .
Furthermore ||| S:26870 E:26881 ||| RB
,  ||| S:26881 E:26883 ||| ,
experimentally  ||| S:26883 E:26898 ||| RB
it  ||| S:26898 E:26901 ||| PRP
was  ||| S:26901 E:26905 ||| VBD
shown  ||| S:26905 E:26911 ||| VBN
that  ||| S:26911 E:26924 ||| IN
constitutive  ||| S:26924 E:26937 ||| JJ
expression  ||| S:26937 E:26948 ||| NN
of  ||| S:26948 E:26951 ||| IN
the  ||| S:26951 E:26955 ||| DT
glyoxylate  ||| S:26955 E:26966 ||| JJ
bypass  ||| S:26966 E:26973 ||| NN
suppressed  ||| S:26973 E:26992 ||| VBD
the  ||| S:26992 E:26996 ||| DT
PEP  ||| S:26996 E:27000 ||| FW
deficient  ||| S:27000 E:27010 ||| FW
phenotype  ||| S:27010 E:27020 ||| FW
[  ||| S:27020 E:27022 ||| -LRB-
30 ||| S:27022 E:27024 ||| CD
,  ||| S:27024 E:27026 ||| ,
31 ||| S:27026 E:27028 ||| CD
] ||| S:27028 E:27029 ||| -RRB-
.  ||| S:27029 E:27031 ||| .
The  ||| S:27031 E:27035 ||| DT
PEP  ||| S:27035 E:27039 ||| NNP
regeneration  ||| S:27039 E:27060 ||| NN
routes  ||| S:27060 E:27067 ||| NNS
( ||| S:27067 E:27068 ||| -LRB-
discussed  ||| S:27068 E:27078 ||| VBN
above ||| S:27078 E:27083 ||| IN
)  ||| S:27083 E:27085 ||| -RRB-
theoretically  ||| S:27085 E:27099 ||| RB
allow  ||| S:27099 E:27105 ||| VB
the  ||| S:27105 E:27118 ||| DT
tpi  ||| S:27118 E:27122 ||| JJ
-to  ||| S:27122 E:27126 ||| JJ
grow ||| S:27126 E:27130 ||| NN
,  ||| S:27130 E:27132 ||| ,
and  ||| S:27132 E:27136 ||| CC
one  ||| S:27136 E:27140 ||| CD
of  ||| S:27140 E:27143 ||| IN
these  ||| S:27143 E:27157 ||| DT
solutions  ||| S:27157 E:27167 ||| NNS
was  ||| S:27167 E:27171 ||| VBD
required  ||| S:27171 E:27180 ||| VBN
for  ||| S:27180 E:27184 ||| IN
the  ||| S:27184 E:27188 ||| DT
growth  ||| S:27188 E:27195 ||| NN
of  ||| S:27195 E:27198 ||| IN
the  ||| S:27198 E:27211 ||| DT
tpi  ||| S:27211 E:27215 ||| NN
-  ||| S:27215 E:27226 ||| :
in  ||| S:27226 E:27229 ||| IN
silico  ||| S:27229 E:27236 ||| CD
strain.  ||| S:27236 E:27261 ||| CD
zwf  ||| S:27261 E:27265 ||| NNS
:  ||| S:27265 E:27276 ||| :
zwf  ||| S:27276 E:27280 ||| JJ
codes  ||| S:27280 E:27286 ||| NNS
for  ||| S:27286 E:27290 ||| IN
glucose-6-phosphate  ||| S:27290 E:27318 ||| CD
dehydrogenase  ||| S:27318 E:27332 ||| NNS
( ||| S:27332 E:27333 ||| -LRB-
G6PDH ||| S:27333 E:27338 ||| NNP
) ||| S:27338 E:27339 ||| -RRB-
,  ||| S:27339 E:27341 ||| ,
the  ||| S:27341 E:27345 ||| DT
first  ||| S:27345 E:27351 ||| JJ
enzyme  ||| S:27351 E:27358 ||| NN
in  ||| S:27358 E:27361 ||| IN
the  ||| S:27361 E:27365 ||| DT
oxidative  ||| S:27365 E:27383 ||| JJ
branch  ||| S:27383 E:27390 ||| NN
of  ||| S:27390 E:27393 ||| IN
the  ||| S:27393 E:27397 ||| DT
PPP.  ||| S:27397 E:27411 ||| JJ
zwf  ||| S:27411 E:27415 ||| NN
has  ||| S:27415 E:27419 ||| VBZ
been  ||| S:27419 E:27424 ||| VBN
shown  ||| S:27424 E:27430 ||| VBN
to  ||| S:27430 E:27433 ||| TO
be  ||| S:27433 E:27436 ||| VB
a  ||| S:27436 E:27446 ||| DT
non-essential  ||| S:27446 E:27460 ||| JJ
gene  ||| S:27460 E:27465 ||| NN
for  ||| S:27465 E:27469 ||| IN
the  ||| S:27469 E:27473 ||| DT
growth  ||| S:27473 E:27480 ||| NN
of  ||| S:27480 E:27492 ||| IN
E.  ||| S:27492 E:27495 ||| NNP
coli  ||| S:27495 E:27500 ||| NNS
in  ||| S:27500 E:27503 ||| IN
glucose  ||| S:27503 E:27511 ||| JJ
minimal  ||| S:27511 E:27519 ||| JJ
media ||| S:27519 E:27524 ||| NNS
,  ||| S:27524 E:27526 ||| ,
and  ||| S:27526 E:27547 ||| CC
zwf  ||| S:27547 E:27551 ||| JJ
strains  ||| S:27551 E:27559 ||| NNS
grow  ||| S:27559 E:27564 ||| VBP
at  ||| S:27564 E:27567 ||| IN
near  ||| S:27567 E:27572 ||| JJ
wild-type  ||| S:27572 E:27590 ||| JJ
growth  ||| S:27590 E:27597 ||| NN
rates  ||| S:27597 E:27603 ||| NNS
[  ||| S:27603 E:27605 ||| -LRB-
32 ||| S:27605 E:27607 ||| CD
] ||| S:27607 E:27608 ||| -RRB-
.  ||| S:27608 E:27619 ||| .
zwf  ||| S:27619 E:27623 ||| NNS
was  ||| S:27623 E:27627 ||| VBD
predicted  ||| S:27627 E:27637 ||| VBN
by  ||| S:27637 E:27640 ||| IN
FBA  ||| S:27640 E:27644 ||| NNP
to  ||| S:27644 E:27647 ||| TO
be  ||| S:27647 E:27650 ||| VB
a  ||| S:27650 E:27660 ||| DT
non-essential  ||| S:27660 E:27674 ||| JJ
gene  ||| S:27674 E:27679 ||| NN
for  ||| S:27679 E:27683 ||| IN
growth  ||| S:27683 E:27690 ||| NN
in  ||| S:27690 E:27693 ||| IN
glucose  ||| S:27693 E:27701 ||| JJ
minimal  ||| S:27701 E:27709 ||| JJ
media  ||| S:27709 E:27723 ||| NNS
( ||| S:27723 E:27724 ||| -LRB-
Fig.  ||| S:27724 E:27729 ||| CD
1 ||| S:27729 E:27730 ||| CD
) ||| S:27730 E:27731 ||| -RRB-
.  ||| S:27731 E:27733 ||| .
We  ||| S:27733 E:27736 ||| PRP
conducted  ||| S:27736 E:27746 ||| VBD
a  ||| S:27746 E:27748 ||| DT
phenotype  ||| S:27748 E:27758 ||| JJ
phase  ||| S:27758 E:27764 ||| NN
plane  ||| S:27764 E:27770 ||| NN
analysis  ||| S:27770 E:27779 ||| NN
of  ||| S:27779 E:27790 ||| IN
the  ||| S:27790 E:27803 ||| DT
zwf  ||| S:27803 E:27807 ||| JJ
strain  ||| S:27807 E:27814 ||| NN
and  ||| S:27814 E:27818 ||| CC
examined  ||| S:27818 E:27827 ||| VBD
the  ||| S:27827 E:27831 ||| DT
systemic  ||| S:27831 E:27848 ||| JJ
metabolic  ||| S:27848 E:27858 ||| JJ
function  ||| S:27858 E:27867 ||| NN
of  ||| S:27867 E:27879 ||| IN
zwf  ||| S:27879 E:27883 ||| NN
and  ||| S:27883 E:27887 ||| CC
its  ||| S:27887 E:27891 ||| PRP$
relation  ||| S:27891 E:27900 ||| NN
to  ||| S:27900 E:27903 ||| TO
the  ||| S:27903 E:27915 ||| DT
environmental  ||| S:27915 E:27929 ||| JJ
conditions  ||| S:27929 E:27949 ||| NNS
in  ||| S:27949 E:27952 ||| IN
silico  ||| S:27952 E:27959 ||| NNS
( ||| S:27959 E:27960 ||| -LRB-
Fig.  ||| S:27960 E:27965 ||| NNP
2B ||| S:27965 E:27967 ||| NNP
) ||| S:27967 E:27968 ||| -RRB-
.  ||| S:27968 E:27970 ||| .
The  ||| S:27970 E:27974 ||| DT
slope  ||| S:27974 E:27980 ||| NN
of  ||| S:27980 E:27983 ||| IN
the  ||| S:27983 E:27995 ||| DT
LO  ||| S:27995 E:28007 ||| NNP
zwf  ||| S:28007 E:28011 ||| VBD
slightly  ||| S:28011 E:28020 ||| RB
increased  ||| S:28020 E:28030 ||| VBN
( ||| S:28030 E:28031 ||| -LRB-
relative  ||| S:28031 E:28040 ||| JJ
to  ||| S:28040 E:28051 ||| TO
the  ||| S:28051 E:28055 ||| DT
wild-type ||| S:28055 E:28064 ||| JJ
) ||| S:28064 E:28065 ||| -RRB-
,  ||| S:28065 E:28067 ||| ,
indicating  ||| S:28067 E:28078 ||| VBG
a  ||| S:28078 E:28080 ||| DT
higher  ||| S:28080 E:28087 ||| JJR
oxygen ||| S:28087 E:28093 ||| NN
: ||| S:28093 E:28094 ||| :
glucose  ||| S:28094 E:28102 ||| JJ
ratio  ||| S:28102 E:28116 ||| NN
for  ||| S:28116 E:28120 ||| IN
optimal  ||| S:28120 E:28128 ||| JJ
growth ||| S:28128 E:28134 ||| NN
.  ||| S:28134 E:28136 ||| .
Removing  ||| S:28136 E:28145 ||| VBG
the  ||| S:28145 E:28149 ||| DT
G6PDH  ||| S:28149 E:28155 ||| NN
from  ||| S:28155 E:28160 ||| IN
the  ||| S:28160 E:28164 ||| DT
metabolic  ||| S:28164 E:28182 ||| JJ
network  ||| S:28182 E:28190 ||| NN
eliminated  ||| S:28190 E:28201 ||| VBD
all  ||| S:28201 E:28205 ||| DT
metabolic  ||| S:28205 E:28215 ||| JJ
pathways  ||| S:28215 E:28224 ||| NN
that  ||| S:28224 E:28229 ||| IN
utilized  ||| S:28229 E:28238 ||| VBG
the  ||| S:28238 E:28250 ||| DT
oxidative  ||| S:28250 E:28260 ||| JJ
branch  ||| S:28260 E:28267 ||| NN
of  ||| S:28267 E:28270 ||| IN
the  ||| S:28270 E:28274 ||| DT
PPP ||| S:28274 E:28277 ||| NNP
.  ||| S:28277 E:28279 ||| .
Therefore ||| S:28279 E:28288 ||| RB
,  ||| S:28288 E:28290 ||| ,
the  ||| S:28290 E:28303 ||| DT
zwf  ||| S:28303 E:28307 ||| JJ
PhPP  ||| S:28307 E:28312 ||| NN
was  ||| S:28312 E:28316 ||| VBD
significantly  ||| S:28316 E:28330 ||| RB
changed  ||| S:28330 E:28338 ||| VBN
in  ||| S:28338 E:28349 ||| IN
the  ||| S:28349 E:28353 ||| DT
phases  ||| S:28353 E:28360 ||| NNS
that  ||| S:28360 E:28365 ||| WDT
utilized  ||| S:28365 E:28374 ||| VBZ
the  ||| S:28374 E:28378 ||| DT
oxidative  ||| S:28378 E:28388 ||| JJ
branch  ||| S:28388 E:28395 ||| NN
of  ||| S:28395 E:28398 ||| IN
the  ||| S:28398 E:28402 ||| DT
PPP  ||| S:28402 E:28406 ||| NNP
( ||| S:28406 E:28407 ||| -LRB-
P  ||| S:28407 E:28426 ||| NN
zwf  ||| S:28426 E:28430 ||| VBD
2  ||| S:28430 E:28441 ||| CD
glucose ||| S:28441 E:28448 ||| NN
,  ||| S:28448 E:28450 ||| ,
oxygen  ||| S:28450 E:28457 ||| NN
and  ||| S:28457 E:28461 ||| CC
P  ||| S:28461 E:28472 ||| NN
zwf  ||| S:28472 E:28476 ||| VBD
3  ||| S:28476 E:28487 ||| CD
glucose ||| S:28487 E:28494 ||| NN
,  ||| S:28494 E:28496 ||| ,
oxygen  ||| S:28496 E:28503 ||| NN
)  ||| S:28503 E:28505 ||| -RRB-
but  ||| S:28505 E:28509 ||| CC
was  ||| S:28509 E:28513 ||| VBD
unchanged  ||| S:28513 E:28523 ||| JJ
in  ||| S:28523 E:28534 ||| IN
phases  ||| S:28534 E:28541 ||| NNS
that  ||| S:28541 E:28546 ||| WDT
did  ||| S:28546 E:28550 ||| VBD
not  ||| S:28550 E:28554 ||| RB
optimally  ||| S:28554 E:28564 ||| RB
utilize  ||| S:28564 E:28572 ||| VB
the  ||| S:28572 E:28585 ||| DT
zwf  ||| S:28585 E:28589 ||| JJ
gene  ||| S:28589 E:28594 ||| NN
product  ||| S:28594 E:28602 ||| NN
( ||| S:28602 E:28603 ||| -LRB-
P  ||| S:28603 E:28614 ||| NN
zwf  ||| S:28614 E:28618 ||| VBD
4  ||| S:28618 E:28629 ||| CD
glucose ||| S:28629 E:28636 ||| NN
,  ||| S:28636 E:28638 ||| ,
oxygen  ||| S:28638 E:28645 ||| NN
) ||| S:28645 E:28646 ||| -RRB-
.  ||| S:28646 E:28665 ||| .
pta  ||| S:28665 E:28669 ||| SYM
:  ||| S:28669 E:28671 ||| :
Acetate  ||| S:28671 E:28679 ||| NNP
excretion  ||| S:28679 E:28689 ||| NN
is  ||| S:28689 E:28692 ||| VBZ
a  ||| S:28692 E:28694 ||| DT
common  ||| S:28694 E:28709 ||| JJ
characteristic  ||| S:28709 E:28724 ||| NN
of  ||| S:28724 E:28736 ||| IN
E.  ||| S:28736 E:28739 ||| NNP
coli  ||| S:28739 E:28744 ||| JJ
metabolism  ||| S:28744 E:28755 ||| NN
and  ||| S:28755 E:28759 ||| CC
several  ||| S:28759 E:28775 ||| JJ
approaches  ||| S:28775 E:28786 ||| NNS
have  ||| S:28786 E:28791 ||| VBP
been  ||| S:28791 E:28796 ||| VBN
applied  ||| S:28796 E:28804 ||| VBN
to  ||| S:28804 E:28807 ||| TO
reduce  ||| S:28807 E:28814 ||| VB
acetate  ||| S:28814 E:28822 ||| JJ
production  ||| S:28822 E:28841 ||| NN
to  ||| S:28841 E:28844 ||| TO
improve  ||| S:28844 E:28852 ||| VB
the  ||| S:28852 E:28856 ||| DT
productivity  ||| S:28856 E:28869 ||| NN
of  ||| S:28869 E:28872 ||| IN
engineering  ||| S:28872 E:28884 ||| NN
strains  ||| S:28884 E:28892 ||| NNS
[  ||| S:28892 E:28894 ||| -LRB-
33 ||| S:28894 E:28896 ||| CD
,  ||| S:28896 E:28906 ||| ,
34 ||| S:28906 E:28908 ||| CD
,  ||| S:28908 E:28910 ||| ,
35 ||| S:28910 E:28912 ||| CD
] ||| S:28912 E:28913 ||| -RRB-
.  ||| S:28913 E:28915 ||| .
Acetate  ||| S:28915 E:28923 ||| JJ
production  ||| S:28923 E:28934 ||| NN
can  ||| S:28934 E:28938 ||| MD
be  ||| S:28938 E:28941 ||| VB
interpreted  ||| S:28941 E:28953 ||| VBN
using  ||| S:28953 E:28959 ||| VBG
FBA  ||| S:28959 E:28963 ||| NNP
[  ||| S:28963 E:28973 ||| -LRB-
36 ||| S:28973 E:28975 ||| CD
,  ||| S:28975 E:28977 ||| ,
37 ||| S:28977 E:28979 ||| CD
] ||| S:28979 E:28980 ||| -RRB-
,  ||| S:28980 E:28982 ||| ,
and  ||| S:28982 E:28986 ||| CC
we  ||| S:28986 E:28989 ||| PRP
have  ||| S:28989 E:28994 ||| VBP
used  ||| S:28994 E:28999 ||| VBN
a  ||| S:28999 E:29001 ||| DT
phase  ||| S:29001 E:29007 ||| NN
plane  ||| S:29007 E:29013 ||| NN
analysis  ||| S:29013 E:29022 ||| NN
to  ||| S:29022 E:29033 ||| TO
quantitatively  ||| S:29033 E:29048 ||| VB
analyze  ||| S:29048 E:29056 ||| VB
the  ||| S:29056 E:29060 ||| DT
conditions  ||| S:29060 E:29071 ||| NNS
for  ||| S:29071 E:29075 ||| IN
which  ||| S:29075 E:29081 ||| WDT
acetate  ||| S:29081 E:29097 ||| VBZ
excretion  ||| S:29097 E:29107 ||| JJ
optimally  ||| S:29107 E:29117 ||| NN
occurs ||| S:29117 E:29123 ||| VBZ
.  ||| S:29123 E:29125 ||| .
Acetate  ||| S:29125 E:29133 ||| NNP
was  ||| S:29133 E:29137 ||| VBD
optimally  ||| S:29137 E:29147 ||| JJ
excreted  ||| S:29147 E:29164 ||| NN
from  ||| S:29164 E:29169 ||| IN
the  ||| S:29169 E:29173 ||| DT
cell  ||| S:29173 E:29178 ||| NN
within  ||| S:29178 E:29185 ||| IN
all  ||| S:29185 E:29189 ||| DT
phases  ||| S:29189 E:29196 ||| NNS
of  ||| S:29196 E:29199 ||| IN
the  ||| S:29199 E:29203 ||| DT
glucose-oxygen  ||| S:29203 E:29218 ||| JJ
PhPP  ||| S:29218 E:29231 ||| NN
below  ||| S:29231 E:29237 ||| IN
the  ||| S:29237 E:29241 ||| DT
LO ||| S:29241 E:29243 ||| NNP
.  ||| S:29243 E:29245 ||| .
We  ||| S:29245 E:29248 ||| PRP
have  ||| S:29248 E:29253 ||| VBP
generated  ||| S:29253 E:29263 ||| VBN
the  ||| S:29263 E:29276 ||| DT
pta  ||| S:29276 E:29280 ||| JJ
-PhPP  ||| S:29280 E:29286 ||| JJ
and  ||| S:29286 E:29290 ||| CC
analyzed  ||| S:29290 E:29299 ||| VBD
the  ||| S:29299 E:29303 ||| DT
metabolic  ||| S:29303 E:29321 ||| JJ
characteristics  ||| S:29321 E:29337 ||| NNS
of  ||| S:29337 E:29340 ||| IN
the  ||| S:29340 E:29344 ||| DT
in  ||| S:29344 E:29356 ||| FW
silico  ||| S:29356 E:29363 ||| FW
pta  ||| S:29363 E:29367 ||| FW
-strain  ||| S:29367 E:29375 ||| FW
( ||| S:29375 E:29376 ||| -LRB-
Fig.  ||| S:29376 E:29381 ||| NNP
2C ||| S:29381 E:29383 ||| NNP
) ||| S:29383 E:29384 ||| -RRB-
.  ||| S:29384 E:29386 ||| .
The  ||| S:29386 E:29399 ||| DT
pta  ||| S:29399 E:29403 ||| JJ
-PhPP  ||| S:29403 E:29409 ||| NN
indicated  ||| S:29409 E:29419 ||| VBD
that  ||| S:29419 E:29424 ||| IN
this  ||| S:29424 E:29429 ||| DT
mutant  ||| S:29429 E:29444 ||| JJ
strain  ||| S:29444 E:29451 ||| NN
maintained  ||| S:29451 E:29462 ||| VBD
the  ||| S:29462 E:29466 ||| DT
potential  ||| S:29466 E:29476 ||| JJ
to  ||| S:29476 E:29479 ||| TO
support  ||| S:29479 E:29487 ||| VB
growth  ||| S:29487 E:29494 ||| NN
( ||| S:29494 E:29495 ||| -LRB-
both  ||| S:29495 E:29508 ||| DT
aerobically  ||| S:29508 E:29520 ||| NN
and  ||| S:29520 E:29524 ||| CC
anaerobically ||| S:29524 E:29537 ||| CD
) ||| S:29537 E:29538 ||| -RRB-
.  ||| S:29538 E:29540 ||| .
Experimentally ||| S:29540 E:29554 ||| NNP
,  ||| S:29554 E:29565 ||| ,
the  ||| S:29565 E:29569 ||| DT
pta  ||| S:29569 E:29573 ||| NN
-  ||| S:29573 E:29584 ||| :
E.  ||| S:29584 E:29587 ||| NNP
coli  ||| S:29587 E:29592 ||| JJ
strain  ||| S:29592 E:29599 ||| NN
has  ||| S:29599 E:29603 ||| VBZ
been  ||| S:29603 E:29608 ||| VBN
shown  ||| S:29608 E:29614 ||| VBN
to  ||| S:29614 E:29617 ||| TO
grow  ||| S:29617 E:29630 ||| VB
aerobically  ||| S:29630 E:29642 ||| NNS
and  ||| S:29642 E:29646 ||| CC
anaerobically  ||| S:29646 E:29660 ||| NN
on  ||| S:29660 E:29663 ||| IN
glucose  ||| S:29663 E:29671 ||| JJ
minimal  ||| S:29671 E:29679 ||| JJ
media  ||| S:29679 E:29685 ||| NNS
[  ||| S:29685 E:29695 ||| -LRB-
38 ||| S:29695 E:29697 ||| CD
] ||| S:29697 E:29698 ||| -RRB-
.  ||| S:29698 E:29700 ||| .
The  ||| S:29700 E:29713 ||| DT
in  ||| S:29713 E:29716 ||| IN
silico  ||| S:29716 E:29723 ||| JJ
analysis  ||| S:29723 E:29732 ||| NN
predicted  ||| S:29732 E:29742 ||| VBD
that  ||| S:29742 E:29756 ||| IN
the  ||| S:29756 E:29760 ||| DT
pta  ||| S:29760 E:29764 ||| JJ
-strain  ||| S:29764 E:29772 ||| JJ
optimally  ||| S:29772 E:29782 ||| NN
shifted  ||| S:29782 E:29790 ||| VBD
the  ||| S:29790 E:29802 ||| DT
carbon  ||| S:29802 E:29809 ||| NN
flux  ||| S:29809 E:29814 ||| NN
from  ||| S:29814 E:29819 ||| IN
acetate  ||| S:29819 E:29827 ||| VBG
to  ||| S:29827 E:29830 ||| TO
ethanol  ||| S:29830 E:29838 ||| VB
in  ||| S:29838 E:29841 ||| IN
P  ||| S:29841 E:29852 ||| NN
pta  ||| S:29852 E:29856 ||| VBD
3 ||| S:29856 E:29857 ||| CD
.  ||| S:29857 E:29859 ||| .
However ||| S:29859 E:29866 ||| RB
,  ||| S:29866 E:29868 ||| ,
in  ||| S:29868 E:29871 ||| IN
P  ||| S:29871 E:29882 ||| NN
pta  ||| S:29882 E:29886 ||| VBD
4 ||| S:29886 E:29887 ||| CD
,  ||| S:29887 E:29889 ||| ,
the  ||| S:29889 E:29893 ||| DT
optimal  ||| S:29893 E:29901 ||| JJ
metabolic  ||| S:29901 E:29919 ||| JJ
by-products  ||| S:29919 E:29931 ||| NN
included  ||| S:29931 E:29940 ||| VBD
lactate ||| S:29940 E:29947 ||| CD
,  ||| S:29947 E:29949 ||| ,
ethanol ||| S:29949 E:29956 ||| NN
,  ||| S:29956 E:29958 ||| ,
and  ||| S:29958 E:29962 ||| CC
pyruvate ||| S:29962 E:29970 ||| NN
,  ||| S:29970 E:29972 ||| ,
and  ||| S:29972 E:29984 ||| CC
under  ||| S:29984 E:29990 ||| IN
completely  ||| S:29990 E:30001 ||| RB
anaerobic  ||| S:30001 E:30011 ||| JJ
conditions ||| S:30011 E:30021 ||| NNS
,  ||| S:30021 E:30023 ||| ,
succinate  ||| S:30023 E:30033 ||| NN
was  ||| S:30033 E:30037 ||| VBD
also  ||| S:30037 E:30050 ||| RB
optimally  ||| S:30050 E:30060 ||| VB
produced  ||| S:30060 E:30069 ||| VBN
as  ||| S:30069 E:30072 ||| IN
a  ||| S:30072 E:30074 ||| DT
metabolic  ||| S:30074 E:30084 ||| JJ
byproduct ||| S:30084 E:30093 ||| NN
.  ||| S:30093 E:30095 ||| .
These  ||| S:30095 E:30109 ||| DT
metabolic  ||| S:30109 E:30119 ||| JJ
byproducts  ||| S:30119 E:30130 ||| NN
were  ||| S:30130 E:30135 ||| VBD
qualitatively  ||| S:30135 E:30149 ||| JJ
consistent  ||| S:30149 E:30160 ||| JJ
with  ||| S:30160 E:30173 ||| IN
experimental  ||| S:30173 E:30186 ||| JJ
observations  ||| S:30186 E:30199 ||| NNS
in  ||| S:30199 E:30202 ||| IN
the  ||| S:30202 E:30215 ||| DT
pta  ||| S:30215 E:30219 ||| JJ
-strain  ||| S:30219 E:30227 ||| NN
[  ||| S:30227 E:30229 ||| -LRB-
38 ||| S:30229 E:30231 ||| CD
] ||| S:30231 E:30232 ||| -RRB-
.  ||| S:30232 E:30256 ||| .
Discussion  ||| S:30256 E:30275 ||| NN
The  ||| S:30275 E:30279 ||| DT
rapid  ||| S:30279 E:30285 ||| JJ
development  ||| S:30285 E:30297 ||| NN
of  ||| S:30297 E:30300 ||| IN
bioinformatic  ||| S:30300 E:30314 ||| JJ
databases  ||| S:30314 E:30324 ||| NN
is  ||| S:30324 E:30335 ||| VBZ
resulting  ||| S:30335 E:30345 ||| VBG
in  ||| S:30345 E:30348 ||| IN
extensive  ||| S:30348 E:30358 ||| JJ
information  ||| S:30358 E:30370 ||| NN
about  ||| S:30370 E:30376 ||| IN
the  ||| S:30376 E:30380 ||| DT
molecular  ||| S:30380 E:30398 ||| JJ
composition  ||| S:30398 E:30410 ||| NN
and  ||| S:30410 E:30414 ||| CC
function  ||| S:30414 E:30423 ||| NN
of  ||| S:30423 E:30426 ||| IN
several  ||| S:30426 E:30434 ||| JJ
single  ||| S:30434 E:30441 ||| JJ
cellular  ||| S:30441 E:30458 ||| JJ
organisms ||| S:30458 E:30467 ||| NNS
.  ||| S:30467 E:30469 ||| .
These  ||| S:30469 E:30475 ||| DT
genetic  ||| S:30475 E:30483 ||| JJ
and  ||| S:30483 E:30487 ||| CC
biochemical  ||| S:30487 E:30499 ||| JJ
databases  ||| S:30499 E:30509 ||| NNS
[  ||| S:30509 E:30511 ||| -LRB-
21 ||| S:30511 E:30513 ||| CD
,  ||| S:30513 E:30523 ||| ,
23 ||| S:30523 E:30525 ||| CD
,  ||| S:30525 E:30527 ||| ,
39 ||| S:30527 E:30529 ||| CD
]  ||| S:30529 E:30531 ||| -RRB-
have  ||| S:30531 E:30536 ||| VBP
now  ||| S:30536 E:30540 ||| RB
been  ||| S:30540 E:30545 ||| VBN
developed  ||| S:30545 E:30555 ||| VBN
to  ||| S:30555 E:30558 ||| TO
the  ||| S:30558 E:30562 ||| DT
point  ||| S:30562 E:30568 ||| NN
where  ||| S:30568 E:30574 ||| WRB
the  ||| S:30574 E:30586 ||| DT
methods  ||| S:30586 E:30594 ||| NNS
of  ||| S:30594 E:30597 ||| IN
systems  ||| S:30597 E:30605 ||| NNS
science  ||| S:30605 E:30613 ||| NN
need  ||| S:30613 E:30618 ||| NN
to  ||| S:30618 E:30621 ||| TO
be  ||| S:30621 E:30624 ||| VB
used  ||| S:30624 E:30629 ||| VBN
to  ||| S:30629 E:30632 ||| TO
analyze ||| S:30632 E:30639 ||| VB
,  ||| S:30639 E:30649 ||| ,
interpret ||| S:30649 E:30658 ||| NN
,  ||| S:30658 E:30660 ||| ,
and  ||| S:30660 E:30664 ||| CC
predict  ||| S:30664 E:30672 ||| VB
the  ||| S:30672 E:30676 ||| DT
integrated  ||| S:30676 E:30687 ||| JJ
behavior  ||| S:30687 E:30696 ||| NN
of  ||| S:30696 E:30699 ||| IN
complex  ||| S:30699 E:30715 ||| JJ
multigeneic  ||| S:30715 E:30727 ||| JJ
biological  ||| S:30727 E:30738 ||| JJ
processes ||| S:30738 E:30747 ||| NNS
.  ||| S:30747 E:30749 ||| .
Herein ||| S:30749 E:30755 ||| NNP
,  ||| S:30755 E:30757 ||| ,
we  ||| S:30757 E:30760 ||| PRP
have  ||| S:30760 E:30765 ||| VBP
utilized  ||| S:30765 E:30782 ||| VBG
an  ||| S:30782 E:30794 ||| DT
in  ||| S:30794 E:30797 ||| IN
silico  ||| S:30797 E:30804 ||| JJ
representation  ||| S:30804 E:30819 ||| NN
of  ||| S:30819 E:30831 ||| IN
E.  ||| S:30831 E:30834 ||| NNP
coli  ||| S:30834 E:30839 ||| VBD
to  ||| S:30839 E:30842 ||| TO
study  ||| S:30842 E:30848 ||| VB
the  ||| S:30848 E:30852 ||| DT
condition  ||| S:30852 E:30870 ||| NN
dependent  ||| S:30870 E:30880 ||| JJ
phenotype  ||| S:30880 E:30890 ||| NN
of  ||| S:30890 E:30902 ||| IN
E.  ||| S:30902 E:30905 ||| NNP
coli  ||| S:30905 E:30910 ||| NNS
and  ||| S:30910 E:30914 ||| CC
central  ||| S:30914 E:30922 ||| JJ
metabolism  ||| S:30922 E:30933 ||| JJ
gene  ||| S:30933 E:30946 ||| NN
deletion  ||| S:30946 E:30955 ||| NN
strains ||| S:30955 E:30962 ||| NNS
.  ||| S:30962 E:30964 ||| .
We  ||| S:30964 E:30967 ||| PRP
have  ||| S:30967 E:30972 ||| VBP
shown  ||| S:30972 E:30978 ||| VBN
that  ||| S:30978 E:30983 ||| IN
a  ||| S:30983 E:30985 ||| DT
computational  ||| S:30985 E:31007 ||| JJ
analysis  ||| S:31007 E:31016 ||| NN
of  ||| S:31016 E:31019 ||| IN
the  ||| S:31019 E:31023 ||| DT
metabolic  ||| S:31023 E:31033 ||| JJ
behavior  ||| S:31033 E:31042 ||| NN
can  ||| S:31042 E:31046 ||| MD
provide  ||| S:31046 E:31054 ||| VB
valuable  ||| S:31054 E:31071 ||| JJ
insight  ||| S:31071 E:31079 ||| NN
into  ||| S:31079 E:31084 ||| IN
cellular  ||| S:31084 E:31093 ||| JJ
metabolism ||| S:31093 E:31103 ||| NN
.  ||| S:31103 E:31105 ||| .
The  ||| S:31105 E:31109 ||| DT
results  ||| S:31109 E:31117 ||| NNS
presented  ||| S:31117 E:31135 ||| VBD
herein  ||| S:31135 E:31142 ||| RB
address  ||| S:31142 E:31150 ||| VB
a  ||| S:31150 E:31152 ||| DT
pressing  ||| S:31152 E:31161 ||| JJ
question  ||| S:31161 E:31170 ||| NN
in  ||| S:31170 E:31173 ||| IN
the  ||| S:31173 E:31177 ||| DT
post-genome  ||| S:31177 E:31189 ||| JJ
era ||| S:31189 E:31192 ||| NN
;  ||| S:31192 E:31203 ||| :
how  ||| S:31203 E:31207 ||| WRB
can  ||| S:31207 E:31211 ||| MD
genome  ||| S:31211 E:31218 ||| VB
sequence  ||| S:31218 E:31227 ||| JJ
information  ||| S:31227 E:31239 ||| NN
be  ||| S:31239 E:31250 ||| VB
used  ||| S:31250 E:31255 ||| VBN
to  ||| S:31255 E:31258 ||| TO
analyze  ||| S:31258 E:31266 ||| VB
integrated  ||| S:31266 E:31277 ||| VBN
cellular  ||| S:31277 E:31286 ||| JJ
functions ||| S:31286 E:31295 ||| NNS
?  ||| S:31295 E:31297 ||| .
Given  ||| S:31297 E:31311 ||| VBN
the  ||| S:31311 E:31315 ||| DT
central  ||| S:31315 E:31323 ||| JJ
importance  ||| S:31323 E:31334 ||| NN
of  ||| S:31334 E:31337 ||| IN
this  ||| S:31337 E:31342 ||| DT
question ||| S:31342 E:31350 ||| NN
,  ||| S:31350 E:31352 ||| ,
we  ||| S:31352 E:31355 ||| PRP
will  ||| S:31355 E:31360 ||| MD
discuss  ||| S:31360 E:31376 ||| VB
the  ||| S:31376 E:31380 ||| DT
general  ||| S:31380 E:31388 ||| JJ
applicability ||| S:31388 E:31401 ||| NN
,  ||| S:31401 E:31403 ||| ,
limitations ||| S:31403 E:31414 ||| NNS
,  ||| S:31414 E:31416 ||| ,
and  ||| S:31416 E:31420 ||| CC
future  ||| S:31420 E:31435 ||| JJ
prospects  ||| S:31435 E:31445 ||| NNS
for  ||| S:31445 E:31449 ||| IN
FBA  ||| S:31449 E:31453 ||| NNP
and  ||| S:31453 E:31457 ||| CC
functional  ||| S:31457 E:31468 ||| JJ
genomics ||| S:31468 E:31476 ||| NN
.  ||| S:31476 E:31486 ||| .
The  ||| S:31486 E:31490 ||| DT
FBA  ||| S:31490 E:31494 ||| FW
metabolic  ||| S:31494 E:31504 ||| FW
modeling  ||| S:31504 E:31513 ||| FW
framework  ||| S:31513 E:31523 ||| FW
is  ||| S:31523 E:31526 ||| VBZ
different  ||| S:31526 E:31536 ||| JJ
than  ||| S:31536 E:31549 ||| IN
other  ||| S:31549 E:31555 ||| JJ
well-known  ||| S:31555 E:31566 ||| JJ
metabolic  ||| S:31566 E:31576 ||| JJ
modeling  ||| S:31576 E:31585 ||| NN
approaches ||| S:31585 E:31595 ||| NNS
.  ||| S:31595 E:31597 ||| .
FBA  ||| S:31597 E:31601 ||| NNP
can  ||| S:31601 E:31613 ||| MD
more  ||| S:31613 E:31618 ||| RBR
accurately  ||| S:31618 E:31629 ||| RB
be  ||| S:31629 E:31632 ||| VB
defined  ||| S:31632 E:31640 ||| VBN
as  ||| S:31640 E:31643 ||| IN
a  ||| S:31643 E:31645 ||| DT
metabolic  ||| S:31645 E:31655 ||| JJ
constraining  ||| S:31655 E:31676 ||| JJ
approach ||| S:31676 E:31684 ||| NN
,  ||| S:31684 E:31686 ||| ,
this  ||| S:31686 E:31691 ||| DT
is  ||| S:31691 E:31694 ||| VBZ
because  ||| S:31694 E:31702 ||| IN
FBA  ||| S:31702 E:31706 ||| NNP
defines  ||| S:31706 E:31714 ||| VBZ
the  ||| S:31714 E:31718 ||| DT
' ||| S:31718 E:31719 ||| POS
best ||| S:31719 E:31723 ||| JJS
'  ||| S:31723 E:31725 ||| ''
the  ||| S:31725 E:31729 ||| DT
cell  ||| S:31729 E:31742 ||| NN
can  ||| S:31742 E:31746 ||| MD
do ||| S:31746 E:31748 ||| VB
,  ||| S:31748 E:31750 ||| ,
rather  ||| S:31750 E:31757 ||| RB
than  ||| S:31757 E:31762 ||| IN
predicting  ||| S:31762 E:31773 ||| VBG
the  ||| S:31773 E:31777 ||| DT
metabolic  ||| S:31777 E:31787 ||| JJ
behavior ||| S:31787 E:31795 ||| NN
.  ||| S:31795 E:31797 ||| .
To  ||| S:31797 E:31808 ||| TO
accomplish  ||| S:31808 E:31819 ||| VB
this ||| S:31819 E:31823 ||| DT
,  ||| S:31823 E:31825 ||| ,
we  ||| S:31825 E:31828 ||| PRP
have  ||| S:31828 E:31833 ||| VBP
constrained  ||| S:31833 E:31845 ||| VBN
metabolic  ||| S:31845 E:31855 ||| NNS
function  ||| S:31855 E:31872 ||| VBP
based  ||| S:31872 E:31878 ||| VBN
on  ||| S:31878 E:31881 ||| IN
the  ||| S:31881 E:31885 ||| DT
most  ||| S:31885 E:31890 ||| RBS
reliable  ||| S:31890 E:31899 ||| JJ
information ||| S:31899 E:31910 ||| NN
,  ||| S:31910 E:31912 ||| ,
the  ||| S:31912 E:31916 ||| DT
metabolic  ||| S:31916 E:31934 ||| JJ
stoichiometry  ||| S:31934 E:31948 ||| NNS
( ||| S:31948 E:31949 ||| -LRB-
the  ||| S:31949 E:31953 ||| DT
stoichiometry  ||| S:31953 E:31967 ||| NN
is  ||| S:31967 E:31970 ||| VBZ
well  ||| S:31970 E:31975 ||| RB
known  ||| S:31975 E:31981 ||| VBN
for  ||| S:31981 E:31985 ||| IN
the  ||| S:31985 E:31989 ||| DT
vast  ||| S:31989 E:32002 ||| JJ
majority  ||| S:32002 E:32011 ||| NN
of  ||| S:32011 E:32014 ||| IN
the  ||| S:32014 E:32018 ||| DT
metabolic  ||| S:32018 E:32028 ||| JJ
processes ||| S:32028 E:32037 ||| NNS
) ||| S:32037 E:32038 ||| -RRB-
.  ||| S:32038 E:32040 ||| .
However ||| S:32040 E:32047 ||| RB
,  ||| S:32047 E:32049 ||| ,
FBA  ||| S:32049 E:32053 ||| NNP
does  ||| S:32053 E:32066 ||| VBZ
have  ||| S:32066 E:32071 ||| VB
predictive  ||| S:32071 E:32082 ||| JJ
capabilities  ||| S:32082 E:32095 ||| NNS
when  ||| S:32095 E:32100 ||| WRB
a  ||| S:32100 E:32102 ||| DT
physiologically  ||| S:32102 E:32126 ||| JJ
meaningful  ||| S:32126 E:32137 ||| JJ
objective  ||| S:32137 E:32147 ||| NN
function  ||| S:32147 E:32156 ||| NN
can  ||| S:32156 E:32160 ||| MD
be  ||| S:32160 E:32163 ||| VB
defined ||| S:32163 E:32170 ||| VBN
,  ||| S:32170 E:32172 ||| ,
and  ||| S:32172 E:32176 ||| CC
the  ||| S:32176 E:32189 ||| DT
E.  ||| S:32189 E:32192 ||| NNP
coli  ||| S:32192 E:32197 ||| VBD
FBA  ||| S:32197 E:32201 ||| NNP
results ||| S:32201 E:32208 ||| NNS
,  ||| S:32208 E:32210 ||| ,
with  ||| S:32210 E:32215 ||| IN
maximal  ||| S:32215 E:32231 ||| JJ
growth  ||| S:32231 E:32238 ||| NN
rate  ||| S:32238 E:32243 ||| NN
as  ||| S:32243 E:32246 ||| IN
the  ||| S:32246 E:32250 ||| DT
objective  ||| S:32250 E:32260 ||| JJ
function ||| S:32260 E:32268 ||| NN
,  ||| S:32268 E:32270 ||| ,
have  ||| S:32270 E:32275 ||| VBP
been  ||| S:32275 E:32280 ||| VBN
shown  ||| S:32280 E:32286 ||| VBN
to  ||| S:32286 E:32297 ||| TO
be  ||| S:32297 E:32300 ||| VB
consistent  ||| S:32300 E:32311 ||| JJ
with  ||| S:32311 E:32316 ||| IN
experimental  ||| S:32316 E:32329 ||| JJ
data  ||| S:32329 E:32334 ||| NNS
under  ||| S:32334 E:32340 ||| IN
nutritionally  ||| S:32340 E:32362 ||| JJ
rich  ||| S:32362 E:32367 ||| JJ
conditions  ||| S:32367 E:32378 ||| NNS
[  ||| S:32378 E:32380 ||| -LRB-
40 ||| S:32380 E:32382 ||| CD
] ||| S:32382 E:32383 ||| -RRB-
.  ||| S:32383 E:32385 ||| .
It  ||| S:32385 E:32388 ||| PRP
should  ||| S:32388 E:32395 ||| MD
be  ||| S:32395 E:32398 ||| VB
mentioned  ||| S:32398 E:32408 ||| VBN
that  ||| S:32408 E:32413 ||| IN
FBA  ||| S:32413 E:32417 ||| NNP
does  ||| S:32417 E:32430 ||| VBZ
not  ||| S:32430 E:32434 ||| RB
directly  ||| S:32434 E:32443 ||| RB
consider  ||| S:32443 E:32452 ||| VB
regulation ||| S:32452 E:32462 ||| NN
,  ||| S:32462 E:32464 ||| ,
or  ||| S:32464 E:32467 ||| CC
the  ||| S:32467 E:32471 ||| DT
regulatory  ||| S:32471 E:32490 ||| JJ
constraints  ||| S:32490 E:32502 ||| NNS
on  ||| S:32502 E:32505 ||| IN
the  ||| S:32505 E:32509 ||| DT
metabolic  ||| S:32509 E:32519 ||| JJ
network ||| S:32519 E:32526 ||| NN
,  ||| S:32526 E:32528 ||| ,
but  ||| S:32528 E:32532 ||| CC
rather  ||| S:32532 E:32539 ||| RB
FBA  ||| S:32539 E:32551 ||| NNP
assumes  ||| S:32551 E:32559 ||| VBZ
that  ||| S:32559 E:32564 ||| IN
the  ||| S:32564 E:32568 ||| DT
regulation  ||| S:32568 E:32579 ||| NN
is  ||| S:32579 E:32582 ||| VBZ
such  ||| S:32582 E:32587 ||| PDT
that  ||| S:32587 E:32592 ||| DT
metabolic  ||| S:32592 E:32602 ||| JJ
behavior  ||| S:32602 E:32619 ||| NN
is  ||| S:32619 E:32622 ||| VBZ
optimal ||| S:32622 E:32629 ||| VBN
.  ||| S:32629 E:32631 ||| .
This  ||| S:32631 E:32636 ||| DT
assumption  ||| S:32636 E:32647 ||| NN
produces  ||| S:32647 E:32656 ||| VBZ
results  ||| S:32656 E:32664 ||| NNS
that  ||| S:32664 E:32669 ||| WDT
are  ||| S:32669 E:32681 ||| VBP
generally  ||| S:32681 E:32691 ||| RB
consistent  ||| S:32691 E:32702 ||| JJ
with  ||| S:32702 E:32707 ||| IN
experimental  ||| S:32707 E:32720 ||| JJ
data ||| S:32720 E:32724 ||| NNS
,  ||| S:32724 E:32726 ||| ,
however ||| S:32726 E:32733 ||| RB
,  ||| S:32733 E:32735 ||| ,
this  ||| S:32735 E:32748 ||| DT
assumption  ||| S:32748 E:32759 ||| NN
is  ||| S:32759 E:32762 ||| VBZ
only  ||| S:32762 E:32767 ||| RB
valid  ||| S:32767 E:32773 ||| JJ
for  ||| S:32773 E:32777 ||| IN
a  ||| S:32777 E:32779 ||| DT
system  ||| S:32779 E:32786 ||| NN
that  ||| S:32786 E:32791 ||| WDT
has  ||| S:32791 E:32795 ||| VBZ
evolved  ||| S:32795 E:32811 ||| VBN
toward  ||| S:32811 E:32818 ||| IN
optimality ||| S:32818 E:32828 ||| NN
.  ||| S:32828 E:32830 ||| .
In  ||| S:32830 E:32833 ||| IN
mutant  ||| S:32833 E:32840 ||| JJ
strains ||| S:32840 E:32847 ||| NNS
,  ||| S:32847 E:32849 ||| ,
the  ||| S:32849 E:32853 ||| DT
regulation  ||| S:32853 E:32864 ||| NN
of  ||| S:32864 E:32867 ||| IN
the  ||| S:32867 E:32879 ||| DT
metabolic  ||| S:32879 E:32889 ||| JJ
network  ||| S:32889 E:32897 ||| NN
has  ||| S:32897 E:32901 ||| VBZ
not  ||| S:32901 E:32905 ||| RB
evolved  ||| S:32905 E:32913 ||| VBN
to  ||| S:32913 E:32916 ||| TO
operate  ||| S:32916 E:32924 ||| VB
in  ||| S:32924 E:32927 ||| IN
an  ||| S:32927 E:32930 ||| DT
optimal  ||| S:32930 E:32946 ||| JJ
fashion ||| S:32946 E:32953 ||| NN
.  ||| S:32953 E:32955 ||| .
Therefore ||| S:32955 E:32964 ||| RB
,  ||| S:32964 E:32966 ||| ,
the  ||| S:32966 E:32970 ||| DT
optimal  ||| S:32970 E:32978 ||| JJ
utilization  ||| S:32978 E:32990 ||| NN
of  ||| S:32990 E:32993 ||| IN
the  ||| S:32993 E:32997 ||| DT
mutant  ||| S:32997 E:33012 ||| JJ
metabolic  ||| S:33012 E:33022 ||| JJ
network  ||| S:33022 E:33030 ||| NN
does  ||| S:33030 E:33035 ||| VBZ
not  ||| S:33035 E:33039 ||| RB
necessarily  ||| S:33039 E:33051 ||| RB
correspond  ||| S:33051 E:33062 ||| VB
to  ||| S:33062 E:33065 ||| TO
the  ||| S:33065 E:33078 ||| DT
in  ||| S:33078 E:33081 ||| IN
vivo  ||| S:33081 E:33086 ||| JJ
utilization  ||| S:33086 E:33098 ||| NN
of  ||| S:33098 E:33101 ||| IN
the  ||| S:33101 E:33105 ||| DT
metabolic  ||| S:33105 E:33123 ||| JJ
network ||| S:33123 E:33130 ||| NN
.  ||| S:33130 E:33132 ||| .
Computational  ||| S:33132 E:33146 ||| JJ
analysis  ||| S:33146 E:33155 ||| NN
of  ||| S:33155 E:33158 ||| IN
metabolic  ||| S:33158 E:33168 ||| JJ
processes ||| S:33168 E:33177 ||| NNS
,  ||| S:33177 E:33187 ||| ,
coupled  ||| S:33187 E:33195 ||| VBN
to  ||| S:33195 E:33198 ||| TO
an  ||| S:33198 E:33201 ||| DT
experimental  ||| S:33201 E:33214 ||| JJ
program  ||| S:33214 E:33222 ||| NN
may  ||| S:33222 E:33226 ||| MD
provide  ||| S:33226 E:33234 ||| VB
valuable  ||| S:33234 E:33251 ||| JJ
information  ||| S:33251 E:33263 ||| NN
regarding  ||| S:33263 E:33273 ||| VBG
the  ||| S:33273 E:33277 ||| DT
regulatory  ||| S:33277 E:33288 ||| JJ
structure  ||| S:33288 E:33298 ||| NN
of  ||| S:33298 E:33301 ||| IN
metabolic  ||| S:33301 E:33319 ||| JJ
networks ||| S:33319 E:33327 ||| NNS
,  ||| S:33327 E:33329 ||| ,
and  ||| S:33329 E:33333 ||| CC
will  ||| S:33333 E:33338 ||| MD
provide  ||| S:33338 E:33346 ||| VB
a  ||| S:33346 E:33348 ||| DT
challenge  ||| S:33348 E:33358 ||| NN
for  ||| S:33358 E:33362 ||| IN
future  ||| S:33362 E:33377 ||| JJ
computational  ||| S:33377 E:33391 ||| JJ
studies  ||| S:33391 E:33399 ||| NNS
coupled  ||| S:33399 E:33407 ||| VBN
to  ||| S:33407 E:33410 ||| TO
highly  ||| S:33410 E:33417 ||| RB
parallel  ||| S:33417 E:33434 ||| VB
experimental  ||| S:33434 E:33447 ||| JJ
programs ||| S:33447 E:33455 ||| NNS
,  ||| S:33455 E:33457 ||| ,
such  ||| S:33457 E:33462 ||| JJ
as  ||| S:33462 E:33465 ||| IN
large-scale  ||| S:33465 E:33477 ||| JJ
mutation  ||| S:33477 E:33486 ||| NN
studies  ||| S:33486 E:33502 ||| NNS
[  ||| S:33502 E:33504 ||| -LRB-
41 ||| S:33504 E:33506 ||| CD
] ||| S:33506 E:33507 ||| -RRB-
.  ||| S:33507 E:33517 ||| .
Currently ||| S:33517 E:33526 ||| RB
,  ||| S:33526 E:33528 ||| ,
about  ||| S:33528 E:33534 ||| IN
one-third  ||| S:33534 E:33544 ||| NN
of  ||| S:33544 E:33547 ||| IN
the  ||| S:33547 E:33560 ||| DT
E.  ||| S:33560 E:33563 ||| NNP
coli  ||| S:33563 E:33568 ||| VBD
open  ||| S:33568 E:33573 ||| JJ
reading  ||| S:33573 E:33581 ||| NN
frames  ||| S:33581 E:33588 ||| NNS
do  ||| S:33588 E:33591 ||| VBP
not  ||| S:33591 E:33603 ||| RB
have  ||| S:33603 E:33608 ||| VB
a  ||| S:33608 E:33610 ||| DT
functional  ||| S:33610 E:33621 ||| JJ
assignment ||| S:33621 E:33631 ||| NN
.  ||| S:33631 E:33633 ||| .
Thus ||| S:33633 E:33637 ||| RB
,  ||| S:33637 E:33639 ||| ,
the  ||| S:33639 E:33643 ||| DT
metabolic  ||| S:33643 E:33653 ||| JJ
network  ||| S:33653 E:33669 ||| NN
studied  ||| S:33669 E:33677 ||| VBD
here  ||| S:33677 E:33682 ||| RB
is  ||| S:33682 E:33685 ||| VBZ
incomplete  ||| S:33685 E:33696 ||| JJ
and  ||| S:33696 E:33700 ||| CC
does  ||| S:33700 E:33705 ||| VBZ
not  ||| S:33705 E:33709 ||| RB
account  ||| S:33709 E:33717 ||| VBP
for  ||| S:33717 E:33721 ||| IN
all  ||| S:33721 E:33725 ||| PDT
the  ||| S:33725 E:33737 ||| DT
metabolic  ||| S:33737 E:33747 ||| NN
processes  ||| S:33747 E:33757 ||| VBZ
carried  ||| S:33757 E:33765 ||| VBN
out  ||| S:33765 E:33769 ||| RP
by  ||| S:33769 E:33781 ||| IN
E.  ||| S:33781 E:33784 ||| NNP
coli ||| S:33784 E:33788 ||| NNS
.  ||| S:33788 E:33790 ||| .
However ||| S:33790 E:33797 ||| RB
,  ||| S:33797 E:33799 ||| ,
we  ||| S:33799 E:33802 ||| PRP
have  ||| S:33802 E:33807 ||| VBP
used  ||| S:33807 E:33812 ||| VBN
the  ||| S:33812 E:33824 ||| DT
biochemical  ||| S:33824 E:33836 ||| JJ
literature  ||| S:33836 E:33847 ||| NN
to  ||| S:33847 E:33850 ||| TO
refine  ||| S:33850 E:33857 ||| VB
the  ||| S:33857 E:33870 ||| DT
in  ||| S:33870 E:33873 ||| IN
silico  ||| S:33873 E:33880 ||| JJ
metabolic  ||| S:33880 E:33890 ||| JJ
genotype  ||| S:33890 E:33899 ||| NN
and  ||| S:33899 E:33911 ||| CC
given  ||| S:33911 E:33917 ||| VBN
the  ||| S:33917 E:33921 ||| DT
long  ||| S:33921 E:33926 ||| JJ
history  ||| S:33926 E:33934 ||| NN
of  ||| S:33934 E:33946 ||| IN
E.  ||| S:33946 E:33949 ||| NNP
coli  ||| S:33949 E:33954 ||| VBD
metabolic  ||| S:33954 E:33964 ||| JJ
research  ||| S:33964 E:33973 ||| NN
[  ||| S:33973 E:33975 ||| -LRB-
20 ||| S:33975 E:33977 ||| CD
] ||| S:33977 E:33978 ||| -RRB-
,  ||| S:33978 E:33980 ||| ,
a  ||| S:33980 E:33990 ||| DT
large  ||| S:33990 E:33996 ||| JJ
percentage  ||| S:33996 E:34007 ||| NN
of  ||| S:34007 E:34010 ||| IN
the  ||| S:34010 E:34023 ||| DT
E.  ||| S:34023 E:34026 ||| NNP
coli  ||| S:34026 E:34031 ||| VBD
metabolic  ||| S:34031 E:34041 ||| JJ
capabilities  ||| S:34041 E:34054 ||| NNS
have  ||| S:34054 E:34067 ||| VBP
likely  ||| S:34067 E:34074 ||| RB
been  ||| S:34074 E:34079 ||| VBN
identified ||| S:34079 E:34089 ||| VBN
.  ||| S:34089 E:34091 ||| .
However ||| S:34091 E:34098 ||| RB
,  ||| S:34098 E:34100 ||| ,
when  ||| S:34100 E:34105 ||| WRB
additional  ||| S:34105 E:34116 ||| JJ
metabolic  ||| S:34116 E:34134 ||| JJ
capabilities  ||| S:34134 E:34147 ||| NNS
are  ||| S:34147 E:34151 ||| VBP
discovered  ||| S:34151 E:34162 ||| VBN
[  ||| S:34162 E:34164 ||| -LRB-
42 ||| S:34164 E:34166 ||| CD
] ||| S:34166 E:34167 ||| -RRB-
,  ||| S:34167 E:34169 ||| ,
the  ||| S:34169 E:34182 ||| DT
E.  ||| S:34182 E:34185 ||| NNP
coli  ||| S:34185 E:34190 ||| FW
stoichiometric  ||| S:34190 E:34205 ||| FW
matrix  ||| S:34205 E:34212 ||| FW
can  ||| S:34212 E:34216 ||| MD
be  ||| S:34216 E:34227 ||| VB
updated ||| S:34227 E:34234 ||| VBN
,  ||| S:34234 E:34236 ||| ,
leading  ||| S:34236 E:34244 ||| VBG
to  ||| S:34244 E:34247 ||| TO
an  ||| S:34247 E:34250 ||| DT
iterative  ||| S:34250 E:34260 ||| JJ
model  ||| S:34260 E:34266 ||| NN
building  ||| S:34266 E:34275 ||| NN
process ||| S:34275 E:34282 ||| NN
.  ||| S:34282 E:34292 ||| .
Furthermore ||| S:34292 E:34303 ||| RB
,  ||| S:34303 E:34305 ||| ,
inconsistencies  ||| S:34305 E:34321 ||| NNS
between  ||| S:34321 E:34329 ||| IN
the  ||| S:34329 E:34333 ||| DT
model  ||| S:34333 E:34339 ||| NN
and  ||| S:34339 E:34351 ||| CC
experimental  ||| S:34351 E:34364 ||| JJ
data  ||| S:34364 E:34369 ||| NNS
may  ||| S:34369 E:34373 ||| MD
help  ||| S:34373 E:34378 ||| VB
point  ||| S:34378 E:34384 ||| NN
to  ||| S:34384 E:34387 ||| TO
unidentified  ||| S:34387 E:34400 ||| JJ
metabolic  ||| S:34400 E:34418 ||| JJ
functions ||| S:34418 E:34427 ||| NNS
.  ||| S:34427 E:34429 ||| .
Additionally ||| S:34429 E:34441 ||| RB
,  ||| S:34441 E:34443 ||| ,
the  ||| S:34443 E:34456 ||| DT
in  ||| S:34456 E:34459 ||| IN
silico  ||| S:34459 E:34466 ||| JJ
analysis  ||| S:34466 E:34475 ||| NN
can  ||| S:34475 E:34479 ||| MD
help  ||| S:34479 E:34484 ||| VB
identify  ||| S:34484 E:34501 ||| VB
missing  ||| S:34501 E:34509 ||| VBG
or  ||| S:34509 E:34512 ||| CC
incorrect  ||| S:34512 E:34522 ||| JJ
functional  ||| S:34522 E:34533 ||| JJ
assignments ||| S:34533 E:34544 ||| NN
;  ||| S:34544 E:34546 ||| :
for  ||| S:34546 E:34550 ||| IN
example ||| S:34550 E:34557 ||| NN
,  ||| S:34557 E:34567 ||| ,
by  ||| S:34567 E:34570 ||| IN
identifying  ||| S:34570 E:34582 ||| VBG
sets  ||| S:34582 E:34587 ||| NNS
of  ||| S:34587 E:34590 ||| IN
metabolic  ||| S:34590 E:34600 ||| JJ
reactions  ||| S:34600 E:34610 ||| NNS
that  ||| S:34610 E:34615 ||| WDT
are  ||| S:34615 E:34619 ||| VBP
not  ||| S:34619 E:34631 ||| RB
connected  ||| S:34631 E:34641 ||| VBN
to  ||| S:34641 E:34644 ||| TO
the  ||| S:34644 E:34648 ||| DT
metabolic  ||| S:34648 E:34658 ||| JJ
network  ||| S:34658 E:34666 ||| NN
by  ||| S:34666 E:34669 ||| IN
the  ||| S:34669 E:34673 ||| DT
mass  ||| S:34673 E:34678 ||| JJ
balance  ||| S:34678 E:34694 ||| NN
constraints ||| S:34694 E:34705 ||| NNS
.  ||| S:34705 E:34715 ||| .
The  ||| S:34715 E:34719 ||| DT
study  ||| S:34719 E:34725 ||| NN
presented  ||| S:34725 E:34735 ||| VBN
herein  ||| S:34735 E:34742 ||| NN
is  ||| S:34742 E:34745 ||| VBZ
an  ||| S:34745 E:34748 ||| DT
example  ||| S:34748 E:34756 ||| NN
of  ||| S:34756 E:34759 ||| IN
the  ||| S:34759 E:34763 ||| DT
rapidly  ||| S:34763 E:34779 ||| RB
growing  ||| S:34779 E:34787 ||| VBG
field  ||| S:34787 E:34793 ||| NN
of  ||| S:34793 E:34805 ||| IN
in  ||| S:34805 E:34808 ||| IN
silico  ||| S:34808 E:34815 ||| JJ
biology ||| S:34815 E:34822 ||| NN
.  ||| S:34822 E:34824 ||| .
It  ||| S:34824 E:34827 ||| PRP
is  ||| S:34827 E:34830 ||| VBZ
clear  ||| S:34830 E:34836 ||| JJ
that  ||| S:34836 E:34849 ||| IN
computer  ||| S:34849 E:34858 ||| NN
modeling  ||| S:34858 E:34867 ||| NN
and  ||| S:34867 E:34871 ||| CC
simulations  ||| S:34871 E:34883 ||| NNS
must  ||| S:34883 E:34888 ||| MD
be  ||| S:34888 E:34891 ||| VB
used  ||| S:34891 E:34896 ||| VBN
iteratively  ||| S:34896 E:34916 ||| VBN
with  ||| S:34916 E:34921 ||| IN
an  ||| S:34921 E:34924 ||| DT
experimental  ||| S:34924 E:34937 ||| JJ
program  ||| S:34937 E:34945 ||| NN
to  ||| S:34945 E:34948 ||| TO
continually  ||| S:34948 E:34960 ||| RB
improve  ||| S:34960 E:34977 ||| VB
in  ||| S:34977 E:34980 ||| IN
silico  ||| S:34980 E:34987 ||| JJ
models  ||| S:34987 E:34994 ||| NNS
and  ||| S:34994 E:34998 ||| CC
to  ||| S:34998 E:35001 ||| TO
develop  ||| S:35001 E:35017 ||| VB
systemic  ||| S:35017 E:35026 ||| JJ
understanding  ||| S:35026 E:35040 ||| NN
of  ||| S:35040 E:35043 ||| IN
cellular  ||| S:35043 E:35052 ||| JJ
functions ||| S:35052 E:35061 ||| NNS
.  ||| S:35061 E:35063 ||| .
Thus ||| S:35063 E:35067 ||| RB
,  ||| S:35067 E:35069 ||| ,
an  ||| S:35069 E:35081 ||| DT
in  ||| S:35081 E:35084 ||| IN
silico  ||| S:35084 E:35091 ||| JJ
analysis  ||| S:35091 E:35100 ||| NN
can  ||| S:35100 E:35104 ||| MD
be  ||| S:35104 E:35107 ||| VB
used  ||| S:35107 E:35112 ||| VBN
to  ||| S:35112 E:35123 ||| TO
define  ||| S:35123 E:35130 ||| VB
an  ||| S:35130 E:35133 ||| DT
experimental  ||| S:35133 E:35146 ||| JJ
program ||| S:35146 E:35153 ||| NN
.  ||| S:35153 E:35155 ||| .
For  ||| S:35155 E:35159 ||| IN
example ||| S:35159 E:35166 ||| NN
,  ||| S:35166 E:35168 ||| ,
the  ||| S:35168 E:35172 ||| DT
ability  ||| S:35172 E:35180 ||| NN
to  ||| S:35180 E:35191 ||| TO
construct  ||| S:35191 E:35201 ||| VB
well-defined  ||| S:35201 E:35214 ||| JJ
knockout  ||| S:35214 E:35223 ||| NN
strains  ||| S:35223 E:35231 ||| NNS
of  ||| S:35231 E:35243 ||| IN
E.  ||| S:35243 E:35246 ||| NNP
coli  ||| S:35246 E:35251 ||| NNS
[  ||| S:35251 E:35253 ||| -LRB-
43 ||| S:35253 E:35255 ||| CD
]  ||| S:35255 E:35257 ||| -RRB-
opens  ||| S:35257 E:35263 ||| VBZ
the  ||| S:35263 E:35267 ||| DT
possibility  ||| S:35267 E:35287 ||| NN
to  ||| S:35287 E:35290 ||| TO
critically  ||| S:35290 E:35301 ||| RB
evaluate  ||| S:35301 E:35310 ||| VB
the  ||| S:35310 E:35314 ||| DT
relation  ||| S:35314 E:35323 ||| NN
between  ||| S:35323 E:35331 ||| IN
the  ||| S:35331 E:35344 ||| DT
in  ||| S:35344 E:35347 ||| IN
silico  ||| S:35347 E:35354 ||| JJ
representation  ||| S:35354 E:35369 ||| NN
of  ||| S:35369 E:35372 ||| IN
mutant  ||| S:35372 E:35387 ||| JJ
behavior  ||| S:35387 E:35396 ||| NN
and  ||| S:35396 E:35400 ||| CC
the  ||| S:35400 E:35413 ||| DT
in  ||| S:35413 E:35416 ||| IN
vivo  ||| S:35416 E:35421 ||| JJ
metabolic  ||| S:35421 E:35431 ||| JJ
network  ||| S:35431 E:35439 ||| NN
under  ||| S:35439 E:35453 ||| IN
well-defined  ||| S:35453 E:35466 ||| JJ
genetic  ||| S:35466 E:35474 ||| JJ
and  ||| S:35474 E:35478 ||| CC
environmental  ||| S:35478 E:35492 ||| JJ
conditions  ||| S:35492 E:35503 ||| NNS
for  ||| S:35503 E:35515 ||| IN
strategically  ||| S:35515 E:35529 ||| RB
chosen  ||| S:35529 E:35536 ||| VBN
genes ||| S:35536 E:35541 ||| NNS
.  ||| S:35541 E:35543 ||| .
This  ||| S:35543 E:35548 ||| DT
possibility  ||| S:35548 E:35560 ||| NN
is  ||| S:35560 E:35571 ||| VBZ
particularly  ||| S:35571 E:35584 ||| RB
timely ||| S:35584 E:35590 ||| JJ
,  ||| S:35590 E:35592 ||| ,
given  ||| S:35592 E:35598 ||| VBN
the  ||| S:35598 E:35602 ||| DT
increasing  ||| S:35602 E:35613 ||| JJ
number  ||| S:35613 E:35620 ||| NN
of  ||| S:35620 E:35623 ||| IN
genome  ||| S:35623 E:35638 ||| JJ
scale  ||| S:35638 E:35644 ||| NN
measurements  ||| S:35644 E:35657 ||| NNS
that  ||| S:35657 E:35662 ||| WDT
are  ||| S:35662 E:35666 ||| VBP
now  ||| S:35666 E:35670 ||| RB
possible ||| S:35670 E:35678 ||| JJ
,  ||| S:35678 E:35680 ||| ,
through  ||| S:35680 E:35688 ||| IN
2D  ||| S:35688 E:35691 ||| CD
gels  ||| S:35691 E:35696 ||| NNS
[  ||| S:35696 E:35706 ||| -LRB-
44 ||| S:35706 E:35708 ||| CD
,  ||| S:35708 E:35710 ||| ,
45 ||| S:35710 E:35712 ||| CD
]  ||| S:35712 E:35714 ||| -RRB-
and  ||| S:35714 E:35718 ||| CC
DNA  ||| S:35718 E:35722 ||| NNP
array  ||| S:35722 E:35728 ||| NN
technology  ||| S:35728 E:35739 ||| NN
[  ||| S:35739 E:35741 ||| -LRB-
46 ||| S:35741 E:35743 ||| CD
,  ||| S:35743 E:35745 ||| ,
47 ||| S:35745 E:35747 ||| CD
] ||| S:35747 E:35748 ||| -RRB-
.  ||| S:35748 E:35772 ||| .
Conclusions  ||| S:35772 E:35792 ||| NNP
Herein ||| S:35792 E:35798 ||| NNP
,  ||| S:35798 E:35800 ||| ,
we  ||| S:35800 E:35803 ||| PRP
have  ||| S:35803 E:35808 ||| VBP
utilized  ||| S:35808 E:35817 ||| VBG
an  ||| S:35817 E:35829 ||| DT
in  ||| S:35829 E:35832 ||| IN
silico  ||| S:35832 E:35839 ||| JJ
representation  ||| S:35839 E:35854 ||| NN
of  ||| S:35854 E:35866 ||| IN
E.  ||| S:35866 E:35869 ||| NNP
coli  ||| S:35869 E:35874 ||| VBD
to  ||| S:35874 E:35877 ||| TO
study  ||| S:35877 E:35883 ||| VB
the  ||| S:35883 E:35887 ||| DT
condition  ||| S:35887 E:35905 ||| NN
dependent  ||| S:35905 E:35915 ||| JJ
phenotype  ||| S:35915 E:35925 ||| NN
of  ||| S:35925 E:35937 ||| IN
E.  ||| S:35937 E:35940 ||| NNP
coli  ||| S:35940 E:35945 ||| NNS
and  ||| S:35945 E:35949 ||| CC
central  ||| S:35949 E:35957 ||| JJ
metabolism  ||| S:35957 E:35968 ||| JJ
gene  ||| S:35968 E:35981 ||| NN
deletion  ||| S:35981 E:35990 ||| NN
strains ||| S:35990 E:35997 ||| NNS
.  ||| S:35997 E:35999 ||| .
We  ||| S:35999 E:36002 ||| PRP
have  ||| S:36002 E:36007 ||| VBP
shown  ||| S:36007 E:36013 ||| VBN
that  ||| S:36013 E:36018 ||| IN
a  ||| S:36018 E:36020 ||| DT
computational  ||| S:36020 E:36042 ||| JJ
analysis  ||| S:36042 E:36051 ||| NN
of  ||| S:36051 E:36054 ||| IN
the  ||| S:36054 E:36058 ||| DT
metabolic  ||| S:36058 E:36068 ||| JJ
behavior  ||| S:36068 E:36077 ||| NN
can  ||| S:36077 E:36081 ||| MD
provide  ||| S:36081 E:36089 ||| VB
valuable  ||| S:36089 E:36106 ||| JJ
insight  ||| S:36106 E:36114 ||| NN
into  ||| S:36114 E:36119 ||| IN
cellular  ||| S:36119 E:36128 ||| JJ
metabolism ||| S:36128 E:36138 ||| NN
.  ||| S:36138 E:36140 ||| .
The  ||| S:36140 E:36144 ||| DT
present  ||| S:36144 E:36161 ||| JJ
in  ||| S:36161 E:36164 ||| IN
silico  ||| S:36164 E:36171 ||| JJ
study  ||| S:36171 E:36177 ||| NN
builds  ||| S:36177 E:36184 ||| VBZ
on  ||| S:36184 E:36187 ||| IN
the  ||| S:36187 E:36191 ||| DT
ability  ||| S:36191 E:36207 ||| NN
to  ||| S:36207 E:36210 ||| TO
define  ||| S:36210 E:36217 ||| VB
metabolic  ||| S:36217 E:36227 ||| JJ
genotypes  ||| S:36227 E:36237 ||| NN
in  ||| S:36237 E:36240 ||| IN
bacteria  ||| S:36240 E:36249 ||| NNS
and  ||| S:36249 E:36253 ||| CC
mathematical  ||| S:36253 E:36274 ||| JJ
methods  ||| S:36274 E:36282 ||| NNS
to  ||| S:36282 E:36285 ||| TO
analyze  ||| S:36285 E:36293 ||| VB
the  ||| S:36293 E:36297 ||| DT
possible  ||| S:36297 E:36306 ||| JJ
and  ||| S:36306 E:36310 ||| CC
optimal  ||| S:36310 E:36318 ||| JJ
phenotypes  ||| S:36318 E:36329 ||| NN
that  ||| S:36329 E:36342 ||| IN
they  ||| S:36342 E:36347 ||| PRP
can  ||| S:36347 E:36351 ||| MD
express ||| S:36351 E:36358 ||| VB
.  ||| S:36358 E:36360 ||| .
These  ||| S:36360 E:36366 ||| DT
capabilities  ||| S:36366 E:36379 ||| NNS
open  ||| S:36379 E:36384 ||| VBP
the  ||| S:36384 E:36388 ||| DT
possibility  ||| S:36388 E:36408 ||| NN
to  ||| S:36408 E:36411 ||| TO
perform  ||| S:36411 E:36428 ||| VB
in  ||| S:36428 E:36431 ||| IN
silico  ||| S:36431 E:36438 ||| JJ
deletion  ||| S:36438 E:36447 ||| NN
studies  ||| S:36447 E:36455 ||| NNS
to  ||| S:36455 E:36458 ||| TO
help  ||| S:36458 E:36471 ||| VB
sort  ||| S:36471 E:36476 ||| NN
out  ||| S:36476 E:36480 ||| IN
the  ||| S:36480 E:36484 ||| DT
complexities  ||| S:36484 E:36497 ||| NN
of  ||| S:36497 E:36509 ||| IN
E.  ||| S:36509 E:36512 ||| NNP
coli  ||| S:36512 E:36517 ||| FW
mutant  ||| S:36517 E:36524 ||| FW
phenotypes ||| S:36524 E:36534 ||| FW
.  ||| S:36534 E:36551 ||| .
